0 [14C]AP306在中国健康受试者中的物质平衡研究
1 Table, Listing and Figure Shells
```json
{
    "临床试验方案编号（版本）：": {
        "0": "作者：",
        "1": "申办单位：",
        "2": "临床试验单位：",
        "3": "合同研究组织：",
        "4": "生物样本分析单位：",
        "5": "数据管理及统计单位：",
        "6": "TFL Shells版本号:",
        "7": "TFL Shells版本日期：",
        "8": ""
    },
    "AP306-ADME-01（1.0）": {
        "0": "刘欣，生物统计师，辽宁亦度医药数据科技有限公司",
        "1": "上海礼邦医药科技有限公司",
        "2": "苏州大学附属第一医院",
        "3": "北京亦度正康健康科技有限公司",
        "4": "江苏万略医药科技有限公司",
        "5": "辽宁亦度医药数据科技有限公司",
        "6": "0.1",
        "7": "2025-07-11",
        "8": ""
    }
}
```
11 修改记录
```json
{
    "版本号": {
        "0": "0.1"
    },
    "版本日期": {
        "0": "2025-07-11"
    },
    "作者": {
        "0": "刘欣"
    },
    "备注": {
        "0": "首版草稿"
    }
}
```
15 目录
16 修改记录	2
17 目录	3
18 1.	一般编程规范说明	11
19 1.1	输出编号、题目和脚注的表述	11
20 1.2	列表显示格式	11
21 1.3	表显示格式	12
22 2.	临床试验分析输出	14
23 图10.1 受试者分布流程图	14
24 14 参考但不纳入文本的表格、图示和图表^^TABLES, LISTINGS, AND FIGURES REFERRED TO BUT NOT INCORPORATED IN THE TEXT	15
25 14.1 人口统计学数据^^Demographic Data	15
26 表 14.1-1.1 受试者分布^^Summary of Subject Disposition 筛选集^^Screening Set	15
27 表 14.1-1.2 分析集汇总^^Summary of Analysis Sets 所有入组受试者^^All Enrolled Subjects	16
28 表 14.1-2.1 受试者人口学资料^^Summary of Subject Demographic Characteristics 安全性分析集^^Safety set	17
29 表 14.1-2.2 病史^^Summary of Medical History 安全性分析集^^Safety set	18
30 表 14.1-2.3 手术史^^Summary of Operation history 安全性分析集^^Safety set	19
31 表 14.1-2.4 过敏史^^Summary of Allery 安全性分析集^^Safety set	20
32 表 14.1-2.5 一般情况问询^^Summary of General Information Inquiries 安全性分析集^^Safety set	20
33 表 14.1-2.6 既往用药^^Summary of Previous Medications 安全性分析集^^Safety set	22
34 表 14.1-3.1 酒精呼气测试基线汇总^^Summary of Baseline Results in Alcohol Breath Test 安全性分析集^^Safety set	23
35 表 14.1-3.2 尿药筛查基线汇总^^Summary of Baseline Results in Urine Drug Test 安全性分析集^^Safety set	24
36 表 14.1-3.3 病毒学筛查基线汇总^^Summary of Baseline Results in Virological Screening 安全性分析集^^Safety set	25
37 表 14.1-3.4 病毒学筛查基线临床意义判定^^Summary of Baseline Clinical Significance Results in Virological Screening 安全性分析集^^Safety set	26
38 表 14.1-3.5 腹部B超检查基线结果判定^^Summary of Baseline Results in Abdominal B ultrasound 安全性分析集^^Safety set	26
39 表 14.1-3.6 胸部X光片检查基线结果判定^^Summary of Baseline Results in Chest X-ray 安全性分析集^^Safety set	27
40 表 14.1-3.7 甲状腺功能检查基线汇总^^Summary of Baseline Results in Thyroid Function 安全性分析集^^Safety set	28
41 表 14.1-3.8 甲状腺功能基线临床意义判定^^Summary of Baseline Clinical significance Results in Thyroid Function 安全性分析集^^Safety set	29
42 表 14.1-3.9 肛门指检基线临床意义判定^^Summary of Baseline Clinical significance Results in Digital Rectal Examination 安全性分析集^^Safety set	29
43 14.3 安全性数据^^Safety Data	30
44 表 14.3-1.1 合并用药^^Concomitant Medications 安全性分析集^^Safety Set	30
45 表 14.3-1.2 非药物治疗^^Concomitant Procedure/Surgery 安全性分析集^^Safety Set	31
46 表 14.3-2.1 血常规检查^^Hematology Test 安全性分析集^^Safety Set	32
47 表 14.3-2.2 血常规检查临床意义判定变化^^Shift Summary of Clinically Significant Results in Hematology Test 安全性分析集^^Safety Set	33
48 表 14.3-3.1 血生化检查^^Blood Chemistry 安全性分析集^^Safety Set	34
49 表 14.3-3.2 血生化检查临床意义判定变化^^Shift Summary of Clinically Significant Results in Blood Chemistry Test 安全性分析集^^Safety Set	34
50 表 14.3-4.1 尿常规检查临床意义判定变化^^Shift Summary of Clinically Significant Results in Urinalysis Test 安全性分析集^^Safety Set	35
51 表 14.3-5.1 凝血功能检查^^Coagulation Test 安全性分析集^^Safety Set	35
52 表 14.3-5.2 凝血功能检查临床意义判定变化^^Shift Summary of Clinically Significant Results in Coagulation Function Test 安全性分析集^^Safety Set	36
53 表 14.3-6.1 便常规+隐血检查临床意义判定变化^^Shift Summary of Clinically Significant Results in Stool Routine and Occult Blood Test 安全性分析集^^Safety Set	36
54 表 14.3-7.1 12导联心电图检查^^12-Lead ECG 安全性分析集^^Safety Set	37
55 表 14.3-7.2 12导联心电图检查临床意义判定变化^^Shift Summary of Clinically Significant Results in 12-Lead ECG 安全性分析集^^Safety Set	38
56 表 14.3-8.1 生命体征^^Vital Signs 安全性分析集^^Safety Set	40
57 表 14.3-8.2 生命体征临床意义判定变化^^Shift Summary of Clinically Significant Results in Vital Signs 安全性分析集^^Safety Set	41
58 表 14.3-9.1 体格检查临床意义判定变化^^Shift Summary of Clinically Significant Results in Physical Examination 安全性分析集^^Safety Set	42
59 14.3.1 不良事件列表^^Table of Adverse Events	43
60 表 14.3.1-1.1 不良事件汇总^^Summary of AEs 安全性分析集^^Safety Set	43
61 表 14.3.1-1.2 AE按系统器官、术语和严重程度汇总^^Summary of AE by System Organ Class, Preferred Term and CTCAE Severity Grade 安全性分析集^^Safety Set	44
62 表 14.3.1-1.3 TEAE按系统器官、术语和严重程度汇总^^Summary of TEAE by System Organ Class, Preferred Term and CTCAE Severity Grade 安全性分析集^^Safety Set	46
63 表 14.3.1-1.4 与试验用药品相关的TEAE按系统器官、术语和严重程度汇总^^Summary of TEAEs of End of Study by System Organ Class, Preferred Term and CTCAE Severity Grade 安全性分析集	46
64 表 14.3.1-1.5 SAE按系统器官、术语和严重程度汇总^^Summary of SAE by System Organ Class, Preferred Term and CTCAE Severity Grade 安全性分析集^^Safety Set	47
65 表 14.3.1-1.6 TESAE按系统器官、术语和严重程度汇总^^Summary of TESAE by System Organ Class, Preferred Term and CTCAE Severity Grade 安全性分析集^^Safety Set	48
66 表 14.3.1-1.7 与研究药物相关的TESAE按系统器官、术语和严重程度汇总^^Summary of Treatment-related TESAEs of End of Study by System Organ Class, Preferred Term and CTCAE Severity Grade 安全性分析集^^Safety Set	49
67 表 14.3.1-1.8 导致退出实验的TEAE按系统器官、术语和严重程度汇总^^Summary of TEAEs leading to subject withdrawal from the study by System Organ Class, Preferred Term and CTCAE Severity Grade 安全性分析集^^Safety Set	49
68 表 14.3.1-1.9 导致死亡的AE按系统器官、术语和严重程度汇总^^Summary of deaths related to AEs by System Organ Class, Preferred Term and CTCAE Severity Grade 安全性分析集^^Safety Set	50
69 14.4 药代动力学分析和排泄分析^^Pharmacokinetic Analysis and Excretion Analysis	51
70 14.4.1 血药浓度分析^^Drug Concentration Analysis	51
71 表 14.4.1-1.1 血浆实际采集时间（h）^^Actual Plasma Collection Times (h) PK浓度集^^PK Concentration Set	51
72 表 14.4.1-2.1 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆总放射性度（ng Eq./mL）^^The Total Radioactivity (ng Eq./mL) in Plasma following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi PK浓度集^^PK Concentration Set	52
73 表 14.4.1-2.2 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血总放射性换算的质量浓度（ng Eq./mL）^^The Total Radioactivity (ng Eq./mL) in Whole Blood following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi PK浓度集^^PK Concentration Set	54
74 表 14.4.1-2.3 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆中原形药AP306的浓度（ng/mL）^^The Concentration of Unchanged AP306 (ng/mL) in Plasma following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi PK浓度集^^PK Concentration Set	56
75 表 14.4.1-3.1 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血与血浆总放射性的比值^^Whole Blood-to-plasma Ratios of the Total Radioactivity following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi PK浓度集^^PK Concentration Set	57
76 图 14.4.1-1.1 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血和血浆总放射性（ng Eq./mL）、血浆中原形药AP306（ng/mL）的平均血药浓度和时间曲线图（算术均值±标准差）^^Total Radioactivity (ng Eq./mL) in Whole Blood and Plasma, Unchanged AP306 (ng/mL) in Plasma versus Time Linear Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi (Mean±SD) PK浓度集^^PK Concentration Set	59
77 图 14.4.1-1.2 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血和血浆总放射性（ng Eq./mL）、血浆中原形药AP306的平均血药浓度和时间半对数曲线图（算术均值±标准差）^^Total Radioactivity (ng Eq./mL) in Whole Blood and Plasma, Unchanged AP306 in Plasma versus Time Semi-logarithmic Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi (Mean±SD) PK浓度集^^PK Concentration Set	62
78 图 14.4.1-1.3 6例受试者单次口服约150mg/200µCi的[14C]AP306后0-24h内全血和血浆总放射性（ng Eq./mL）、血浆中原形药AP306（ng/mL）的平均血药浓度和时间曲线图（算术均值±标准差）^^Total Radioactivity (ng Eq./mL) in Whole Blood and Plasma, Unchanged AP306 (ng/mL) in Plasma versus Time Linear Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi within 24h postdose (Mean±SD) PK浓度集^^PK Concentration Set	65
79 图 14.4.1-1.4 6例受试者单次口服约150mg/200µCi的[14C]AP306后0-24h内全血和血浆总放射性（ng Eq./mL）、血浆中原形药AP306（ng/mL）的平均血药浓度和时间半对数曲线图（算术均值±标准差）^^Total Radioactivity (ng Eq./mL) in Whole Blood and Plasma, Unchanged AP306 (ng/mL) in Plasma versus Time Semi-logarithmic Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi within 24h postdose (Mean±SD) PK浓度集^^PK Concentration Set	68
80 图 14.4.1-2.1 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血总放射性（ng Eq./mL）与时间的个体曲线线性坐标图^^Individual Total Radioactivity (ng Eq./mL) in Whole Blood versus Time Linear Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi PK浓度集^^PK Concentration Set	70
81 图 14.4.1-2.2 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血总放射性（ng Eq./mL）与时间的个体曲线半对数坐标图^^Individual Total Radioactivity(ng Eq./mL) in Whole Blood versus Time Semi-logarithmic Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi PK浓度集^^PK Concentration Set	72
82 图 14.4.1-3.1 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆总放射性（ng Eq./mL）与时间的个体曲线线性坐标图^^Individual Total Radioactivity(ng Eq./mL) in Plasma versus Time Linear Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi PK浓度集^^PK Concentration Set	74
83 图 14.4.1-3.2 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆总放射性（ng Eq./mL）与时间的个体曲线半对数坐标图^^Individual Total Radioactivity(ng Eq./mL) in Plasma versus Time Semi-logarithmic Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi PK浓度集^^PK Concentration Set	75
84 图 14.4.1-4.1 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆中原形药AP306（ng/mL）与时间的个体曲线线性坐标图^^Individual Unchanged AP306 (ng/mL) in Plasma versus Time Linear Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi PK浓度集^^PK Concentration Set	75
85 图 14.4.1-4.2 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆中原形药AP306（ng/mL）与时间的个体曲线半对数坐标图^^Individual Unchanged AP306 (ng/mL) in Plasma versus Time Semi-logarithmic Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi PK浓度集^^PK Concentration Set	76
86 14.4.2 药代动力学参数分析^^Analysis of the Pharmacokinetic Parameters	77
87 表 14.4.2-1.1 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆总放射性的主要药代动力学参数^^Pharmacokinetic Parameters of the Total Radioactivity in Plasma following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi PK参数集^^PK Parameter Set	77
88 表 14.4.2-2.1 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆中原形药AP306的主要药代动力学参数^^Pharmacokinetic Parameters of Unchanged AP306 in Plasma following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi PK参数集^^PK Parameter Set	79
89 14.4.3 放射性排泄统计分析^^Statistical Analysis of the Radioactivity Excretion	80
90 表 14.4.3-1.1 6例受试者单次口服约150mg/200µCi的[14C]AP306后尿液和粪便中总放射性回收率（% 给药量）^^Percentages of the Administrated Dose Recovered in Urine and Feces following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi (% Dose) 物质平衡分析集^^Mass Balance Set	80
91 表 14.4.3-1.2 6例受试者单次口服约150mg/200µCi的[14C]AP306后尿液和粪便各采集时间段的放射性回收率（% 给药量）^^Incremental Recovery of the Total Radioactivity in Urine and Feces following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi (% Dose) 物质平衡分析集^^Mass Balance Set	81
92 表 14.4.3-1.3 6例受试者单次口服约150mg/200µCi的[14C]AP306后尿液和粪便的累计放射性回收率（% 给药量）^^Cumulative Recovery of the Total Radioactivity in Urine and Feces following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi (% Dose) 物质平衡分析集^^Mass Balance Set	83
93 表 14.4.3-1.4 6例受试者单次口服约150mg/200µCi的[14C]AP306后尿液和粪便的平均累计放射性回收率（% 给药量）^^Mean Cumulative Recovery of the Total Radioactivity in Urine and Feces following a Single Oral Dose of [14C]AP306in 6 Subjects at 150 mg/200 µCi (% Dose) 物质平衡分析集^^Mass Balance Set	85
94 图 14.4.3-1.1 6例受试者单次口服约150mg/200µCi的[14C]AP306后平均累计放射性回收率曲线（算术均值±标准差）^^Mean Cumulative Recovery of Total Radioactivity following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi (Mean±SD) 物质平衡分析集^^Mass Balance Set	87
95 图 14.4.3-1.2 6例受试者单次口服约150mg/200µCi的[14C]AP306后在尿液中累计放射性回收率的个体曲线^^Individual Cumulative Recovery of Total Radioactivity in Urine following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi 物质平衡分析集^^Mass Balance Set	90
96 图 14.4.3-1.3 6例受试者单次口服约150mg/200µCi的[14C]AP306后在粪便中累计放射性回收率的个体曲线^^Individual Cumulative Recovery of Total Radioactivity in Feces following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi 物质平衡分析集^^Mass Balance Set	92
97 图 14.4.3-1.4 6例受试者单次口服约150mg/200µCi的[14C]AP306后在尿液和粪便中累计放射性回收率的个体曲线^^Individual Cumulative Recovery of Total Radioactivity in Urine and Feces following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi 物质平衡分析集^^Mass Balance Set	92
98 16 附录^^APPENDICES	93
99 16.2 受试者数据列表^^Subject Data List	93
100 16.2.1 研究受试者^^Study Subject	93
101 列表 16.2.1-1.1 受试者分布^^Subject Disposition 筛选集^^Screening Set	93
102 列表 16.2.1-1.2 受试者所属分析集^^Subject in the Analysis Set 所有入组受试者^^All Enrolled Subjects	94
103 16.2.2 方案偏离^^Protocol Deviation	95
104 列表 16.2.2-1.1 受试者方案偏离汇总^^Summary of Subject Protocol Deviations 安全性分析集^^Safety set	95
105 16.2.4 人口统计学和其他基线特征^^Demographic and Other Baseline Characteristics	95
106 列表 16.2.4-1.1 受试者人口学资料^^Subject Demographic Data 安全性分析集^^Safety set	95
107 列表 16.2.4-1.2 酒精呼气测试^^Alcohol Breath Test 安全性分析集^^Safety set	96
108 列表 16.2.4-1.3 尿药筛查^^Urine Drug Test 安全性分析集^^Safety set	97
109 列表 16.2.4-1.4 病毒学筛查^^Virological screening 安全性分析集^^Safety set	98
110 列表 16.2.4-1.5 腹部B超^^Abdominal B ultrasound 安全性分析集^^Safety set	99
111 列表 16.2.4-1.6 胸部X光片^^Chest X-ray  安全性分析集^^Safety set	100
112 列表 16.2.4-1.7 甲状腺功能检查^^Thyroid Function Examination 安全性分析集^^Safety set	101
113 列表 16.2.4-1.8 肛门指检^^Digital Rectal Examination 安全性分析集^^Safety set	102
114 列表 16.2.4-2.1 病史^^Medical History 安全性分析集^^Safety set	102
115 列表 16.2.4-2.2 手术史^^Operation history 安全性分析集^^Safety set	103
116 列表 16.2.4-2.3 过敏史^^Allergy History 安全性分析集^^Safety set	104
117 列表 16.2.4-2.4 一般情况问询^^General Information Inquiries 安全性分析集^^Safety set	105
118 列表 16.2.4-2.5 既往用药^^Previous Medications 安全性分析集^^Safety set	106
119 16.2.5 依从性^^Compliance	107
120 列表 16.2.5-1.1 服药记录^^Study Medication Administration 安全性分析集^^Safety Set	107
121 列表 16.2.5-1.2 禁食/禁水情况记录^^Food Fasting/Water Fasting 安全性分析集^^Safety Set	108
122 列表 16.2.5-1.3 合并用药^^Concomitant Medications 安全性分析集^^Safety Set	108
123 列表 16.2.5-1.4 非药物治疗^^Concomitant Procedure/ Surgery 安全性分析集^^Safety Set	109
124 16.2.7 不良事件列表^^Listing of Adverse Events	111
125 列表 16.2.7-1.1 不良事件^^Adverse Events 安全性分析集^^Safety Set	111
126 16.2.8 实验室检查列表^^Listing of Clinical Laboratory Tests	114
127 列表 16.2.8-1.1 血常规检查^^Hematology Test 安全性分析集^^Safety Set	114
128 列表 16.2.8-1.2 尿常规检查^^Urinalysis Test 安全性分析集^^Safety Set	115
129 列表 16.2.8-1.3 血生化检查^^Blood ChemistryTest 安全性分析集^^Safety Set	115
130 列表 16.2.8-1.4 凝血功能检查^^Coagulation Test 安全性分析集^^Safety Set	116
131 列表 16.2.8-1.5 便常规+隐血检查^^Stool Routine and Occult Blood Test 安全性分析集^^Safety Set	116
132 列表 16.2.8-1.6 实验室检查指标临床意义变化^^Change of Clinical Significance of Laboratory Tests 安全性分析集^^Safety Set	117
133 列表 16.2.8-2.1 12导联心电图^^12-Lead ECG 安全性分析集^^Safety Set	118
134 列表 16.2.8-2.2 12导联心电图临床意义变化^^Change of Clinical Significance of 12-Lead ECG 安全性分析集^^Safety Set	120
135 列表 16.2.8-3.1 生命体征^^Vital Signs 安全性分析集^^Safety Set	121
136 列表 16.2.8-3.2 生命体征检查临床意义变化^^Change of Clinical Significance of Vital Signs 安全性分析集^^Safety Set	123
137 列表 16.2.8-4.1 体格检查^^Physical Examination 安全性分析集^^Safety Set	124
138 列表 16.2.8-4.2 体格检查临床意义变化^^Change of Clinical Significance of Physical Examination 安全性分析集^^Safety Set	126
139 列表 16.2.8-5.1 其他检查^^Other Test 安全性分析集^^Safety Set	126
140 16.2.9 血药浓度和排泄数据^^Drug Concentration and Excretion Data	127
141  6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆总放射性数据^^The Total Radioactivity Data in Plasma following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi PK浓度集^^PK Concentration Set	127
142 列表 16.2.9-1.1 	127
143 列表 16.2.9-1.2 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血总放射性数据^^The Total Radioactivity Data in Whole Blood following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi PK浓度集^^PK Concentration Set	129
144 列表 16.2.9-2.1 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆中原形药AP306数据^^The Unchanged AP306 Data in Plasma following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi PK浓度集^^PK Concentration Set	130
145 列表 16.2.9-3.1 受试者R001单次口服约150mg/200µCi的[14C]AP306后尿液中的回收率数据^^Excretion Data in Urine following a Single Oral Dose of [14C]AP306 in Subject R001 at 150 mg/200 µCi 物质平衡分析集^^Mass Balance Set	131
146 列表 16.2.9-3.2 受试者R002单次口服约150mg/200µCi的[14C]AP306后尿液中的回收率数据^^Excretion Data in Urine following a Single Oral Dose of [14C]AP306 in Subject R002 at 150 mg/200 µCi 物质平衡分析集^^Mass Balance Set	131
147 列表 16.2.9-3.3 受试者R003单次口服约150mg/200µCi的[14C]AP306后尿液中的回收率数据^^Excretion Data in Urine following a Single Oral Dose of [14C]AP306 in Subject R003 at 150 mg/200 µCi 物质平衡分析集^^Mass Balance Set	132
148 列表 16.2.9-3.4 受试者R004单次口服约150mg/200µCi的[14C]AP306后尿液中的回收率数据^^Excretion Data in Urine following a Single Oral Dose of [14C]AP306 in Subject R004 at 150 mg/200 µCi 物质平衡分析集^^Mass Balance Set	133
149 列表 16.2.9-3.5 受试者R005单次口服约150mg/200µCi的[14C]AP306后尿液中的回收率数据^^Excretion Data in Urine following a Single Oral Dose of [14C]AP306 in Subject R005 at 150 mg/200 µCi 物质平衡分析集^^Mass Balance Set	133
150 列表 16.2.9-3.6 受试者R006单次口服约150mg/200µCi的[14C]AP306后尿液中的回收率数据^^Excretion Data in Urine following a Single Oral Dose of [14C]AP306 in Subject R006 at 150 mg/200 µCi 物质平衡分析集^^Mass Balance Set	134
151 列表 16.2.9-4.1 受试者R001单次口服约150mg/200µCi的[14C]AP306后粪便中的回收率数据^^Excretion Data in Feces following a Single Oral Dose of [14C]AP306 in Subject R001 at 150 mg/200 µCi 物质平衡分析集^^Mass Balance Set	135
152 列表 16.2.9-4.2 受试者R002单次口服约150mg/200µCi的[14C]AP306后粪便中的回收率数据^^Excretion Data in Feces following a Single Oral Dose of [14C]AP306 in Subject R002 at 150 mg/200 µCi 物质平衡分析集^^Mass Balance Set	135
153 列表 16.2.9-4.3 受试者R003单次口服约150mg/200µCi的[14C]AP306后粪便中的回收率数据^^Excretion Data in Feces following a Single Oral Dose of [14C]AP306 in Subject R003 at 150 mg/200 µCi 物质平衡分析集^^Mass Balance Set	136
154 列表 16.2.9-4.4 受试者R004单次口服约150mg/200µCi的[14C]AP306后粪便中的回收率数据^^Excretion Data in Feces following a Single Oral Dose of [14C]AP306 in Subject R004 at 150 mg/200 µCi 物质平衡分析集^^Mass Balance Set	137
155 列表 16.2.9-4.5 受试者R005单次口服约150mg/200µCi的[14C]AP306后粪便中的回收率数据^^Excretion Data in Feces following a Single Oral Dose of [14C]AP306 in Subject R005 at 150 mg/200 µCi 物质平衡分析集^^Mass Balance Set	137
156 列表 16.2.9-4.6 受试者R006单次口服约150mg/200µCi的[14C]AP306后粪便中的回收率数据^^Excretion Data in Feces following a Single Oral Dose of [14C]AP306 in Subject R006 at 150 mg/200 µCi 物质平衡分析集^^Mass Balance Set	138
158 一般编程规范说明
159 输出编号、题目和脚注的表述
160 题目：
161 所有输出的题目均以页面中央对齐
162 表x-x 题目
163 分析集
165 列表x-x 题目
166 分析集
168 图x-x 题目
169 分析集
170 脚注:
171 所有的脚注必须左对齐以减号加空格开头 (“- ”)
172 - xxxxxxxxxxxxxxxxxxxxxx.
173 - xxxxxxxxxxxxxxxxxxxxxx.
174 - xxxxxxxxxxxxxxxxxxxxxx.
175 如果对于输出需要提示数据来源，则要在其他脚注之前显示
176 - 数据来源：列表 x
177 - xxxxxxxxxxxxxxxxxxxxxx.
178 - xxxxxxxxxxxxxxxxxxxxxx.
179 所有表、列表和图中脚注最后一行要显示编程信息，包括程序路径和名称，输出状态 (Draft或者Final)，以及程序运行时间，如：
180 <路径>/<XXX.SAS>                                 draft YYYY-MM-DD HH:MM
182 <路径>/<XXX.SAS>                                 Final YYYY-MM-DD HH:MM
183 列表显示格式
184 如果列表需要在多页中显示，则列表头必须在输出的每一页均有显示
185 列表中的每列宽度应按照显示内容适当调整
186 除非特殊定义，所有列表将按照受试者编号、访视优先排序
187 除非特别指出，否则所有数据的位数均需显示
188 日期时间格式
189 日期时间: YYYY-MM-DDTHH:MM
190 日期: YYYY-MM-DD
191 时间: HH:MM
192 表显示格式
193 如果表需要在多页中显示，则表头必须在输出的每一页均有显示
194 表中的每列宽度应按照显示内容适当调整以适应页面宽度，即一个表的所有列应在一个页面中显示。若无法将一个表的所有列显示在一个页面中，则需要重新设计表的格式
195 描述性统计量及其通用格式：
196 一、非药代动力学相关指标：
197 1. 连续型变量的统计量通常为受试者例数 (n)、算术均值 (Mean)、标准差 (SD)、第一四分位数 (Q1)、中位数(Median)、第三四分位数 (Q3)、最小值 (Min)、最大值 (Max)。
198 在非药代动力学分析中数字小数位数最大为4位，如有特殊保留规则，需在脚注中进行说明，数字小数位数保留如下：
199 最小值和最大值：与原始数据小数位数一致
200 算术均值、第一四分位数、中位数、第三四分位数：比原始数据最大小数位数多一位
201 标准差：比原始数据最大小数位数多两位
202 2. 分类变量的统计量通常为例数和百分比。
203 百分比：1位小数
204 例数和百分比的左括号之间留一个空格
205 例数为零的百分比显示0.0
206 二、药代动力学相关指标
207 药代动力学相关指标的统计量通常为纳入统计分析的例数 (N)、未纳入统计分析的例数 (Nmiss)、算术均值 (Mean)、标准差 (SD)、变异系数 (CV%)、中位数 (Median)、四分位数 (Q1、Q3)、最小值 (Min)、最大值 (Max)、几何均值 (Geometric Mean)、几何变异系数 (Geometric CV%)或算术均值和标准差。除特殊说明外，描述性统计量保留三位有效数字，其中例数保留整数。保留三位有效数字后结果为0的显示为“0.00”。
208 1.浓度：
209 浓度以ng/mL和ng Eq./mL表达：保留三位有效数字；
210 2.回收率：
211 以% 给药量表达：保留两位小数，算术均值和标准差保留两位小数；
212 3.采样时间（h）：
213 数据＜100，保留三位有效数字；
214 数据≥100，四舍五入后保留整数值；
215 4.药代动力学参数：
216 保留三位有效数字；
217 5.全血和血浆分配比：
218 个体数值、算术均值和标准差均保留三位有效数字；
219 数字居中对齐，如：
```json
{
    "0": {
        "0": "xxx.x\nxx.xx\nxx.xxx\nxxx.xx\nxxx\nxx.x (xxx.x)\nxx.xxx (xx.x)\nxxx.x (x.xx)"
    }
}
```
222 临床试验分析输出
224 图10.1 受试者分布流程图
228 参考但不纳入文本的表格、图示和图表^^TABLES, LISTINGS, AND FIGURES REFERRED TO BUT NOT INCORPORATED IN THE TEXT
229 人口统计学数据^^Demographic Data
230 受试者分布^^Summary of Subject Disposition
筛选集^^Screening Set
```json
{
    "试验完成情况^^Trial Completion Status\n  原因^^Reason": {
        "0": "",
        "1": "筛选^^Screened",
        "2": "筛选失败^^Screen Failure",
        "3": "不符合入选标准^^Not met inclusion criteria",
        "4": "符合排除标准^^Met exclusion criteria",
        "5": "受试者自行退出^^The subject voluntary withdrawal",
        "6": "其他^^Other",
        "7": "未入组^^Non-Enrolled",
        "8": "入组^^Enrollment",
        "9": "接受试验药物^^Drug Administrated",
        "10": "完成试验^^Completed",
        "11": "",
        "12": "提前退出^^Withdrawal",
        "13": "提前退出原因^^Reason for Withdrawal",
        "14": "发生任何临床不良事件、实验室检查异常或其他医疗状况，经研究者判断受试者继续参加试验将不符合其最大获益^^In the event of any adverse clinical event, laboratory abnormality, or other medical condition, the investigator judged that it would not be in the participant's best interest to continue participating in the trial",
        "15": "受试者需要服用的伴随用药会干扰试验用药品^^Concomitant medications may interfere with the investigational drug",
        "16": "受试者违反入选/排除标准入组，且经申办者和研究者评估会影响研究结果^^Subjects were enrolled in violation of the inclusion/exclusion criteria, which would",
        "17": "受试者依从性差^^The subject had poor compliance",
        "18": "受试者不能遵守试验方案^^The subject failed to follow the trial protocol",
        "19": "失访^^Lost to follow up",
        "20": "受试者自行退出^^The subject withdrew voluntarily",
        "21": "研究者认为受试者不宜继续进行临床试验的其他情况^^Other circumstances where the investigator considers it inappropriate for the subject to continue the clinical trial",
        "22": "其他^^Other"
    },
    "试验组^^Treatment\nN=xxx\nn (%)*": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "xxx",
        "5": "xxx",
        "6": "xxx",
        "7": "xxx",
        "8": "xxx (100.0)",
        "9": "xxx ( xx.x)",
        "10": "xxx ( xx.x)",
        "11": "",
        "12": "xxx ( xx.x)",
        "13": "",
        "14": "xxx ( xx.x)",
        "15": "xxx ( xx.x)",
        "16": "xxx ( xx.x)",
        "17": "xxx ( xx.x)",
        "18": "xxx ( xx.x)",
        "19": "xxx ( xx.x)",
        "20": "xxx ( xx.x)",
        "21": "xxx ( xx.x)",
        "22": "xxx ( xx.x)"
    }
}
```
232 数据来源：列表 16.2.1-1.1^^Source: 列表 16.2.1-1.1
233 *：百分比基于入组受试者人数为分母进行计算^^*: Percentages are calculated based on the number of subjects enrolled as the denominator.
234 N：筛选入组的受试者人数^^N: Number of enrolled subjects.
236 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
239 分析集汇总^^Summary of Analysis Sets
所有入组受试者^^All Enrolled Subjects
```json
{
    "分析集^^Analysis Set": {
        "0": "",
        "1": "安全性分析集 (SS)^^Safety Set (SS)",
        "2": "PK浓度集 (PKCS)^^PK Concentration Set (PKCS)",
        "3": "PK参数集 (PKPS)^^PK Parameter Set (PKPS)",
        "4": "物质平衡分析集 (MBS)^^Mass Balance Set (MBS)"
    },
    "试验组^^Treatment\nN=xxx\nn (%)*": {
        "0": "",
        "1": "xxx (xx.x)",
        "2": "xxx (xx.x)",
        "3": "xxx (xx.x)",
        "4": "xxx (xx.x)"
    }
}
```
241 数据来源：列表 16.2.1-1.2^^Source: 列表 16.2.1-1.2
242 *：百分比基于入组受试者人数为分母进行计算^^*: Percentages are calculated based on the number of subjects enrolled as the denominator.
244 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
247 受试者人口学资料^^Summary of Subject Demographic Characteristics
安全性分析集^^Safety set
```json
{
    "": {
        "0": "",
        "1": "年龄 (周岁)^^Age (years)",
        "2": "例数 (%)^^n (%)",
        "3": "算术均值 (标准差)^^Mean (SD)",
        "4": "中位数^^Median",
        "5": "Q1, Q3",
        "6": "最小值, 最大值^^Min, Max",
        "7": "",
        "8": "性别，例数 (%)^^Sex, n (%)",
        "9": "男^^Male",
        "10": "女^^Female",
        "11": "",
        "12": "民族，例数 (%)^^Ethnicity, n (%)",
        "13": "汉族^^Han",
        "14": "其他^^Other",
        "15": "",
        "16": "身高 (cm)^^Height (cm)",
        "17": "例数 (%)^^n (%)",
        "18": "算术均值 (标准差)^^Mean (SD)",
        "19": "中位数^^Median",
        "20": "Q1, Q3",
        "21": "最小值, 最大值^^Min, Max",
        "22": "",
        "23": "体重 (kg)^^Weight (kg)",
        "24": "例数 (%)^^n (%)",
        "25": "算术均值 (标准差)^^Mean (SD)",
        "26": "中位数^^Median",
        "27": "Q1, Q3",
        "28": "最小值, 最大值^^Min, Max",
        "29": "",
        "30": "BMI (kg/m2)",
        "31": "例数 (%)^^n (%)",
        "32": "算术均值 (标准差)^^Mean (SD)",
        "33": "中位数^^Median",
        "34": "Q1, Q3",
        "35": "最小值, 最大值^^Min, Max",
        "36": ""
    },
    "试验组^^Treatment\nN=xxx": {
        "0": "",
        "1": "",
        "2": "xx (xx.x)",
        "3": "xx.xx (xx.xxx)",
        "4": "xx.xx",
        "5": "xx.x ,xx.x",
        "6": "xx.x, xx.x",
        "7": "",
        "8": "",
        "9": "xx (xx.x)",
        "10": "xx (xx.x)",
        "11": "",
        "12": "",
        "13": "xx (xx.x)",
        "14": "xx (xx.x)",
        "15": "",
        "16": "",
        "17": "xx (xx.x)",
        "18": "xx.xx (xx.xxx)",
        "19": "xx.xx",
        "20": "xx.x ,xx.x",
        "21": "xx.x, xx.x",
        "22": "",
        "23": "",
        "24": "xx (xx.x)",
        "25": "xx.xx (xx.xxx)",
        "26": "xx.xx",
        "27": "xx.x ,xx.x",
        "28": "xx.x, xx.x",
        "29": "",
        "30": "",
        "31": "xx (xx.x)",
        "32": "xx.xx (xx.xxx)",
        "33": "xx.xx",
        "34": "xx.x ,xx.x",
        "35": "xx.x, xx.x",
        "36": ""
    }
}
```
249 数据来源：列表 16.2.4-1.1^^Source: 列表 16.2.4-1.1
250 BMI=体重指数：体重kg/ (身高m)2^^BMI= Weight kg/(Height m)2.
252 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
255 病史^^Summary of Medical History
安全性分析集^^Safety set
```json
{
    "SOC\n  PT": {
        "0": "",
        "1": "有任何既往病史和现病史的受试者^^Participant has history or presence of disease",
        "2": "",
        "3": "SOC1xxx",
        "4": "PT1xxx",
        "5": "PT2xxx",
        "6": "……"
    },
    "试验组^^Treatment\nN=xxx\nn (%)": {
        "0": "",
        "1": "xxx (xx.x)",
        "2": "",
        "3": "xxx (xx.x)",
        "4": "xxx (xx.x)",
        "5": "xxx (xx.x)",
        "6": ""
    }
}
```
257 数据来源：列表 16.2.4-2.1^^Source: 列表 16.2.4-2.1
258 病史依据&MedDRA.进行编码^^Medical History encoded according to &MedDRA.
259 SOC：系统器官分类，PT：首选术语^^SOC: System Organ Class; PT: Preferred Term.
261 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
264 编程说明：
265 编程时根据实际字典及版本替换脚注中“&MedDRA.”内容
Don't know what object this is
268 手术史^^Summary of Operation history
安全性分析集^^Safety set
```json
{
    "SOC\n  PT": {
        "0": "",
        "1": "有任何手术史的受试者^^Subjects with any history of surgery",
        "2": "",
        "3": "SOC1xxx",
        "4": "PT1xxx",
        "5": "PT2xxx",
        "6": "……"
    },
    "试验组^^Treatment\nN=xxx\nn (%)": {
        "0": "",
        "1": "xxx (xx.x)",
        "2": "",
        "3": "xxx (xx.x)",
        "4": "xxx (xx.x)",
        "5": "xxx (xx.x)",
        "6": ""
    }
}
```
270 数据来源：列表 16.2.4-2.2^^Source: 列表 16.2.4-2.2
271 手术史依据 &MedDRA. 进行编码^^Surgical Conditions encoded according to &MedDRA.
272 SOC：系统器官分类，PT：首选术语^^SOC: System Organ Class; PT: Preferred Term.
274 <路径>/<XXX.SAS>                                                                                   draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
276 编程说明：
277 根据实际编码字典版本，更新脚注
279 过敏史^^Summary of Allery
安全性分析集^^Safety set
```json
{
    "": {
        "0": "",
        "1": "有任何过敏史的受试者^^Subjects with any history of allergy",
        "2": "是^^Yes",
        "3": "否^^No",
        "4": ""
    },
    "试验组^^Treatment\nN=xxx\nn (%)": {
        "0": "",
        "1": "",
        "2": "xxx (xx.x)",
        "3": "xxx (xx.x)",
        "4": ""
    }
}
```
281 数据来源：列表 16.2.4-2.3、列表 16.2.4-2.4^^Source: 列表 16.2.4-2.3, 列表 16.2.4-2.4
283 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
286 一般情况问询^^Summary of General Information Inquiries
安全性分析集^^Safety set
```json
{
    "": {
        "0": "",
        "1": "受试者是否酗酒或筛选前6个月内经常饮酒，即每周饮酒超过14个单位的酒精（1单位=360mL啤酒或45mL 酒 精量为40%的烈酒或150mL 葡萄酒），或筛选期时酒精呼气试验结果≥20 mg/dl者，或在使用研究药物前48小时内饮酒者，或在试验期间无法戒断酒精^^Whether the subject was heavy drinkers or had been drinking frequently within the 6 months prior to the screening, that is,consuming more than 14 units of alcohol per week (1 unit = 360 mL of beer or 45 mL of 40% alcohol spirits or 150 mL of wine), or if the alcohol breath test result was ≥ 20 mg/dl during the screening period, or if they consumed alcohol within 48 hours before using the study drug, or if they were unable to abstain from alcohol during the trial",
        "2": "是^^Yes",
        "3": "否^^No",
        "4": "NA",
        "5": "",
        "6": "每日吸烟量大于5支或习惯性使用含尼古丁制品者，或在试验期间无法戒断^^Subject smoked more than five cigarettes per day or were habitual users of nicotine-containing products in the 3 months before screening, or were unable to quit during the trial",
        "7": "是^^Yes",
        "8": "否^^No",
        "9": "NA",
        "10": "",
        "11": "受试者是否滥用药物或筛选前3个月使用过软毒品（如 ：大麻）或筛选前1年服用硬 毒品（如：可卡因、苯丙胺 类、苯环己哌啶等）^^Whether the subject abused drugs or used soft drugs (e.g., marijuana) in the 3 months before screening or hard drugs (e.g., cocaine, amphetamines, phyclohexidine) in the year before screening",
        "12": "是^^Yes",
        "13": "否^^No",
        "14": "NA",
        "15": "",
        "16": "受试者是否在筛选前3个月内 参加过任何临床试验且接受 过试验用药品或使用过试验 用器械^^Whether the subject had participated in any clinical trial and received investigational drugs or used investigational devices within 3 months before screening",
        "17": "是^^Yes",
        "18": "否^^No",
        "19": "NA",
        "20": "",
        "21": "受试者是否在签署知情同意书后至完成试验后1年内有生育或捐献精子计划者，或者不同意在签署知情同意书后 至完成试验后1年内受试者及其配偶采取严格的避孕措施^^Whether the subject had a plan to give birth or donate sperm within 1 year after signing the informed consent form or did not agree to use strict contraception for the subject and his/her spouse within 1 year after signing the informed consent form and completing the trial",
        "22": "是^^Yes",
        "23": "否^^No",
        "24": "NA",
        "25": "",
        "26": "受试者是否在筛选前3个月内曾有过失血或献血≥400 mL者，或1个月内接受输血/血液成分者，或计划服药期间及停药后3个月内献血^^Whether the subject had lost blood or donated ≥400 mL of blood within 3 months before screening, received blood transfusion/blood components within 1 month, or donated blood during planned medication and within 3 months after discontinuation",
        "27": "是^^Yes",
        "28": "否^^No",
        "29": "NA"
    },
    "试验组^^Treatment\nN=xxx\nn (%)": {
        "0": "",
        "1": "",
        "2": "xxx (xx.x)",
        "3": "xxx (xx.x)",
        "4": "xxx (xx.x)",
        "5": "",
        "6": "",
        "7": "xxx (xx.x)",
        "8": "xxx (xx.x)",
        "9": "xxx (xx.x)",
        "10": "",
        "11": "",
        "12": "xxx (xx.x)",
        "13": "xxx (xx.x)",
        "14": "xxx (xx.x)",
        "15": "",
        "16": "",
        "17": "xxx (xx.x)",
        "18": "xxx (xx.x)",
        "19": "xxx (xx.x)",
        "20": "",
        "21": "",
        "22": "xxx (xx.x)",
        "23": "xxx (xx.x)",
        "24": "xxx (xx.x)",
        "25": "",
        "26": "",
        "27": "xxx (xx.x)",
        "28": "xxx (xx.x)",
        "29": "xxx (xx.x)"
    }
}
```
288 数据来源：列表 16.2.4-2.3、列表 16.2.4-2.4^^Source: 列表 16.2.4-2.3, 列表 16.2.4-2.4
290 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
293 既往用药^^Summary of Previous Medications
安全性分析集^^Safety set
```json
{
    "ATC2\n  PN": {
        "0": "",
        "1": "在研究期间有既往用药的受试者^^Subjects with any previous medications during the study",
        "2": "",
        "3": "ATC2xxx",
        "4": "PN1xxx",
        "5": "PN2xxx",
        "6": "PN3xxx",
        "7": "",
        "8": "ATC2xxx",
        "9": "PN1xxx",
        "10": "……"
    },
    "试验组^^Treatment\nN=xxx\nn (%)": {
        "0": "",
        "1": "xxx (xx.x)",
        "2": "",
        "3": "xxx (xx.x)",
        "4": "xxx (xx.x)",
        "5": "xxx (xx.x)",
        "6": "xxx (xx.x)",
        "7": "",
        "8": "xxx (xx.x)",
        "9": "xxx (xx.x)",
        "10": "……"
    }
}
```
295 数据来源：列表 16.2.4-2.5^^Source: 列表 16.2.4-2.5
296 编码字典：&DrugDIR.^^Encoded dictionary: &DrugDIR.
297 ATC2：解剖学、治疗学及化学分类法2级，PN：首选药名^^ATC2: Anatomical Therapeutic Classification 2nd; PN: Preferred Name.
299 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
302 编程说明：
303 编程时根据实际字典及版本替换脚注中“&DrugDIR.”内容
305 酒精呼气测试基线汇总^^Summary of Baseline Results in Alcohol Breath Test
安全性分析集^^Safety set
```json
{
    "统计量^^Statistics": {
        "0": "",
        "1": "例数 (%)^^n (%)",
        "2": "算术均值 (标准差)^^Mean (SD)",
        "3": "中位数^^Median",
        "4": "Q1, Q3",
        "5": "最小值, 最大值^^Min, Max",
        "6": ""
    },
    "试验组^^Treatment\nN=xxx": {
        "0": "",
        "1": "xx (xx.x)",
        "2": "xx.x (xx.xx)",
        "3": "xx.x",
        "4": "xx.x ,xx.x",
        "5": "xx, xx",
        "6": ""
    }
}
```
307 数据来源：列表 16.2.4-1.2^^Source: 列表 16.2.4-1.2
308 酒精呼气测试单位：mg/dl^^Alcohol breath test unit: mg/dl
310 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
313 尿药筛查基线汇总^^Summary of Baseline Results in Urine Drug Test
安全性分析集^^Safety set
```json
{
    "项目^^Test Name\n  结果^^Result": {
        "0": "",
        "1": "吗啡^^Morphine",
        "2": "阴性^^Negative",
        "3": "阳性^^Positive",
        "4": "未查^^Not done",
        "5": "……"
    },
    "试验组^^Treatment\nN=xxx\nn (%)": {
        "0": "",
        "1": "",
        "2": "xxx (xx.x)",
        "3": "xxx (xx.x)",
        "4": "xxx (xx.x)",
        "5": ""
    }
}
```
315 数据来源：列表 16.2.4-1.3^^Source: 列表 16.2.4-1.3
317 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
320 编程说明：
321 “未查”项只在“试验组”列中有值的时候才显示
322 使用尿药筛查指标
324 病毒学筛查基线汇总^^Summary of Baseline Results in Virological Screening
安全性分析集^^Safety set
```json
{
    "项目 (单位)^^Test Name (Unit)\n  统计量^^Statistics": {
        "0": "",
        "1": "乙肝表面抗原 (xxx^^Hepatitis B surface antigen (xxx)",
        "2": "例数 (%)^^n (%)",
        "3": "算术均值 (标准差)^^Mean (SD)",
        "4": "中位数^^Median",
        "5": "Q1, Q3",
        "6": "最小值, 最大值^^Min, Max",
        "7": "……"
    },
    "试验组^^Treatment\nN=xxx\nn (%)": {
        "0": "",
        "1": "",
        "2": "xx (xx.x)",
        "3": "xx.x (xx.xx)",
        "4": "xx.x",
        "5": "xx.x ,xx.x",
        "6": "xx, xx",
        "7": ""
    }
}
```
326 数据来源：列表 16.2.4-1.4^^Source: 列表 16.2.4-1.4
328 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
330 编程说明：
331 使用病毒学筛查指标，如有单位需带上单位
333 病毒学筛查基线临床意义判定^^Summary of Baseline Clinical Significance Results in Virological Screening
安全性分析集^^Safety set
```json
{
    "项目^^Test Name\n  临床意义判定^^Clinical Significance": {
        "0": "",
        "1": "乙肝表面抗原^^Hepatitis B surface antigen",
        "2": "正常^^Normal",
        "3": "异常无临床意义^^Abnormal, not clinically significant",
        "4": "异常有临床意义^^Abnormal, clinically significant",
        "5": "未查^^Not done",
        "6": "……"
    },
    "试验组^^Treatment\nN=xxx\nn (%)": {
        "0": "",
        "1": "",
        "2": "xxx (xx.x)",
        "3": "xxx (xx.x)",
        "4": "xxx (xx.x)",
        "5": "xxx (xx.x)",
        "6": ""
    }
}
```
335 数据来源：列表 16.2.4-1.4^^Source: 列表 16.2.4-1.4
337 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
340 编程说明：
341 “未查”项只在“试验组”列中有值的时候才显示
342 使用病毒学筛查指标
343 腹部B超检查基线结果判定^^Summary of Baseline Results in Abdominal B ultrasound
安全性分析集^^Safety set
```json
{
    "检查结果^^Result": {
        "0": "肝^^Liver",
        "1": "正常^^Normal",
        "2": "异常无临床意义^^Abnormal, not clinically significant",
        "3": "异常有临床意义^^Abnormal, clinically significant",
        "4": "未查^^Not done",
        "5": "胆^^Gallbladder",
        "6": "……"
    },
    "试验组^^Treatment\nN=xxx\nn (%)": {
        "0": "",
        "1": "xxx (xx.x)",
        "2": "xxx (xx.x)",
        "3": "xxx (xx.x)",
        "4": "xxx (xx.x)",
        "5": "",
        "6": ""
    }
}
```
345 数据来源：列表 16.2.4-1.5^^Source: 列表 16.2.4-1.5
347 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
350 编程说明：
351 “未查”项只在“试验组”列中有值的时候才显示
353 胸部X光片检查基线结果判定^^Summary of Baseline Results in Chest X-ray
安全性分析集^^Safety set
```json
{
    "结果判定^^Result": {
        "0": "",
        "1": "正常^^Normal",
        "2": "异常无临床意义^^Abnormal, not clinically significant",
        "3": "异常有临床意义^^Abnormal, clinically significant",
        "4": "未查^^Not done",
        "5": "……"
    },
    "试验组\nN=xxx\nn (%)": {
        "0": "",
        "1": "xxx ( xx.x)",
        "2": "xxx ( xx.x)",
        "3": "xxx ( xx.x)",
        "4": "xxx ( xx.x)",
        "5": ""
    }
}
```
355 数据来源：列表 16.2.4-1.6^^Source: 列表 16.2.4-1.6
357 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
360 编程说明：^^Programming Note:
361 按照表 14.1-3.5的表结构生成此表^^Use the same shell with 表 14.1-3.5
362 “未查”项只在“试验组”列中有值的时候才显示
364 甲状腺功能检查基线汇总^^Summary of Baseline Results in Thyroid Function
安全性分析集^^Safety set
```json
{
    "项目 (单位)^^Test Name (Unit)\n  统计量^^Statistics": {
        "0": "",
        "1": "游离T3 (xxx)^^Free T3 (xxx)",
        "2": "例数 (%)^^n (%)",
        "3": "算术均值 (标准差)^^Mean (SD)",
        "4": "中位数^^Median",
        "5": "Q1, Q3",
        "6": "最小值, 最大值^^Min, Max",
        "7": "……"
    },
    "试验组^^Treatment\nN=xxx": {
        "0": "",
        "1": "",
        "2": "xx (xx.x)",
        "3": "xx.x (xx.xx)",
        "4": "xx.x",
        "5": "xx.x ,xx.x",
        "6": "xx, xx",
        "7": "……"
    }
}
```
366 数据来源：列表 16.2.4-1.7^^Source: 列表 16.2.4-1.7
368 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
371 编程说明：
372 使用甲状腺功能检查指标，上述检查指标如有单位需带上单位
374 甲状腺功能基线临床意义判定^^Summary of Baseline Clinical significance Results in Thyroid Function
安全性分析集^^Safety set
```json
{
    "项目^^Test Name\n  临床意义判定^^Clinical Significance": {
        "0": "",
        "1": "游离T3^^Free T3",
        "2": "正常^^Normal",
        "3": "异常无临床意义^^Abnormal, not clinically significant",
        "4": "异常有临床意义^^Abnormal, clinically significant",
        "5": "未查^^Not done",
        "6": "……",
        "7": ""
    },
    "试验组^^Treatment\nN=xxx\nn (%)": {
        "0": "",
        "1": "",
        "2": "xxx (xx.x)",
        "3": "xxx (xx.x)",
        "4": "xxx (xx.x)",
        "5": "xxx (xx.x)",
        "6": "……",
        "7": ""
    }
}
```
376 数据来源：列表 16.2.4-1.7^^Source: 列表 16.2.4-1.7
378 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
381 编程说明：
382 使用甲状腺功能检查指标
383 “未查”项只在“试验组”列中有值的时候才显示
385 肛门指检基线临床意义判定^^Summary of Baseline Clinical significance Results in Digital Rectal Examination
安全性分析集^^Safety set
386 数据来源：列表 16.2.4-1.8^^Source: 列表 16.2.4-1.8
388 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
391 编程说明：^^Programming Note:
392 按照表 14.1-3.5的表结构生成此表^^Use the same shell with 表 14.1-3.5
393 “未查”项只在“试验组”列中有值的时候才显示
395 安全性数据^^Safety Data
396 合并用药^^Concomitant Medications
安全性分析集^^Safety Set
```json
{
    "ATC2\n  PN": {
        "0": "",
        "1": "有合并用药的受试者^^Subjects with Any Concomitant Medications",
        "2": "",
        "3": "ATC2xxx",
        "4": "PN1xxx",
        "5": "PN2xxx",
        "6": "PN3xxx",
        "7": "",
        "8": "ATC2xxx",
        "9": "PN1xxx",
        "10": "……"
    },
    "试验组^^Treatment\nN=xxx\nn (%)": {
        "0": "",
        "1": "xxx (xx.x)",
        "2": "",
        "3": "xxx (xx.x)",
        "4": "xxx (xx.x)",
        "5": "xxx (xx.x)",
        "6": "xxx (xx.x)",
        "7": "",
        "8": "xxx (xx.x)",
        "9": "xxx (xx.x)",
        "10": ""
    }
}
```
398 数据来源：列表 16.2.5-1.3^^Source: 列表 16.2.5-1.3
399 编码字典：&DrugDIR.^^Encoded dictionary: &DrugDIR.
400 ATC2：解剖学、治疗学及化学分类法2级，PN：首选药名^^ATC2: Anatomical Therapeutic Classification 2nd; PN: Preferred Name.
402 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
405 编程说明：
406 编程时根据实际字典及版本替换脚注中“&DrugDIR.”内容
408 非药物治疗^^Concomitant Procedure/Surgery
安全性分析集^^Safety Set
```json
{
    "SOC\n  PT": {
        "0": "",
        "1": "研究期间内接受过非药物治疗的受试者^^Subjects with Any Concomitant Procedure/Surgery",
        "2": "",
        "3": "SOC1xxx",
        "4": "PT1xxx",
        "5": "PT2xxx",
        "6": "……"
    },
    "试验组^^Treatment\nN=xxx\nn (%)": {
        "0": "",
        "1": "xxx (xx.x)",
        "2": "",
        "3": "xxx (xx.x)",
        "4": "xxx (xx.x)",
        "5": "xxx (xx.x)",
        "6": "……"
    }
}
```
410 数据来源：列表 16.2.5-1.4^^Source: 列表 16.2.5-1.4
411 非药物治疗依据&MedDRA.进行编码^^Concomitant Procedure/Surgery encoded according to &MedDRA.
412 SOC：系统器官分类，PT：首选术语^^SOC: System Organ Class; PT: Preferred Term.
414 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
416 编程说明：
417 编程时根据实际字典及版本替换脚注中“&MedDRA.”内容
419 血常规检查^^Hematology Test
安全性分析集^^Safety Set
```json
{
    "项目 (单位)^^Test Name (Unit)\n  时间^^Visit\n    统计量^^Statistics": {
        "0": "",
        "1": "白细胞计数 (xxx)^^White blood cells (xxx)",
        "2": "基线^^Baseline",
        "3": "例数 (%)^^n (%)",
        "4": "算术均值 (标准差)^^Mean (SD)",
        "5": "中位数^^Median",
        "6": "Q1, Q3",
        "7": "最小值, 最大值^^Min, Max",
        "8": "样本采集结束/提前出组^^end of sample collection/ early withdrawal",
        "9": "例数 (%)^^n (%)",
        "10": "算术均值 (标准差)^^Mean (SD)",
        "11": "中位数^^Median",
        "12": "Q1, Q3",
        "13": "最小值, 最大值^^Min, Max",
        "14": "……",
        "15": "",
        "16": "淋巴细胞计数 (xxx)^^Lymphocyte Count (xxx)",
        "17": "基线^^Baseline",
        "18": "例数 (%)^^n (%)",
        "19": "算术均值 (标准差)^^Mean (SD)",
        "20": "中位数^^Median",
        "21": "Q1, Q3",
        "22": "最小值, 最大值^^Min, Max",
        "23": "……"
    },
    "试验组^^Treatment\nN=xxx": {
        "0": "",
        "1": "",
        "2": "",
        "3": "xx (xx.x)",
        "4": "xx.x (xx.xx)",
        "5": "xx.x",
        "6": "xx.x ,xx.x",
        "7": "xx, xx",
        "8": "",
        "9": "xx (xx.x)",
        "10": "xx.x (xx.xx)",
        "11": "xx.x",
        "12": "xx.x ,xx.x",
        "13": "xx, xx",
        "14": "……",
        "15": "",
        "16": "",
        "17": "",
        "18": "xx (xx.x)",
        "19": "xx.x (xx.xx)",
        "20": "xx.x",
        "21": "xx.x ,xx.x",
        "22": "xx, xx",
        "23": "……"
    },
    "试验组^^Treatment\n相对基线变化^^Change from Baseline": {
        "0": "",
        "1": "",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "",
        "7": "",
        "8": "",
        "9": "xx (xx.x)",
        "10": "xx.x (xx.xx)",
        "11": "xx.x",
        "12": "xx.x ,xx.x",
        "13": "xx, xx",
        "14": "……",
        "15": "",
        "16": "",
        "17": "",
        "18": "",
        "19": "",
        "20": "",
        "21": "",
        "22": "",
        "23": ""
    }
}
```
421 数据来源：列表 16.2.8-1.1^^Source: 列表 16.2.8-1.1
423 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
425 编程说明：
426 检测时间点：基线、样本采集结束/提前出组
427 使用血常规检查指标，检查指标如有单位需带上单位
429 血常规检查临床意义判定变化^^Shift Summary of Clinically Significant Results in Hematology Test
安全性分析集^^Safety Set
```json
Error: table can't be loaded to json
```
431 数据来源：列表 16.2.8-1.1^^Source: 列表 16.2.8-1.1
433 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
436 编程说明：
437 检测时间点：基线、样本采集结束/提前出组
438 使用血常规检查指标
440 血生化检查^^Blood Chemistry
安全性分析集^^Safety Set
441 数据来源：列表 16.2.8-1.3^^Source: 列表 16.2.8-1.3
443 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
446 编程说明：^^Programming Note:
447 按照表 14.3-1.1的表结构生成此表^^Use the same shell with 表 14.3-1.1
448 检测时间点：基线、样本采集结束/提前出组
449 使用血生化指标，检查指标有单位需带上单位
451 血生化检查临床意义判定变化^^Shift Summary of Clinically Significant Results in Blood Chemistry Test
安全性分析集^^Safety Set
452 数据来源：列表 16.2.8-1.3^^Source: 列表 16.2.8-1.3
454 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
457 编程说明：^^Programming Note:
458 按照表 14.3-2.2的表结构生成此表^^Use the same shell with 表 14.3-2.2
459 检测时间点：基线、样本采集结束/提前出组
460 使用血生化指标
462 尿常规检查临床意义判定变化^^Shift Summary of Clinically Significant Results in Urinalysis Test
安全性分析集^^Safety Set
463 数据来源：列表 16.2.8-1.2^^Source: 列表 16.2.8-1.2
465 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
468 编程说明：^^Programming Note:
469 按照表 14.3-2.2的表结构生成此表^^Use the same shell with 表 14.3-2.2
470 检测时间点：基线、样本采集结束/提前出组
471 “未查”项只在“试验组”列中有值的时候才显示
472 使用尿常规指标
474 凝血功能检查^^Coagulation Test
安全性分析集^^Safety Set
475 数据来源：列表 16.2.8-1.4^^Source: 列表 16.2.8-1.4
477 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
480 编程说明：^^Programming Note:
481 按照表 14.3-1.1的表结构生成此表^^Use the same shell with 表 14.3-1.1
482 检测时间点：基线、样本采集结束/提前出组
483 使用凝血功能指标，检查指标有单位需带上单位
485 凝血功能检查临床意义判定变化^^Shift Summary of Clinically Significant Results in Coagulation Function Test
安全性分析集^^Safety Set
486 数据来源：列表 16.2.8-1.4^^Source: 列表 16.2.8-1.4
488 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
491 编程说明：^^Programming Note:
492 按照表 14.3-2.2的表结构生成此表^^Use the same shell with 表 14.3-2.2
493 检测时间点：基线、样本采集结束/提前出组
494 使用凝血功能指标
496 便常规+隐血检查临床意义判定变化^^Shift Summary of Clinically Significant Results in Stool Routine and Occult Blood Test
安全性分析集^^Safety Set
497 数据来源：列表 16.2.8-1.5^^Source: 列表 16.2.8-1.5
499 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
502 编程说明：^^Programming Note:
503 按照表 14.3-2.2的表结构生成此表^^Use the same shell with 表 14.3-2.2
504 检测时间点：基线、样本采集结束/提前出组
505 使用便常规+隐血检查指标，检查指标有单位需带上单位指标
507 12导联心电图检查^^12-Lead ECG
安全性分析集^^Safety Set
```json
{
    "项目 (单位)^^Test Name (Unit)\n  时间^^Visit\n    统计量^^Statistics": {
        "0": "",
        "1": "心率 (次/分)^^Heart Rate (Bpm)",
        "2": "基线^^Baseline",
        "3": "例数 (%)^^n (%)",
        "4": "算术均值 (标准差)^^Mean (SD)",
        "5": "中位数^^Median",
        "6": "Q1, Q3",
        "7": "最小值, 最大值^^Min, Max",
        "8": "给药后6h^^6 hours post-dose",
        "9": "例数 (%)^^n (%)",
        "10": "算术均值 (标准差)^^Mean (SD)",
        "11": "中位数^^Median",
        "12": "Q1, Q3",
        "13": "最小值, 最大值^^Min, Max",
        "14": "……",
        "15": "PR间期 (ms)^^PR-interval (ms)",
        "16": "基线^^Baseline",
        "17": "例数 (%)^^n (%)",
        "18": "算术均值 (标准差)^^Mean (SD)",
        "19": "中位数^^Median",
        "20": "Q1, Q3",
        "21": "最小值, 最大值^^Min, Max",
        "22": "……"
    },
    "试验组^^Treatment\nN=xxx": {
        "0": "",
        "1": "",
        "2": "",
        "3": "xx (xx.x)",
        "4": "xx.x (xx.xx)",
        "5": "xx.x",
        "6": "xx.x ,xx.x",
        "7": "xx, xx",
        "8": "",
        "9": "xx (xx.x)",
        "10": "xx.x (xx.xx)",
        "11": "xx.x",
        "12": "xx.x ,xx.x",
        "13": "xx, xx",
        "14": "……",
        "15": "",
        "16": "",
        "17": "xx (xx.x)",
        "18": "xx.x (xx.xx)",
        "19": "xx.x",
        "20": "xx.x ,xx.x",
        "21": "xx, xx",
        "22": ""
    },
    "试验组^^Treatment\n相对基线变化^^Change from Baseline": {
        "0": "",
        "1": "",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "",
        "7": "",
        "8": "",
        "9": "xx (xx.x)",
        "10": "xx.x (xx.xx)",
        "11": "xx.x",
        "12": "xx.x ,xx.x",
        "13": "xx, xx",
        "14": "",
        "15": "",
        "16": "",
        "17": "",
        "18": "",
        "19": "",
        "20": "",
        "21": "",
        "22": ""
    }
}
```
509 数据来源：列表 16.2.8-2.1^^Source: 列表 16.2.8-2.1
511 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
513 编程说明：
514 检测时间点：于筛选期、给药前（-1 h内）及给药后6 h（时间窗为±30 min）、出组时进行；给药前（-1 h内）检测结果作为基线；
515 使用12-导联心电图检查指标，检查指标有单位需带上单位
517 12导联心电图检查临床意义判定变化^^Shift Summary of Clinically Significant Results in 12-Lead ECG
安全性分析集^^Safety Set
```json
Error: table can't be loaded to json
```
519 数据来源：列表 16.2.8-2.1^^Source: 列表 16.2.8-2.1
521 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
524 编程说明：
525 检测时间点：基线、给药后6h、样本采集结束/提前出组
527 生命体征^^Vital Signs
安全性分析集^^Safety Set
```json
{
    "项目 (单位)^^Test Name (Unit)\n  时间^^Visit\n    统计量^^Statistics": {
        "0": "",
        "1": "耳温 (℃)^^Ear Temperature (℃)",
        "2": "基线^^Baseline",
        "3": "例数 (%)^^n (%)",
        "4": "算术均值 (标准差)^^Mean (SD)",
        "5": "中位数^^Median",
        "6": "Q1, Q3",
        "7": "最小值, 最大值^^Min, Max",
        "8": "给药后6h^^6 hours post-dose",
        "9": "例数 (%)^^n (%)",
        "10": "算术均值 (标准差)^^Mean (SD)",
        "11": "中位数^^Median",
        "12": "Q1, Q3",
        "13": "最小值, 最大值^^Min, Max",
        "14": "",
        "15": "……",
        "16": "收缩压 (mmHg)^^Systolic blood pressure (mmHg)",
        "17": "基线^^Baseline",
        "18": "例数 (%)^^n (%)",
        "19": "算术均值 (标准差)^^Mean (SD)",
        "20": "中位数^^Median",
        "21": "Q1, Q3",
        "22": "最小值, 最大值^^Min, Max",
        "23": "……"
    },
    "试验组^^Treatment\nN=xxx": {
        "0": "",
        "1": "",
        "2": "",
        "3": "xx (xx.x)",
        "4": "xx.x (xx.xx)",
        "5": "xx.x",
        "6": "xx.x ,xx.x",
        "7": "xx, xx",
        "8": "",
        "9": "xx (xx.x)",
        "10": "xx.x (xx.xx)",
        "11": "xx.x",
        "12": "xx.x ,xx.x",
        "13": "xx, xx",
        "14": "",
        "15": "……",
        "16": "",
        "17": "",
        "18": "xx (xx.x)",
        "19": "xx.x (xx.xx)",
        "20": "xx.x",
        "21": "xx.x ,xx.x",
        "22": "xx, xx",
        "23": "……"
    },
    "试验组^^Treatment\n相对基线变化^^Change from Baseline": {
        "0": "",
        "1": "",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "",
        "7": "",
        "8": "",
        "9": "xx (xx.x)",
        "10": "xx.x (xx.xx)",
        "11": "xx.x",
        "12": "xx.x ,xx.x",
        "13": "xx, xx",
        "14": "",
        "15": "……",
        "16": "",
        "17": "",
        "18": "",
        "19": "",
        "20": "",
        "21": "",
        "22": "",
        "23": "……"
    }
}
```
529 数据来源：列表 16.2.8-3.1^^Source: 列表 16.2.8-3.1
531 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
534 编程说明：
535 使用生命体征指标，检查指标有单位需带上单位e
536 生命体征检查时间点：于筛选期、入住（D-2）、基线（D-1）、给药前1 h内及给药后6 h、24 h、48 h、72 h、96 h、 120 h、144 h、168 h、192 h、216 h、240 h、264 h、288 h、312 h、336 h、360 h、384 h、408 h、432 h、456 h、480 h、504 h 进行，测定时间窗为±30 min；若研究时间需延长超过504 h，则后续仍然需要每天测量一次生命体征。如有新增检查时间点，请编程时同步更新
538 生命体征临床意义判定变化^^Shift Summary of Clinically Significant Results in Vital Signs
安全性分析集^^Safety Set
```json
Error: table can't be loaded to json
```
540 数据来源：列表 16.2.8-3.1^^Source: 列表 16.2.8-3.1
542 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
545 编程说明：
546 使用生命体征指标
547 同基线相比较的生命体征检查时间点：于筛选期、入住（D-2）、基线（D-1）、给药前1 h内及给药后6 h、24 h、48 h、72 h、96 h、 120 h、144 h、168 h、192 h、216 h、240 h、264 h、288 h、312 h、336 h、360 h、384 h、408 h、432 h、456 h、480 h、504 h 进行，测定时间窗为±30 min；若研究时间需延长超过504 h，则后续仍然需要每天测量一次生命体征。如有新增检查时间点，请编程时同步更新
549 体格检查临床意义判定变化^^Shift Summary of Clinically Significant Results in Physical Examination
安全性分析集^^Safety Set
550 数据来源：列表 16.2.8-4.1^^Source: 列表 16.2.8-4.1
552 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
555 编程说明：^^Programming Note:
556 按照表 14.3-2.2的表结构生成此表^^Use the same shell with 表 14.3-2.2
557 检测时间点：基线、样本采集结束/提前出组
558 使用体格检查指标 
561 不良事件列表^^Table of Adverse Events
562 不良事件汇总^^Summary of AEs
安全性分析集^^Safety Set
```json
{
    "": {
        "0": "",
        "1": "AE",
        "2": "TEAE",
        "3": "与试验用药品相关的TEAE^^TEAEs related to the investigational product",
        "4": "SAE",
        "5": "TESAE",
        "6": "与试验用药品相关的TESAE^^TESAEs related to the investigational product",
        "7": "导致退出研究的TESAE^^TEAEs leading to subject withdrawal from the study",
        "8": "导致死亡的AE^^Fatal AE",
        "9": "",
        "10": "TEAE严重程度^^TEAE CTCAE Severity Grade",
        "11": "1级^^Grade 1",
        "12": "2级^^Grade 2",
        "13": "3级^^Grade 3",
        "14": "4级^^Grade 4",
        "15": "5级^^Grade 5",
        "16": "",
        "17": "与试验用药品相关的SAE严重程度^^Drug-related SAE CTCAE Severity Grade",
        "18": "1级^^Grade 1",
        "19": "2级^^Grade 2",
        "20": "3级^^Grade 3",
        "21": "4级^^Grade 4",
        "22": "5级^^Grade 5"
    },
    "试验组^^Treatment\nN=xxx\n例数 (%) 例次^^n (%) Events": {
        "0": "",
        "1": "xxx (xx.x) xxx",
        "2": "xxx (xx.x) xxx",
        "3": "xxx (xx.x) xxx",
        "4": "xxx (xx.x) xxx",
        "5": "xxx (xx.x) xxx",
        "6": "xxx (xx.x) xxx",
        "7": "xxx (xx.x) xxx",
        "8": "xxx (xx.x) xxx",
        "9": "",
        "10": "",
        "11": "xxx (xx.x) xxx",
        "12": "xxx (xx.x) xxx",
        "13": "xxx (xx.x) xxx",
        "14": "xxx (xx.x) xxx",
        "15": "xxx (xx.x) xxx",
        "16": "",
        "17": "",
        "18": "xxx (xx.x) xxx",
        "19": "xxx (xx.x) xxx",
        "20": "xxx (xx.x) xxx",
        "21": "xxx (xx.x) xxx",
        "22": "xxx (xx.x) xxx"
    }
}
```
564 数据来源：列表 16.2.7-1.1^^Source: 列表 16.2.7-1.1
565 例数：发生不良事件的受试者人数；例次：发生不良事件的次数^^n: number of subjects with AEs; Events: number of AEs.
566 一个受试者在用药期间发生多次不良事件，对不良事件例数只计算一次，但对例次分别计算^^If a subject has multiple AEs during the treatment period, the number of subjects is counted only once, but the events are counted separately.
567 AE：不良事件；TEAE：治疗期不良事件；SAE：严重不良事件；TESAE: 治疗期不良事件^^AE: Adverse Event; TEAE: Treatment Emergent AE; SAE: Serious AE; TESAE: Treatment Emergent SAE;
569 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
572 编程说明：
573 显示所有严重程度即使在试验期间没有任何AE发生 当例数和例次为0时，例数 (%) 例次中展示为“0”
576 AE按系统器官、术语和严重程度汇总^^Summary of AE by System Organ Class, Preferred Term and CTCAE Severity Grade
安全性分析集^^Safety Set
```json
{
    "SOC\n  PT\n    严重程度^^Severity": {
        "0": "",
        "1": "AE",
        "2": "",
        "3": "SOC1xxx",
        "4": "1级^^Grade 1",
        "5": "2级^^Grade 2",
        "6": "......",
        "7": "PT1xxx",
        "8": "1级^^Grade 1",
        "9": "....",
        "10": "PT2xxx",
        "11": "1级^^Grade 1",
        "12": "......",
        "13": "SOC2xxx",
        "14": "...."
    },
    "试验组^^Treatment\nN=xxx\n例数 (%) 例次^^n (%) Events": {
        "0": "",
        "1": "x (xx.x) x",
        "2": "",
        "3": "x (xx.x) x",
        "4": "x (xx.x) x",
        "5": "x (xx.x) x",
        "6": "",
        "7": "x (xx.x) x",
        "8": "x (xx.x) x",
        "9": "",
        "10": "x (xx.x) x",
        "11": "x (xx.x) x",
        "12": "",
        "13": "x (xx.x) x",
        "14": ""
    }
}
```
578 数据来源：列表 16.2.7-1.1^^Source: 列表 16.2.7-1.1
579 例数：发生不良事件的受试者人数；例次：发生不良事件的次数^^n: number of subjects with AEs; Events: number of AEs.
580 不良事件采用&MedDRA.进行编码^^AE is Encoded by &MedDRA.
581 SOC：系统器官分类，PT：首选术语^^SOC: System Organ Class; PT: Preferred Term.
582 一个受试者在用药期间发生了多次同一个系统器官分类/首选术语/严重程度内的不良事件，则对应系统器官分类/首选术语/严重程度的不良事件例数只计算一次，但例次分别计算^^If a subject has multiple AEs with the same SOC/PT/CTCAE severity grade during the treatment period, the number of subjects corresponding to the SOC/PT/CTCAE severity grade is counted only once, but the events are counted separately.
583 AE：不良事件；^^AE: Adverse Event
585 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
588 编程说明：
589 若某严重程度在试验期间没有AE发生，则不显示此严重程度
590 编程时根据实际字典及版本替换脚注中“&MedDRA.”内容 
591 当例数和例次为0时，例数 (%) 例次中展示为“0”
593 TEAE按系统器官、术语和严重程度汇总^^Summary of TEAE by System Organ Class, Preferred Term and CTCAE Severity Grade
安全性分析集^^Safety Set
594 数据来源：列表 16.2.7-1.1^^Source: 列表 16.2.7-1.1
595 例数：发生不良事件的受试者人数；例次：发生不良事件的次数;^^n: the number of subjects with adverse events; Events: the number of adverse events;
596 不良事件采用&MedDRA.进行编码;^^Adverse events are coded according to &MedDRA;
597 SOC：系统器官分类，PT：首选术语;^^SOC: System Organ Classification, PT: Preferred Term; 
598 一个受试者在用药期间发生了多次同一个系统器官分类/首选术语/严重程度内的不良事件，则对应系统器官分类/首选术语/严重程度的不良事件例数只计算一次，但例次分别计算^^If a subject has multiple adverse events during the medication period, the number of adverse events is counted only once, but the cases are counted separately;
599 TEAE：治疗期间不良事件.^^TEAE: Treatment Emergent AE
601 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
604 编程说明：
605 对所有TEAE按照表 14.3.1-1.2的表结构生成此表
606 编程时根据实际字典及版本替换脚注中“&MedDRA.”内容 
607 当例数和例次为0时，例数 (%) 例次中展示为“0”
609 与试验用药品相关的TEAE按系统器官、术语和严重程度汇总^^Summary of TEAEs of End of Study by System Organ Class, Preferred Term and CTCAE Severity Grade
安全性分析集
610 数据来源：列表 16.2.7-1.1^^Source: 列表 16.2.7-1.1
611 例数：发生不良事件的受试者人数；例次：发生不良事件的次数;^^n: the number of subjects with adverse events; Events: the number of adverse events;
612 不良事件采用&MedDRA.进行编码;^^Adverse events are coded according to &MedDRA;
613 SOC：系统器官分类，PT：首选术语;^^SOC: System Organ Classification, PT: Preferred Term; 
614 一个受试者在用药期间发生了多次同一个系统器官分类/首选术语/严重程度内的不良事件，则对应系统器官分类/首选术语/严重程度的不良事件例数只计算一次，但例次分别计算^^If a subject has multiple adverse events during the medication period, the number of adverse events is counted only once, but the cases are counted separately;
615 TEAE：治疗期间不良事件.^^TEAE: Treatment Emergent AE
617 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
619 编程说明：^^Programming Note:
620 对所有AE按照表 14.3.1-1.2的表结构生成此表^^Use the same shell with 表 14.3.1-1.2
621 编程时根据实际字典及版本替换脚注中“&MedDRA.”内容 
622 当例数和例次为0时，例数 (%) 例次中展示为“0”
Don't know what object this is
Don't know what object this is
Don't know what object this is
627 SAE按系统器官、术语和严重程度汇总^^Summary of SAE by System Organ Class, Preferred Term and CTCAE Severity Grade
安全性分析集^^Safety Set
628 数据来源：列表 16.2.7-1.1^^Source: 列表 16.2.7-1.1
629 例数：发生不良事件的受试者人数；例次：发生不良事件的次数^^n: number of subjects with AEs; Events: number of AEs.
630 不良事件采用&MedDRA.进行编码^^AE is Encoded by &MedDRA..
631 SOC：系统器官分类，PT：首选术语^^SOC: System Organ Class; PT: Preferred Term.
632 一个受试者在用药期间发生了多次同一个系统器官分类/首选术语/严重程度内的不良事件，则对应系统器官分类/首选术语/严重程度的不良事件例数只计算一次，但例次分别计算^^If a subject has multiple AEs with the same SOC/PT/CTCAE severity grade during the treatment period, the number of subjects corresponding to the SOC/PT/CTCAE severity grade is counted only once, but the events are counted separately.
633 SAE：严重不良事件；^^SAE: Serious AE
635 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
638 编程说明：^^Programming Note:
639 对所有SAE按照表 14.3.1-1.2的表结构生成此表^^Use the same shell with 表 14.3.1-1.2
640 编程时根据实际字典及版本替换脚注中“&MedDRA.”内容 
641 当例数和例次为0时，例数 (%) 例次中展示为“0”
643 TESAE按系统器官、术语和严重程度汇总^^Summary of TESAE by System Organ Class, Preferred Term and CTCAE Severity Grade
安全性分析集^^Safety Set
644 数据来源：列表 16.2.7-1.1^^Source: 列表 16.2.7-1.1
645 例数：发生不良事件的受试者人数；例次：发生不良事件的次数^^n: number of subjects with AEs; Events: number of AEs.
646 不良事件采用&MedDRA.进行编码^^AE is Encoded by &MedDRA..
647 SOC：系统器官分类，PT：首选术语^^SOC: System Organ Class; PT: Preferred Term.
648 一个受试者在用药期间发生了多次同一个系统器官分类/首选术语/严重程度内的不良事件，则对应系统器官分类/首选术语/严重程度的不良事件例数只计算一次，但例次分别计算^^If a subject has multiple AEs with the same SOC/PT/CTCAE severity grade during the treatment period, the number of subjects corresponding to the SOC/PT/CTCAE severity grade is counted only once, but the events are counted separately.
649 TESAE：治疗期严重不良事件；^^TESAE: Treatment-Emergent Serious AE
651 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
654 编程说明：^^Programming Note:
655 对所有TESAE按照表 14.3.1-1.2的表结构生成此表^^Use the same shell with 表 14.3.1-1.2
656 编程时根据实际字典及版本替换脚注中“&MedDRA.”内容 
657 当例数和例次为0时，例数 (%) 例次中展示为“0”
660 与研究药物相关的TESAE按系统器官、术语和严重程度汇总^^Summary of Treatment-related TESAEs of End of Study by System Organ Class, Preferred Term and CTCAE Severity Grade
安全性分析集^^Safety Set
Don't know what object this is
662 数据来源：列表 16.2.7-1.1^^Source: 列表 16.2.7-1.1
663 例数：发生不良事件的受试者人数；例次：发生不良事件的次数^^n: number of subjects with AEs; Events: number of AEs.
664 不良事件采用&MedDRA.进行编码^^AE is Encoded by &MedDRA..
665 SOC：系统器官分类，PT：首选术语^^SOC: System Organ Class; PT: Preferred Term.
666 一个受试者在用药期间发生了多次同一个系统器官分类/首选术语/严重程度内的不良事件，则对应系统器官分类/首选术语/严重程度的不良事件例数只计算一次，但例次分别计算^^If a subject has multiple AEs with the same SOC/PT/CTCAE severity grade during the treatment period, the number of subjects corresponding to the SOC/PT/CTCAE severity grade is counted only once, but the events are counted separately.
667 TESAE：治疗期严重不良事件。^^ TESAE: Treatment-Emergent Serious Adverse Event.
669 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
672 编程说明：^^Programming Note:
673 对所有与研究药物相关TESAE按照表 14.3.1-1.2的表结构生成此表^^Use the same shell with 表 14.3.1-1.2
674 编程时根据实际字典及版本替换脚注中“&MedDRA.”内容 
675 当例数和例次为0时，例数 (%) 例次中展示为“0”
677 导致退出实验的TEAE按系统器官、术语和严重程度汇总^^Summary of TEAEs leading to subject withdrawal from the study by System Organ Class, Preferred Term and CTCAE Severity Grade
安全性分析集^^Safety Set
678 数据来源：列表 16.2.7-1.1^^Source: 列表 16.2.7-1.1
679 例数：发生不良事件的受试者人数；例次：发生不良事件的次数^^n: number of subjects with AEs; Events: number of AEs.
680 不良事件采用&MedDRA.进行编码^^AE is Encoded by &MedDRA..
681 SOC：系统器官分类，PT：首选术语^^SOC: System Organ Class; PT: Preferred Term.
682 一个受试者在用药期间发生了多次同一个系统器官分类/首选术语/严重程度内的不良事件，则对应系统器官分类/首选术语/严重程度的不良事件例数只计算一次，但例次分别计算^^If a subject has multiple AEs with the same SOC/PT/CTCAE severity grade during the treatment period, the number of subjects corresponding to the SOC/PT/CTCAE severity grade is counted only once, but the events are counted separately.
683 TEAE：治疗期不良事件。^^TEAE: Treatment-Emergent Adverse Event.
685 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
688 编程说明：^^Programming Note:
689 对所有导致推出实验的TEAE按照表 14.3.1-1.2的表结构生成此表^^Use the same shell with 表 14.3.1-1.2
690 编程时根据实际字典及版本替换脚注中“&MedDRA.”内容 
691 当例数和例次为0时，例数 (%) 例次中展示为“0”
693 导致死亡的AE按系统器官、术语和严重程度汇总^^Summary of deaths related to AEs by System Organ Class, Preferred Term and CTCAE Severity Grade
安全性分析集^^Safety Set
694 数据来源：列表 16.2.7-1.1^^Source: 列表 16.2.7-1.1
695 例数：发生不良事件的受试者人数；例次：发生不良事件的次数^^n: number of subjects with AEs; Events: number of AEs.
696 不良事件采用&MedDRA.进行编码^^AE is Encoded by &MedDRA..
697 SOC：系统器官分类，PT：首选术语^^SOC: System Organ Class; PT: Preferred Term.
698 一个受试者在用药期间发生了多次同一个系统器官分类/首选术语/严重程度内的不良事件，则对应系统器官分类/首选术语/严重程度的不良事件例数只计算一次，但例次分别计算^^If a subject has multiple AEs with the same SOC/PT/CTCAE severity grade during the treatment period, the number of subjects corresponding to the SOC/PT/CTCAE severity grade is counted only once, but the events are counted separately.
699 AE：不良事件。^^AE: Adverse event.
701 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
704 编程说明：^^Programming Note:
705 对所有导致死亡的AE按照表 14.3.1-1.2的表结构生成此表^^Use the same shell with 表 14.3.1-1.2
706 编程时根据实际字典及版本替换脚注中“&MedDRA.”内容 
707 当例数和例次为0时，例数 (%) 例次中展示为“0”
709 药代动力学分析和排泄分析^^Pharmacokinetic Analysis and Excretion Analysis
710 血药浓度分析^^Drug Concentration Analysis
711 血浆实际采集时间（h）^^Actual Plasma Collection Times (h)
PK浓度集^^PK Concentration Set
```json
Error: table can't be loaded to json
```
713 NS：未采集该时间点样品；^^NS: No samples were collected at that time point;
714 *：该样品实际采集时间超窗^^*: The actual collection time of this sample was out of the window.
716 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
719 编程说明：^^Programming Note:
720 血液样本理论采集时间：给药前1 h和给药后1 h、2 h、4 h、6 h、9 h、12 h、24 h、36 h、48 h、72 h、96 h、120 h、144 h、168 h、360 h、408 h 和 504 h（编程时根据实际采集情况进行调整），展示到所有受试者中最长的采集时间点。
721 尽量保证表格在页面宽度以内，若无法实现则才分成多个续表，列表编号为：^^Try to ensure that the table is within the page width as much as possible. If it cannot be implemented, it will be divided into multiple continue tables. The list number is:
722 表 14.4.1-1.1.1 血浆实际采集时间（h）^^表 14.4.1-1.1.1 Actual Plasma Collection Times - Plasma samples (h)
723 表 14.4.1-1.1.2 血浆实际采集时间（h）-续表<1>^^表 14.4.1-1.1.2 Actual Plasma Collection Times (h)-Continue Table<1>
724 表 14.4.1-1.1.3 血浆实际采集时间（h）-续表<2>^^表 14.4.1-1.1.3 Actual Plasma Collection Times (h)-Continue Table<2>
725 ……^^……
726 修约规则：实际采血时间（h）<100，数值保留三位有效数字；≥100，数值四舍五入后保留整数值。
731 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆总放射性度（ng Eq./mL）^^The Total Radioactivity (ng Eq./mL) in Plasma following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
PK浓度集^^PK Concentration Set
```json
Error: table can't be loaded to json
```
733 BLQ：低于放射性定量下限（血浆总放射性浓度定量下限为XX ng Eq /mL），数值以零值参与描述性统计分析。^^BLQ: below the lower limit of radioactivity quantification (the lower limit of the total radioactivity in plasma is XX ng Eq /mL), values participated in descriptive statistical analysis with a zero value.
734 NS：无样品，未收集。NC：无法计算。^^NS: No sample, no collection. NC: Not calculated.
735 *：该样品实际采集时间超窗，不纳入描述性统计分析^^*: The actual collection time of this sample was out of the window and not included in descriptive statistical analysis.
737 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
740 编程说明：^^Programming Note:
741 如无特殊说明：对于BLQ 的血药浓度，均以零值参与计算，在列表中以“BLQ”作为该点血药浓度。
742 若浓度数据未收集或缺失，不对缺失数据进行填补，缺失数据不参与统计汇总，均以“NS”形式表示。
743 当PK 样本的实际采样时间超出方案规定的f采样时间窗时，仍然列出但不纳入该时间点浓度的描述性统计分析。
744 理论采集时间：给药前1 h和给药后1 h、2 h、4 h、6 h、9 h、12 h、24 h、36 h、48 h、72 h、96 h、120 h、144 h、168 h、360 h、408 h 和 504 h（编程时根据实际采集情况进行调整），展示到所有受试者中最长的采集时间点。
745 描述性统计分析中无法计算的数据，在表中以“NC”表示。
746 尽量保证表格在页面宽度以内，若无法实现则才分成多个续表，列表编号为：^^Try to ensure that the table is within the page width as much as possible. If it cannot be implemented, it will be divided into multiple continue tables. The list number is:
747 表 14.4.1-2.1.1 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆总放射性换算的质量浓度（ng Eq./mL）^^表 14.4.1-2.1.1 The Total Radioactivity (ng Eq./mL) in Plasma following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
748 表 14.4.1-2.1.2 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆总放射性换算的质量浓度（ng Eq./mL）-续表<1>^^表 14.4.1-2.1.2 The Total Radioactivity (ng Eq./mL) in Plasma following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi - Continue Table<1>
749 表 14.4.1-2.1.3 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆总放射性换算的质量浓度（ng Eq./mL）-续表<2>^^表 14.4.1-2.1.3 The Total Radioactivity (ng Eq./mL) in Plasma following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi - Continue Table<2>
750 ……^^……
751 修约规则：所有N及Nmiss取整数；质量浓度（ng/mL或ng Eq./mL）、药代动力学参数和描述性统计数据均保留三位有效数字；实际采血时间（h）<100，数值保留三位有效数字；≥100，数值四舍五入后保留整数值。
754 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血总放射性换算的质量浓度（ng Eq./mL）^^The Total Radioactivity (ng Eq./mL) in Whole Blood following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
PK浓度集^^PK Concentration Set
```json
Error: table can't be loaded to json
```
756 BLQ：低于放射性定量下限（全血总放射性浓度定量下限为XX ng Eq /mL），数值以零值参与描述性统计分析。^^BLQ: below the lower limit of radioactivity quantification (the lower limit of the total radioactivity in whole blood is XX ng Eq /mL), values participated in descriptive statistical analysis with a zero value.
757 NS：无样品，未收集。NC：无法计算。^^NS: No sample, no collection. NC: Not calculated.
758 *：该样品实际采集时间超窗，不纳入描述性统计分析^^*: The actual collection time of this sample was out of the window and not included in descriptive statistical analysis.
760 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
763 编程说明：^^Programming Note:
764 如无特殊说明：对于BLQ 的血药浓度，均以零值参与计算，在列表中以“BLQ”作为该点血药浓度。
765 理论采集时间：给药前1 h和给药后1 h、2 h、4 h、6 h、9 h、12 h、24 h、36 h、48 h、72 h、96 h、120 h、144 h、168 h、360 h、408 h 和 504 h（编程时根据实际采集情况进行调整），展示到所有受试者中最长的采集时间点。
766 若浓度数据未收集或缺失，不对缺失数据进行填补，缺失数据不参与统计汇总，均以“NS”形式表示。
767 当PK 样本的实际采样时间超出方案规定的采样时间窗时，仍然列出但不纳入该时间点浓度的描述性统计分析。
768 描述性统计分析中无法计算的数据，在列表中以“NC”表示。
769 尽量保证表格在页面宽度以内，若无法实现则才分成多个续表，列表编号为：
770 0.1 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血总放射性换算的质量浓度 (ng Eq./mL)
771 0.2 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血总放射性换算的质量浓度 (ng Eq./mL)-续表<1>
772 0.3 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血总放射性换算的质量浓度 (ng Eq./mL)-续表<2>
773 ……^^……
774 修约规则：所有N及Nmiss取整数；质量浓度（ng/mL或ng Eq./mL）、药代动力学参数和描述性统计数据均保留三位有效数字；实际采血时间（h）<100，数值保留三位有效数字；≥100，数值四舍五入后保留整数值。
776 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆中原形药AP306的浓度（ng/mL）^^The Concentration of Unchanged AP306 (ng/mL) in Plasma following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
PK浓度集^^PK Concentration Set
777 BLQ：低于定量下限（原形药AP306定量下限xxx ng/mL），数值以零值参与描述性统计分析。^^	BLQ: below the lower limit of quantification (the lower limit of Unchanged AP306 is xxx ng/mL), values participated in descriptive statistical analysis with a zero value.
778 NS：无样品，未收集。NC：无法计算。^^NS: No sample, no collection. NC: Not calculated.
779 *：该样品实际采集时间超窗，不纳入描述性统计分析。^^*: The actual collection time of this sample was out of the window and not included in descriptive statistical analysis.
781 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
784 编程说明：^^Programming Note:
785 按照Error! Reference source not found.的表结构采用血浆中原形药AP306的浓度（ng/mL）生成此表
786 理论采集时间：给药前1 h和给药后1 h、2 h、4 h、6 h、9 h、12 h、24 h、36 h、48 h、72 h、96 h、120 h、144 h、168 h、360 h、408 h 和 504 h（编程时根据实际采集情况进行调整），展示到所有受试者中最长的采集时间点。
787 如无特殊说明：对于BLQ 的血药浓度，均以零值参与计算，在列表中以“BLQ”作为该点血药浓度。
788 若浓度数据未收集或缺失，不对缺失数据进行填补，缺失数据不参与统计汇总，均以“NS”形式表示。
789 当PK 样本的实际采样时间超出方案规定的采样时间窗时，仍然列出但不纳入该时间点浓度的描述性统计分析。
790 描述性统计分析中无法计算的数据，在列表中以“NC”表示。
791 尽量保证表格在页面宽度以内，若无法实现则才分成多个续表，列表编号为：
792 表 14.4.1-2.3.1 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆中原形药AP306的浓度 (ng/mL)
793 表 14.4.1-2.3.2 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆中原形药AP306的浓度 (ng/mL)-续表<1>
794 表 14.4.1-2.3.3 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆中原形药AP306的浓度 (ng/mL)-续表<2>
795 ……^^……
796 修约规则：所有N及Nmiss取整数；质量浓度（ng/mL或ng Eq./mL）、药代动力学参数和描述性统计数据均保留三位有效数字；实际采血时间（h）<100，数值保留三位有效数字；≥100，数值四舍五入后保留整数值。
799 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血与血浆总放射性的比值^^Whole Blood-to-plasma Ratios of the Total Radioactivity following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
PK浓度集^^PK Concentration Set
```json
Error: table can't be loaded to json
```
801 NA：不适用，该时间点全血或血浆中放射性强度低于定量下限。不参与算术均值和标准差的计算。NC：无法计算。^^NA: Not applicable, the radioactivity in whole blood or plasma is below the lower quantification limit at this time point. Does not participate in the calculation of the mean and the SD. NC: Not Calculate.
803 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
806 编程说明：^^Programming Note:
807 理论采集时间：给药前1 h和给药后1 h、2 h、4 h、6 h、9 h、12 h、24 h、36 h、48 h、72 h、96 h、120 h、144 h、168 h、360 h、408 h 和 504 h（编程时根据实际采集情况进行调整），展示到所有受试者中最长的采集时间点。
808 同一受试者的相同时间点的全血与血浆总放射性进行计算，当比值为“NA”时，不参与该时间点算术均值和标准差计算。
809 描述性统计分析中无法计算的数据，在列表中以“NC”表示。
810 尽量保证表格在页面宽度以内，若无法实现则才分成多个续表，列表编号为：^^Try to ensure that the table is within the page width as much as possible. If it cannot be implemented, it will be divided into multiple continue tables. The list number is:
811 表 14.4.1-3.1.1 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血与血浆总放射性的比值^^表 14.4.1-3.1.1 Whole Blood-to-plasma Ratios of the Total Radioactivity following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
812 表 14.4.1-3.1.2 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血与血浆总放射性的比值-续表<1>^^表 14.4.1-3.1.2 Whole Blood-to-plasma Ratios of the Total Radioactivity following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi - Continue Table<1>
813 表 14.4.1-3.1.3 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血与血浆总放射性的比值-续表<2>^^表 14.4.1-3.1.3 Whole Blood-to-plasma Ratios of the Total Radioactivity following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi - Continue Table<2>
814 ……^^……
815 修约规则：全血与血浆总放射性的比值及相关计算的算术均值和标准差数据均保留三位有效数字；
818 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血和血浆总放射性（ng Eq./mL）、血浆中原形药AP306（ng/mL）的平均血药浓度和时间曲线图（算术均值±标准差）^^Total Radioactivity (ng Eq./mL) in Whole Blood and Plasma, Unchanged AP306 (ng/mL) in Plasma versus Time Linear Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi (Mean±SD)
PK浓度集^^PK Concentration Set
819 ^^
821 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
823 编程说明：
824 采用血浆总放射性浓度 (ng Eq./mL)、全血总放射性 (ng Eq./mL)、血浆中原形药AP306 (ng/mL)数据
825 在绘制平均药时曲线时，基于描述性统计分析绘制：曲线数据为平均浓度±标准差，使用浓度描述性统计的算术均值和标准差数据绘制，遵循BLQ均以0值参与计算的规则。如有缺失数据，画图时直接连接非缺失的数据点。
826 横轴为计划采血时间点 (单位)，范围能够展示所有受试者样本采集的最终时间点，大刻度以24的倍数划分 (如一个大刻度为24h或48h，如果时间轴不长尽量以24h划分)，小刻度以2的倍数划分 (如一个小刻度为2h或4h)，当平均药时曲线可绘制的最后一个时间点不超过24h时，大刻度以2h划分，小刻度以0.5h划分，当平均药时曲线可绘制的最后一个时间点不超过48h时，大刻度以4h划分，小刻度以1h划分；纵轴为血药浓度 (单位)，范围能够完整的显示曲线；标注分析物和基质。
827 平均药时曲线可绘制的最后一个时间点超过72h时，建议再提供一张0-24h的药时曲线图图 14.4.1-1.3，用于清晰的展示小时间点的浓度数据。
828 血药浓度时间曲线均需要使用实线，全血TRA曲线使用红色实线，血浆TRA曲线使用黑色实线，原形药浓度曲线使用蓝色实线，Mark空心不填充，样式无特殊要求，导出的曲线图中Mark大小需要能清晰展示；若有其它代谢产物则使用颜色和Mark样式不重复的深色实线。图例以“生物基质分析物（单位）”的形式横向展示于图片外下方，如血浆原形药AP306 (ng/mL)。
830 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血和血浆总放射性（ng Eq./mL）、血浆中原形药AP306的平均血药浓度和时间半对数曲线图（算术均值±标准差）^^Total Radioactivity (ng Eq./mL) in Whole Blood and Plasma, Unchanged AP306 in Plasma versus Time Semi-logarithmic Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi (Mean±SD)
PK浓度集^^PK Concentration Set
831 ^^
832 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
834 编程说明：
835 采用血浆总放射性浓度 (ng Eq./mL)、全血总放射性 (ng Eq./mL)、血浆原形药AP306 (ng/mL)数据
836 在绘制平均药时曲线时，基于描述性统计分析绘制：曲线数据为平均浓度±标准差，使用浓度描述性统计的算术均值和标准差数据绘制，遵循BLQ均以0值参与计算的规则。对于半对数曲线，0值按缺失处理。如有缺失数据，画图时直接连接非缺失的数据点。半对数坐标中中横坐标长度与非半对数坐标轴长度一致。
837 横轴为计划采血时间点 (单位)，范围能够展示所有受试者样本采集的最终时间点，大刻度以24的倍数划分 (如一个大刻度为24h或48h，如果时间轴不长尽量以24h划分)，小刻度以2的倍数划分 (如一个小刻度为2h或4h)，当平均药时曲线可绘制的最后一个时间点不超过24h时，大刻度以2h划分，小刻度以0.5h划分，当平均药时曲线可绘制的最后一个时间点不超过48h时，大刻度以4h划分，小刻度以1h划分；纵轴为血药浓度 (单位)，范围能够完整的显示曲线；标注分析物和基质。
838 平均药时曲线可绘制的最后一个时间点超过72h时，建议再提供一张0-24h的药时曲线图图 14.4.1-1.4，用于清晰的展示小时间点的浓度数据。
839 血药浓度时间曲线均需要使用实线，全血TRA曲线使用红色实线，血浆TRA曲线使用黑色实线，原形药浓度曲线使用蓝色实线，Mark空心不填充，样式无特殊要求，导出的曲线图中Mark大小需要能清晰展示；若有其它代谢产物则使用颜色和Mark样式不重复的深色实线。图例以“生物基质分析物（单位）”的形式横向展示于图片外下方，如血浆原形药AP306 (ng/mL)。
841 6例受试者单次口服约150mg/200µCi的[14C]AP306后0-24h内全血和血浆总放射性（ng Eq./mL）、血浆中原形药AP306（ng/mL）的平均血药浓度和时间曲线图（算术均值±标准差）^^Total Radioactivity (ng Eq./mL) in Whole Blood and Plasma, Unchanged AP306 (ng/mL) in Plasma versus Time Linear Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi within 24h postdose (Mean±SD)
PK浓度集^^PK Concentration Set
842 ^^
843 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
845 编程说明：
846 平均药时曲线图 14.4.1-1.1可绘制的最后一个时间点超过72h时提供
847 横轴为计划采血时间点 (单位)，大刻度以2h划分，小刻度以0.5h划分；纵轴为血药浓度 (单位)，范围能够完整的显示曲线。
849 6例受试者单次口服约150mg/200µCi的[14C]AP306后0-24h内全血和血浆总放射性（ng Eq./mL）、血浆中原形药AP306（ng/mL）的平均血药浓度和时间半对数曲线图（算术均值±标准差）^^Total Radioactivity (ng Eq./mL) in Whole Blood and Plasma, Unchanged AP306 (ng/mL) in Plasma versus Time Semi-logarithmic Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi within 24h postdose (Mean±SD)
PK浓度集^^PK Concentration Set
850 ^^
851 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
853 编程说明：
854 平均药时曲线图 14.4.1-1.2可绘制的最后一个时间点超过72h时提供
855 横轴为计划采血时间点 (单位)，大刻度以2h划分，小刻度以0.5h划分；纵轴为血药浓度 (单位)，范围能够完整的显示曲线。
856 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血总放射性（ng Eq./mL）与时间的个体曲线线性坐标图^^Individual Total Radioactivity (ng Eq./mL) in Whole Blood versus Time Linear Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
PK浓度集^^PK Concentration Set
857 ^^
859 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
861 编程说明：
862 线性坐标图中每条曲线表示一名受试者的全血总放射性 (ng Eq./mL)浓度与时间的线性关系；提供以分析物和基质划分的6例受试者在一张图上的浓度-时间曲线图
863 横轴为实际采血时间点 (单位)，范围能够展示所有受试者样本采集的最终时间点，大的刻度以24的倍数划分 (如一个大刻度为24h或48h，如果时间轴不长尽量以24h划分)，小刻度以2的倍数划分 (如一个小刻度为2h或4h)，当个体药时曲线可绘制的最后一个时间点不超过24h时，大刻度以2h划分，小刻度以0.5h划分，当个体药时曲线可绘制的最后一个时间点不超过48h时，大刻度以4h划分，小刻度以1h划分；纵轴为血药浓度 (单位)，范围能够完整的显示曲线；标注受试者编号
864 在绘制个体血药浓度-时间曲线时，如无特殊说明：对于BLQ 的血药浓度，Tmax之前出现的按零值处理；Tmax 之后出现的BLQ 处理为缺失，末端连续的BLQ 之后的可测定浓度在个体曲线上保留。如有缺失数据，画图时直接连接非缺失的数据点。
865 血药浓度时间曲线均需要使用颜色和Mark样式不重复的深色实线，Mark空心不填充，导出的曲线图中Mark大小需要能清晰展示。图例横向展示于图片外下方。
867 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血总放射性（ng Eq./mL）与时间的个体曲线半对数坐标图^^Individual Total Radioactivity(ng Eq./mL) in Whole Blood versus Time Semi-logarithmic Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
PK浓度集^^PK Concentration Set
868 ^^
870 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
872 编程说明：
873 半对数图中每条曲线表示一名受试者的全血总放射性 (ng Eq./mL)浓度与时间的半对数关系
874 提供以分析物和基质划分的6例受试者在一张图上的浓度-时间曲线图
875 横轴为实际采血时间点 (单位)，范围能够展示所有受试者样本采集的最终时间点，大的刻度以24的倍数划分 (如一个大刻度为24h或48h，如果时间轴不长尽量以24h划分)，小刻度以2的倍数划分 (如一个小刻度为2h或4h)，当个体药时曲线可绘制的最后一个时间点不超过24h时，大刻度以2h划分，小刻度以0.5h划分，当个体药时曲线可绘制的最后一个时间点不超过48h时，大刻度以4h划分，小刻度以1h划分；纵轴为血药浓度 (单位)，范围能够完整的显示曲线；标注受试者编号
876 在绘制个体血药浓度-时间曲线时，如无特殊说明：对于BLQ 的血药浓度，Tmax之前出现的按零值处理；Tmax 之后出现的BLQ 处理为缺失，末端连续的BLQ 之后的可测定浓度在个体曲线上保留。如有缺失数据，画图时直接连接非缺失的数据点。对于半对数曲线，0值按缺失处理。
877 血药浓度时间曲线均需要使用颜色和Mark样式不重复的深色实线，Mark空心不填充，导出的曲线图中Mark大小需要能清晰展示。图例横向展示于图片外下方。
879 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆总放射性（ng Eq./mL）与时间的个体曲线线性坐标图^^Individual Total Radioactivity(ng Eq./mL) in Plasma versus Time Linear Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
PK浓度集^^PK Concentration Set
880 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
882 编程说明：^^Programming Note:
883 按照图 14.4.1-2.1的结构生成此线性坐标图，线性坐标图中每条曲线表示一名受试者的血浆总放射性 (ng Eq./mL)浓度与时间的线性关系^^This linear graph is generated according to the structure of 图 14.4.1-2.1 , where each curve represents the linear relationship between the concentration of total plasma radioactivity (ng Eq/mL) and time for one subject.
884 提供以分析物和基质划分的6例受试者在一张图上的浓度-时间曲线图
885 横轴为实际采血时间点 (单位)，范围能够展示所有受试者样本采集的最终时间点，大的刻度以24的倍数划分 (如一个大刻度为24h或48h，如果时间轴不长尽量以24h划分)，小刻度以2的倍数划分 (如一个小刻度为2h或4h)，当个体药时曲线可绘制的最后一个时间点不超过24h时，大刻度以2h划分，小刻度以0.5h划分，当个体药时曲线可绘制的最后一个时间点不超过48h时，大刻度以4h划分，小刻度以1h划分；纵轴为血药浓度 (单位)，范围能够完整的显示曲线；标注受试者编号
886 在绘制个体血药浓度-时间曲线时，如无特殊说明：对于BLQ 的血药浓度，Tmax之前出现的按零值处理；Tmax 之后出现的BLQ 处理为缺失，末端连续的BLQ 之后的可测定浓度在个体曲线上保留。如有缺失数据，画图时直接连接非缺失的数据点。
887 血药浓度时间曲线均需要使用颜色和Mark样式不重复的深色实线，Mark空心不填充，导出的曲线图中Mark大小需要能清晰展示。图例横向展示于图片外下方。
889 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆总放射性（ng Eq./mL）与时间的个体曲线半对数坐标图^^Individual Total Radioactivity(ng Eq./mL) in Plasma versus Time Semi-logarithmic Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
PK浓度集^^PK Concentration Set
891 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
893 编程说明：^^Programming Note:
894 按照图 14.4.1-2.2的结构生成此半对数图，半对数图中每条曲线表示一名受试者的血浆总放射性（ng Eq./mL）浓度与时间的半对数关系^^This linear graph is generated according to the structure of 图 14.4.1-2.2, where each curve represents the linear relationship between the concentration of total plasma radioactivity (ng Eq/mL) and time for one subject.
895 提供以分析物和基质划分的6例受试者叠加绘制的浓度-时间曲线图
896 横轴为实际采血时间点 (单位)，范围能够展示所有受试者样本采集的最终时间点，大的刻度以24的倍数划分 (如一个大刻度为24h或48h，如果时间轴不长尽量以24h划分)，小刻度以2的倍数划分 (如一个小刻度为2h或4h)，当个体药时曲线可绘制的最后一个时间点不超过24h时，大刻度以2h划分，小刻度以0.5h划分，当个体药时曲线可绘制的最后一个时间点不超过48h时，大刻度以4h划分，小刻度以1h划分；纵轴为血药浓度 (单位)，范围能够完整的显示曲线；标注受试者编号
897 在绘制个体血药浓度-时间曲线时，如无特殊说明：对于BLQ 的血药浓度，Tmax之前出现的按零值处理；Tmax 之后出现的BLQ 处理为缺失，末端连续的BLQ 之后的可测定浓度在个体曲线上保留。如有缺失数据，画图时直接连接非缺失的数据点。对于半对数曲线，0值按缺失处理。
898 血药浓度时间曲线均需要使用颜色和Mark样式不重复的深色实线，Mark空心不填充，导出的曲线图中Mark大小需要能清晰展示。图例横向展示于图片外下方。
900 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆中原形药AP306（ng/mL）与时间的个体曲线线性坐标图^^Individual Unchanged AP306 (ng/mL) in Plasma versus Time Linear Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
PK浓度集^^PK Concentration Set
901 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
904 编程说明：^^Programming Note:
905 按照图 14.4.1-2.1的结构生成此线性坐标图，线性坐标图中每条曲线表示一名受试者的血浆中原形药AP306 (ng/mL)浓度与时间的线性关系^^This linear graph is generated according to the structure of 图 14.4.1-2.2, where each curve represents the linear relationship between the concentration of total plasma radioactivity (ng Eq/mL) and time for one subject.
906 提供以分析物和基质划分的6例受试者在一张图上的浓度-时间曲线图
907 横轴为实际采血时间点 (单位)，范围能够展示所有受试者样本采集的最终时间点，大的刻度以24的倍数划分 (如一个大刻度为24h或48h，如果时间轴不长尽量以24h划分)，小刻度以2的倍数划分 (如一个小刻度为2h或4h)，当个体药时曲线可绘制的最后一个时间点不超过24h时，大刻度以2h划分，小刻度以0.5h划分，当个体药时曲线可绘制的最后一个时间点不超过48h时，大刻度以4h划分，小刻度以1h划分；纵轴为血药浓度 (单位)，范围能够完整的显示曲线；标注受试者编号
908 在绘制个体血药浓度-时间曲线时，如无特殊说明：对于BLQ 的血药浓度，Tmax之前出现的按零值处理；Tmax 之后出现的BLQ 处理为缺失，末端连续的BLQ 之后的可测定浓度在个体曲线上保留。如有缺失数据，画图时直接连接非缺失的数据点。
909 血药浓度时间曲线均需要使用颜色和Mark样式不重复的深色实线，Mark空心不填充，导出的曲线图中Mark大小需要能清晰展示。图例横向展示于图片外下方。
911 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆中原形药AP306（ng/mL）与时间的个体曲线半对数坐标图^^Individual Unchanged AP306 (ng/mL) in Plasma versus Time Semi-logarithmic Scale Curves following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
PK浓度集^^PK Concentration Set
912 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
914 编程说明：^^Programming Note:
915 按照图 14.4.1-2.2的结构生成此半对数图，半对数图中每条曲线表示一名受试者的血浆中原形药AP306（ng/mL）浓度与时间的线性/半对数关系^^This linear graph is generated according to the structure of 图 14.4.1-2.2, where each curve represents the linear relationship between the concentration of total plasma radioactivity (ng Eq/mL) and time for one subject.
916 提供以分析物和基质划分的6例受试者叠加绘制的浓度-时间曲线图
917 横轴为实际采血时间点 (单位)，范围能够展示所有受试者样本采集的最终时间点，大的刻度以24的倍数划分 (如一个大刻度为24h或48h，如果时间轴不长尽量以24h划分)，小刻度以2的倍数划分 (如一个小刻度为2h或4h)，当个体药时曲线可绘制的最后一个时间点不超过24h时，大刻度以2h划分，小刻度以0.5h划分，当个体药时曲线可绘制的最后一个时间点不超过48h时，大刻度以4h划分，小刻度以1h划分；纵轴为血药浓度 (单位)，范围能够完整的显示曲线；标注受试者编号
918 在绘制个体血药浓度-时间曲线时，如无特殊说明：对于BLQ 的血药浓度，Tmax之前出现的按零值处理；Tmax 之后出现的BLQ 处理为缺失，末端连续的BLQ 之后的可测定浓度在个体曲线上保留。如有缺失数据，画图时直接连接非缺失的数据点。对于半对数曲线，0值按缺失处理。
919 血药浓度时间曲线均需要使用颜色和Mark样式不重复的深色实线，Mark空心不填充，导出的曲线图中Mark大小需要能清晰展示。图例横向展示于图片外下方。
922 药代动力学参数分析^^Analysis of the Pharmacokinetic Parameters
923 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆总放射性的主要药代动力学参数^^Pharmacokinetic Parameters of the Total Radioactivity in Plasma following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
PK参数集^^PK Parameter Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "编号1^^Subject No.1*",
        "1": "编号2^^Subject No.2",
        "2": "编号3^^Subject No.3",
        "3": "编号4^^Subject No.4",
        "4": "编号5^^Subject No.5",
        "5": "编号6^^Subject No.6",
        "6": "N",
        "7": "Nmiss",
        "8": "Mean",
        "9": "SD",
        "10": "CV%",
        "11": "Median",
        "12": "Q1",
        "13": "Q3",
        "14": "Min",
        "15": "Max",
        "16": "Geometric Mean",
        "17": "Geometric CV%"
    },
    "Cmax\n(ng Eq./mL)": {
        "0": "xxx",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "xxx",
        "5": "xxx",
        "6": "x",
        "7": "x",
        "8": "xxx",
        "9": "xxx",
        "10": "xxx",
        "11": "xxx",
        "12": "xxx",
        "13": "xxx",
        "14": "xxx",
        "15": "xxx",
        "16": "xxx",
        "17": "xxx"
    }
}
```
926 *：末消除相回归拟合优度 (Rsq_adjusted)小于0.8<或AUC_%Extrap大于20%>时，汇报t1/2、AUC0-∞、MRT0-∞、λz、Vz/F、CL/F、Rsq_adjusted、N_first、N_last和AUC_%Extrap，但不纳入描述性统计分析。^^*: When the goodness-of-fit (Rsq_adjusted) was less than 0.8< or AUC_%Extrap was more than 20%>, t1/2, AUC0-∞, MRT0-∞, λz, Vz/F, CL/F, Rsq_adjusted, N_first, N_last and AUC_%Extrap were reported, but they were not included in the statistical description.
927 NA：不适用，无法提供。NC：无法计算。^^NA: Not applicable, not available. NC: Not Calculate.
929 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
932 编程说明：
933 采用血浆总放射性浓度（ng Eq./mL）数据，以实际采样时间计算
934 PK参数包括：Cmax、Tmax、AUC0-t、AUC0-∞、MRT0-t、MRT0-∞、t1/2、Vz/F、CL/F、λz、Rsq_adjusted
935 在进行药代动力学参数计算时，如无特殊说明：对于BLQ 的血药浓度，Tmax 之前出现的BLQ以零值参与计算；Tmax 之后出现的BLQ处理为缺失，但两个可测定浓度之间的BLQ 处理为缺失，末端连续的BLQ 之后的可测定浓度也处理为缺失
936 对于末端消除数据少于3个的情况，无法计算t1/2、AUC0-∞、MRT0-∞、Vz/F、CL/F、Rsq_adjusted、λz、N_first、N_last、AUC%Extrap参数，表格中以“NA”表示，并且不参与描述性统计。
937 描述性统计分析中无法计算的数据，在列表中以“NC”表示。
938 修约规则：所有N及Nmiss取整数；质量浓度（ng/mL或ng Eq./mL）、药代动力学参数和描述性统计数据均保留三位有效数字；
Don't know what object this is
941 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆中原形药AP306的主要药代动力学参数^^Pharmacokinetic Parameters of Unchanged AP306 in Plasma following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
PK参数集^^PK Parameter Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "编号1^^Subject No.1*",
        "1": "编号2^^Subject No.2",
        "2": "编号3^^Subject No.3",
        "3": "编号4^^Subject No.4",
        "4": "编号5^^Subject No.5",
        "5": "编号6^^Subject No.6",
        "6": "N",
        "7": "Nmiss",
        "8": "Mean",
        "9": "SD",
        "10": "CV%",
        "11": "Median",
        "12": "Q1",
        "13": "Q3",
        "14": "Min",
        "15": "Max",
        "16": "Geometric Mean",
        "17": "Geometric CV%"
    },
    "Cmax\n(ng/mL)": {
        "0": "xxx",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "xxx",
        "5": "xxx",
        "6": "x",
        "7": "x",
        "8": "xxx",
        "9": "xxx",
        "10": "xxx",
        "11": "xxx",
        "12": "xxx",
        "13": "xxx",
        "14": "xxx",
        "15": "xxx",
        "16": "xxx",
        "17": "xxx"
    }
}
```
943 *：末消除相回归拟合优度 (Rsq_adjusted)小于0.8<或AUC_%Extrap大于20%>时，汇报t1/2、AUC0-∞、MRT0-∞、λz、Vz/F、CL/F、Rsq_adjusted、N_first、N_last和AUC_%Extrap，但不纳入描述性统计分析。^^*: When the goodness-of-fit (Rsq_adjusted) was less than 0.8< or AUC_%Extrap was more than 20%>, t1/2, AUC0-∞, MRT0-∞, λz, Vz/F, CL/F, Rsq_adjusted, N_first, N_last and AUC_%Extrap were reported, but they were not included in the statistical description.
944 NA：不适用，无法提供。NC：无法计算。^^NA: Not applicable, not available. NC: Not Calculate.
946 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
949 编程说明：^^Programming Note:
950 按照表 14.4.2-1.1的表结构，采用血浆中原形药AP306的浓度（ng/mL）数据，以实际采样时间计算生成此表^^Use the same shell with 表 14.4.2-1.1Error! Reference source not found. the plasma concentration (ng/mL) data of unchanged 原形药AP306 1 were used to generate this table based on the actual sampling time.
951 PK参数包括：Cmax、Tmax、AUC0-t、AUC0-∞、MRT0-t、MRT0-∞、t1/2、Vz/F、CL/F、λz、Rsq_adjusted
952 在进行药代动力学参数计算时，如无特殊说明：对于BLQ 的血药浓度，Tmax 之前出现的BLQ以零值参与计算；Tmax 之后出现的BLQ 处理为缺失，但两个可测定浓度之间的BLQ 处理为缺失，末端连续的BLQ 之后的可测定浓度也处理为缺失
953 对于末端消除数据少于3个的情况，无法计算t1/2、AUC0-∞、MRT0-∞、λz、Vz/F、CL/F、Rsq_adjusted、N_first、N_last和AUC_%Extrap，表格中以“NA”表示，并且不参与描述性统计。
954 描述性统计分析中无法计算的数据，在列表中以“NC”表示。
955 修约规则：所有N及Nmiss取整数；质量浓度（ng/mL或ng Eq./mL）、药代动力学参数和描述性统计数据均保留三位有效数字；
958 放射性排泄统计分析^^Statistical Analysis of the Radioactivity Excretion
959 6例受试者单次口服约150mg/200µCi的[14C]AP306后尿液和粪便中总放射性回收率（% 给药量）^^Percentages of the Administrated Dose Recovered in Urine and Feces following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi (% Dose)
物质平衡分析集^^Mass Balance Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "编号1^^Subject No.1",
        "1": "编号2^^Subject No.2",
        "2": "编号3^^Subject No.3",
        "3": "编号4^^Subject No.4",
        "4": "编号5^^Subject No.5",
        "5": "编号6^^Subject No.6",
        "6": "算术均值^^Mean",
        "7": "标准差^^SD"
    },
    "尿液^^Urine": {
        "0": "xx.xx",
        "1": "xx.xx",
        "2": "xx.xx",
        "3": "xx.xx",
        "4": "xx.xx",
        "5": "xx.xx",
        "6": "xx.xx",
        "7": "xx.xx"
    },
    "粪便^^Feces": {
        "0": "x.xx",
        "1": "x.xx",
        "2": "x.xx",
        "3": "x.xx",
        "4": "x.xx",
        "5": "x.xx",
        "6": "x.xx",
        "7": "x.xx"
    }
}
```
961 NA：不适用，无法提供。NC：无法计算。^^NA: Not applicable, not available. NC: Not Calculate.
963 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
965 编程说明：
966 当尿粪样品放射性回收率低于定量下限（BLQ）时，将按照零值参与累计回收率计算；受试者未采集时间段的数据，将按照零值参与累计回收率计算；
967 回收率相关百分比数据及相关计算的算术均值和标准差保留两位小数；
Don't know what object this is
971 6例受试者单次口服约150mg/200µCi的[14C]AP306后尿液和粪便各采集时间段的放射性回收率（% 给药量）^^Incremental Recovery of the Total Radioactivity in Urine and Feces following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi (% Dose)
物质平衡分析集^^Mass Balance Set
```json
{
    "生物基质^^Biological Matrix": {
        "0": "尿液^^Urine",
        "1": "尿液^^Urine",
        "2": "尿液^^Urine",
        "3": "尿液^^Urine",
        "4": "尿液^^Urine",
        "5": "尿液^^Urine",
        "6": "尿液^^Urine",
        "7": "尿液^^Urine",
        "8": "尿液^^Urine",
        "9": "尿液^^Urine",
        "10": "尿液^^Urine",
        "11": "尿液^^Urine",
        "12": "尿液^^Urine",
        "13": "尿液^^Urine",
        "14": "尿液^^Urine",
        "15": "尿液^^Urine",
        "16": "粪便^^Feces",
        "17": "粪便^^Feces",
        "18": "粪便^^Feces",
        "19": "粪便^^Feces",
        "20": "粪便^^Feces",
        "21": "粪便^^Feces",
        "22": "粪便^^Feces",
        "23": "粪便^^Feces",
        "24": "粪便^^Feces",
        "25": "粪便^^Feces",
        "26": "粪便^^Feces",
        "27": "粪便^^Feces",
        "28": "粪便^^Feces"
    },
    "时间 (h)^^Time (h)": {
        "0": "-24~0",
        "1": "0~4",
        "2": "4~8",
        "3": "8~12",
        "4": "12~24",
        "5": "24~48",
        "6": "48~72",
        "7": "72~96",
        "8": "96~120",
        "9": "120~144",
        "10": "144~168",
        "11": "168~192",
        "12": "192~216",
        "13": "216~240",
        "14": "…",
        "15": "累加值^^Sub-total",
        "16": "-48~0",
        "17": "0~24",
        "18": "24~48",
        "19": "48~72",
        "20": "72~96",
        "21": "96~120",
        "22": "120~144",
        "23": "144~168",
        "24": "168~192",
        "25": "192~216",
        "26": "216~240",
        "27": "…",
        "28": "累加值^^Sub-total"
    },
    "编号1^^Subject No.1": {
        "0": "xx.xx",
        "1": "xx.xx",
        "2": "xx.xx",
        "3": "xx.xx",
        "4": "xx.xx",
        "5": "xx.xx",
        "6": "xx.xx",
        "7": "xx.xx",
        "8": "xx.xx",
        "9": "xx.xx",
        "10": "xx.xx",
        "11": "xx.xx",
        "12": "xx.xx",
        "13": "xx.xx",
        "14": "",
        "15": "xx.xx",
        "16": "xx.xx",
        "17": "xx.xx",
        "18": "xx.xx",
        "19": "xx.xx",
        "20": "xx.xx",
        "21": "xx.xx",
        "22": "xx.xx",
        "23": "xx.xx",
        "24": "xx.xx",
        "25": "xx.xx",
        "26": "xx.xx",
        "27": "",
        "28": "xx.xx"
    }
}
```
973 BLQ：低于放射性定量下限^^BLQ: below the lower limit of quantitation of radioactivity.
974 NS：无样品，未收集。^^NS: No sample, no collection.
976 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
978 编程说明：
979 尿液采集时间段：收集给药前24-0 h的随机尿液样本、给药后0-4 h、4-8 h、8-12 h、12-24 h、24-48 h、48-72 h、72-96 h、96-120 h、120-144 h、144-168 h、168-192 h、192-216 h、216-240 h、240~264 h、264~288 h、288~312 h、312~336 h、336~360 h、360~384 h、384~408 h、408~432 h、432~456 h、456~480 h、480~504 h各时间间隔内所有排泄的尿液（编程时根据实际采集情况进行调整）。
980 粪便采集时间段：收集给药前48-0 h的随机粪便样本、给药后0-24 h、24-48 h、48-72 h、72-96 h、96120 h、120-144 h、144-168 h、168-192 h、192-216 h、216-240 h、240-264 h、264-288 h、288-312 h、312-336 h、336-360 h、360-384 h、384-408 h、408-432 h、432-456 h、456-480 h、480-504 h各时间间隔内所有排泄的粪便（编程时根据实际采集情况进行调整）。
981 受试者未采集时间段的数据用“NS”表示，所有受试者共同采集结束后的时间段不展示。例如：如果受试者1尿液采集到168h, 其他受试者尿液采集到192h, 则受试者1的168h~192h 尿液采集数值为“NS”，且所有受试者不显示192~216以及216~240两行内容。“NS”不纳入统计分析。
982 当尿粪样品放射性回收率低于定量下限（BLQ）时，将按照零值参与累计回收率计算，在列表中以“BLQ”作为该点结果。
983 回收率相关百分比数据及相关计算的算术均值和标准差保留两位小数；
Don't know what object this is
986 6例受试者单次口服约150mg/200µCi的[14C]AP306后尿液和粪便的累计放射性回收率（% 给药量）^^Cumulative Recovery of the Total Radioactivity in Urine and Feces following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi (% Dose)
物质平衡分析集^^Mass Balance Set
```json
{
    "生物基质^^Biological Matrix": {
        "0": "尿液^^Urine",
        "1": "尿液^^Urine",
        "2": "尿液^^Urine",
        "3": "尿液^^Urine",
        "4": "尿液^^Urine",
        "5": "尿液^^Urine",
        "6": "尿液^^Urine",
        "7": "尿液^^Urine",
        "8": "尿液^^Urine",
        "9": "尿液^^Urine",
        "10": "尿液^^Urine",
        "11": "尿液^^Urine",
        "12": "尿液^^Urine",
        "13": "尿液^^Urine",
        "14": "尿液^^Urine",
        "15": "粪便^^Feces",
        "16": "粪便^^Feces",
        "17": "粪便^^Feces",
        "18": "粪便^^Feces",
        "19": "粪便^^Feces",
        "20": "粪便^^Feces",
        "21": "粪便^^Feces",
        "22": "粪便^^Feces",
        "23": "粪便^^Feces",
        "24": "粪便^^Feces",
        "25": "粪便^^Feces",
        "26": "粪便^^Feces",
        "27": "总放射性\n回收率^^Total Radioactive Recovery"
    },
    "时间 (h)^^Time (h)": {
        "0": "-24~0",
        "1": "0~4",
        "2": "0~8",
        "3": "0~12",
        "4": "0~24",
        "5": "0~48",
        "6": "0~72",
        "7": "0~96",
        "8": "0~120",
        "9": "0~144",
        "10": "0~168",
        "11": "0~192",
        "12": "0~216",
        "13": "0~240",
        "14": "…",
        "15": "-48~0",
        "16": "0~24",
        "17": "0~48",
        "18": "0~72",
        "19": "0~96",
        "20": "0~120",
        "21": "0~144",
        "22": "0~168",
        "23": "0~192",
        "24": "0~216",
        "25": "0~240",
        "26": "…",
        "27": ""
    },
    "编号1^^Subject No.1": {
        "0": "xx.xx",
        "1": "xx.xx",
        "2": "xx.xx",
        "3": "xx.xx",
        "4": "xx.xx",
        "5": "xx.xx",
        "6": "xx.xx",
        "7": "xx.xx",
        "8": "xx.xx",
        "9": "xx.xx",
        "10": "xx.xx",
        "11": "xx.xx",
        "12": "xx.xx",
        "13": "xx.xx",
        "14": "",
        "15": "xx.xx",
        "16": "xx.xx",
        "17": "xx.xx",
        "18": "xx.xx",
        "19": "xx.xx",
        "20": "xx.xx",
        "21": "xx.xx",
        "22": "xx.xx",
        "23": "xx.xx",
        "24": "xx.xx",
        "25": "xx.xx",
        "26": "",
        "27": "xx.xx"
    }
}
```
988 BLQ：低于放射性定量下限^^BLQ: below the lower limit of quantitation of radioactivity.
989 NS：无样品，未收集。^^NS: No sample, no collection.
991 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
993 编程说明：
994 尿液采集时间段：收集给药前24-0 h的随机尿液样本、给药后0-4 h、4-8 h、8-12 h、12-24 h、24-48 h、48-72 h、72-96 h、96-120 h、120-144 h、144-168 h、168-192 h、192-216 h、216-240 h、240~264 h、264~288 h、288~312 h、312~336 h、336~360 h、360~384 h、384~408 h、408~432 h、432~456 h、456~480 h、480~504 h各时间间隔内所有排泄的尿液（编程时根据实际采集情况进行调整）。
995 粪便采集时间段：收集给药前48-0 h的随机粪便样本、给药后0-24 h、24-48 h、48-72 h、72-96 h、96120 h、120-144 h、144-168 h、168-192 h、192-216 h、216-240 h、240-264 h、264-288 h、288-312 h、312-336 h、336-360 h、360-384 h、384-408 h、408-432 h、432-456 h、456-480 h、480-504 h各时间间隔内所有排泄的粪便（编程时根据实际采集情况进行调整）。
996 所有受试者共同采集结束后的时间段不展示。例如：如果受试者1尿液采集到168h，其他受试者尿液采集到192h，则所有受试者展示到0~192h，不显示0~216以及0~240两行内容。未采集时间段的数据，将按照零值参与累计回收率计算。对于给药前采集时间段未采集的情况，按“NS”展示，如给药后首个采集时间段为“NS”，则应展示为“0.00”。
997 当尿粪样品放射性回收率低于定量下限（BLQ）时，将按照零值参与累计回收率计算。对于给药前采集时间段BLQ的情况，按“BLQ”展示，如给药后首个采集时间段为“BLQ”，则应展示为“0.00”。
998 回收率相关百分比数据及相关计算的算术均值和标准差保留两位小数；
1000 6例受试者单次口服约150mg/200µCi的[14C]AP306后尿液和粪便的平均累计放射性回收率（% 给药量）^^Mean Cumulative Recovery of the Total Radioactivity in Urine and Feces following a Single Oral Dose of [14C]AP306in 6 Subjects at 150 mg/200 µCi (% Dose)
物质平衡分析集^^Mass Balance Set
```json
Error: table can't be loaded to json
```
1002 NA：不适用，未采集该时间段样品^^NA: Not applicable, samples for this time period were not collected
1004 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1006 编程说明：
1007 尿液采集时间段：收集给药前24-0 h的随机尿液样本、给药后0-4 h、4-8 h、8-12 h、12-24 h、24-48 h、48-72 h、72-96 h、96-120 h、120-144 h、144-168 h、168-192 h、192-216 h、216-240 h、240~264 h、264~288 h、288~312 h、312~336 h、336~360 h、360~384 h、384~408 h、408~432 h、432~456 h、456~480 h、480~504 h各时间间隔内所有排泄的尿液（编程时根据实际采集情况进行调整）。
1008 粪便采集时间段：收集给药前48-0 h的随机粪便样本、给药后0-24 h、24-48 h、48-72 h、72-96 h、96120 h、120-144 h、144-168 h、168-192 h、192-216 h、216-240 h、240-264 h、264-288 h、288-312 h、312-336 h、336-360 h、360-384 h、384-408 h、408-432 h、432-456 h、456-480 h、480-504 h各时间间隔内所有排泄的粪便（编程时根据实际采集情况进行调整）。
1009 所有受试者共同采集结束后的时间段不展示。例如：如果受试者1尿液采集到168h，其他受试者尿液采集到192h，则所有受试者展示到0~192h，不显示0~216以及0~240两行内容。未采集时间段的数据，将按照零值参与回收率计算
1010 当尿粪样品放射性回收率低于定量下限（BLQ）时，将按照零值参与回收率计算
1011 回收率相关百分比数据及相关计算的算术均值和标准差保留两位小数；
1012 6例受试者单次口服约150mg/200µCi的[14C]AP306后平均累计放射性回收率曲线（算术均值±标准差）^^Mean Cumulative Recovery of Total Radioactivity following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi (Mean±SD)
物质平衡分析集^^Mass Balance Set
1013 ^^
1015 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1017 编程说明：
1018 绘图基于表 14.4.3-1.4中算术均值、标准差数据，曲线数据为平均回收率±标准差。 
1019 横轴为“时间（小时）”，大的刻度以24的倍数划分 (如一个大刻度为24h或48h，如果时间轴不长尽量以24h划分)，小刻度以4的倍数划分 (如一个小刻度为4h或8h)；纵轴为“累计放射性回收率（% 给药量）”，范围为0-100，以10划分大刻度；回收率曲线从0h回收率为0开始绘制。标注基质。
1020 曲线均需要使用实线，尿液曲线使用红色实线，粪便曲线使用蓝色实线，总回收率（尿液+粪便）曲线使用黑色实线，Mark空心不填充，样式无特殊要求，若有其它基质则使用颜色和Mark不重复的深色实线，导出的曲线图中Mark大小需要能清晰展示。图例横向展示于图片外下方。
1022 6例受试者单次口服约150mg/200µCi的[14C]AP306后在尿液中累计放射性回收率的个体曲线^^Individual Cumulative Recovery of Total Radioactivity in Urine following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
物质平衡分析集^^Mass Balance Set
1023 ^^
1025 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1027 编程说明：
1028 当尿粪样品放射性回收率低于定量下限（BLQ）时，将按照零值参与累计回收率计算；受试者未采集时间段的数据，将按照零值参与累计回收率计算；个体累计回收曲线中各受试者截止至自身的最后一个采集时间段，如受试者1尿液采集到168h，其他受试者尿液采集到192h，则受试者1曲线绘至168h，其余受试者绘至192h。
1029 横轴为“时间（小时）”，大的刻度以24的倍数划分 (如一个大刻度为24h或48h，如果时间轴不长尽量以24h划分)，小刻度以4的倍数划分 (如一个小刻度为4h或8h)；纵轴为“累计放射性回收率（% 给药量）”，范围为0-100，以10划分大刻度；回收率曲线从0h回收率为0开始绘制。可根据实际数据调整纵坐标最大值，以保证可读性；图片外上方居中标识基质。
1030 曲线均需要使用颜色和Mark样式不重复的深色实线，Mark空心不填充，导出的曲线图中Mark大小需要能清晰展示。图例横向展示于图片外下方。
1032 6例受试者单次口服约150mg/200µCi的[14C]AP306后在粪便中累计放射性回收率的个体曲线^^Individual Cumulative Recovery of Total Radioactivity in Feces following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
物质平衡分析集^^Mass Balance Set
1033 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1036 编程说明：^^Programming Note:
1037 按照图 14.4.3-1.2的结构生成此图。^^Use the same shell with the structure of 图 14.4.3-1.2
1038 当尿粪样品放射性回收率低于定量下限（BLQ）时，将按照零值参与累计回收率计算；受试者未采集时间段的数据，将按照零值参与累计回收率计算；个体累计回收曲线中各受试者截止至自身的最后一个采集时间段，如受试者1粪便采集到168h，其他受试者粪便采集到192h，则受试者1曲线绘至168h，其余受试者绘至192h。
1039 横轴为“时间（小时）”，大的刻度以24的倍数划分 (如一个大刻度为24h或48h，如果时间轴不长尽量以24h划分)，小刻度以4的倍数划分 (如一个小刻度为4h或8h)；纵轴为“累计放射性回收率（% 给药量）”，范围为0-100，以10划分大刻度；回收率曲线从0h回收率为0开始绘制。可根据实际数据调整纵坐标最大值，以保证可读性；图片外上方居中标识基质。
1040 曲线均需要使用颜色和Mark样式不重复的深色实线，Mark空心不填充，导出的曲线图中Mark大小需要能清晰展示。图例横向展示于图片外下方。
1042 6例受试者单次口服约150mg/200µCi的[14C]AP306后在尿液和粪便中累计放射性回收率的个体曲线^^Individual Cumulative Recovery of Total Radioactivity in Urine and Feces following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
物质平衡分析集^^Mass Balance Set
1044 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1046 编程说明：^^Programming Note:
1047 按照图 14.4.3-1.2的结构生成此图。^^Use the same shell with the structure of 图 14.4.3-1.2
1048 当尿粪样品放射性回收率低于定量下限（BLQ）时，将按照零值参与累计回收率计算；受试者未采集时间段的数据，将按照零值参与累计回收率计算；个体累计回收曲线中各受试者截止至自身的最后一个采集时间段，如受试者1尿液和粪便最长采集到168h，其他受试者尿液和粪便最长采集到192h，则受试者1曲线绘至168h，其余受试者绘至192h。
1049 横轴为“时间（小时）”，大的刻度以24的倍数划分 (如一个大刻度为24h或48h，如果时间轴不长尽量以24h划分)，小刻度以4的倍数划分 (如一个小刻度为4h或8h)；纵轴为“累计放射性回收率（% 给药量）”，范围为0-100，以10划分大刻度；回收率曲线从0h回收率为0开始绘制。可根据实际数据调整纵坐标最大值，以保证可读性；图片外上方居中标识基质。
1050 曲线均需要使用颜色和Mark样式不重复的深色实线，Mark空心不填充，导出的曲线图中Mark大小需要能清晰展示。图例横向展示于图片外下方。
1052 附录^^APPENDICES
1053 受试者数据列表^^Subject Data List
1054 研究受试者^^Study Subject
1055 受试者分布^^Subject Disposition
筛选集^^Screening Set
```json
{
    "受试者筛选号^^Subject Screening Number": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "xxx",
        "5": "xxx",
        "6": "xxx",
        "7": "……"
    },
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "",
        "2": "",
        "3": "",
        "4": "xxx",
        "5": "xxx",
        "6": "",
        "7": "……"
    },
    "完成情况^^Completion Status": {
        "0": "",
        "1": "筛选失败^^SCREEN FAILURE",
        "2": "筛选失败^^SCREEN FAILURE",
        "3": "筛选失败^^SCREEN FAILURE",
        "4": "完成^^COMPLETED",
        "5": "提前退出^^DISCONTINUED",
        "6": "筛选成功，未入组^^NON-ENROLLED AFTER SCREENING",
        "7": "……"
    },
    "知情同意书签署日期^^Date of Informed Consent": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "YYYY-MM-DD",
        "3": "YYYY-MM-DD",
        "4": "YYYY-MM-DD",
        "5": "YYYY-MM-DD",
        "6": "YYYY-MM-DD",
        "7": "……"
    },
    "入组日期^^Date of Assignment": {
        "0": "",
        "1": "",
        "2": "",
        "3": "",
        "4": "YYYY-MM-DD",
        "5": "YYYY-MM-DD",
        "6": "",
        "7": "……"
    },
    "筛选失败/提前退出原因^^Reason for Screen Failure/ Discontinued": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "",
        "5": "xxx",
        "6": "",
        "7": "……"
    }
}
```
1058 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1061 受试者所属分析集^^Subject in the Analysis Set
所有入组受试者^^All Enrolled Subjects
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "xxx",
        "5": "……"
    },
    "是否纳入SS/未纳入原因^^Whether Included in SS/ Reason Not Included": {
        "0": "",
        "1": "是^^Yes",
        "2": "是^^Yes",
        "3": "是^^Yes",
        "4": "是^^Yes",
        "5": ""
    },
    "是否纳入PKCS/ 未纳入原因^^Whether Included in PKCS/ Reason Not Included": {
        "0": "",
        "1": "是^^Yes",
        "2": "是^^Yes",
        "3": "否/xxxx^^No/xxx",
        "4": "是^^Yes",
        "5": ""
    },
    "是否纳入MBS/未纳入原因^^Whether Included in MBS/ Reason Not Included": {
        "0": "",
        "1": "是^^Yes",
        "2": "是^^Yes",
        "3": "是^^Yes",
        "4": "否/xxxx^^No/xxx",
        "5": "……"
    }
}
```
1064 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1067 方案偏离^^Protocol Deviation
1068 受试者方案偏离汇总^^Summary of Subject Protocol Deviations
安全性分析集^^Safety set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "xxx",
        "5": "……"
    },
    "主要或次要^^Major or Minor": {
        "0": "",
        "1": "主要偏离^^Major protocol deviation",
        "2": "次要偏离^^Minor protocol deviation",
        "3": "主要偏离^^Major protocol deviation",
        "4": "次要偏离^^Minor protocol deviation",
        "5": "……"
    },
    "方案偏离日期^^Date of PDs": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "YYYY-MM-DD",
        "3": "YYYY-MM-DD",
        "4": "YYYY-MM-DD",
        "5": "……"
    }
}
```
1070 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1072 人口统计学和其他基线特征^^Demographic and Other Baseline Characteristics
1073 受试者人口学资料^^Subject Demographic Data
安全性分析集^^Safety set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "xxx",
        "5": "……"
    },
    "出生日期^^Date of Birth": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "YYYY-MM-DD",
        "3": "YYYY-MM-DD",
        "4": "YYYY-MM-DD",
        "5": "……"
    },
    "年龄 (周岁)/性别/民族^^Age (years)/ Sex/ Ethnicity": {
        "0": "",
        "1": "xx/男/汉族^^xx/ Male/ Han",
        "2": "xx/男/其他：xx^^xx/ Male/other: xx",
        "3": "xx/男/汉族^^xx/ Male/ Han",
        "4": "xx/女/汉族^^xx/ Female/ Han",
        "5": "……"
    },
    "体重 (kg)^^Weight (kg)": {
        "0": "",
        "1": "xx.x",
        "2": "xx.x",
        "3": "xx.x",
        "4": "xx.x",
        "5": "……"
    },
    "BMI (kg/m2)": {
        "0": "",
        "1": "xx.xx",
        "2": "xx.xx",
        "3": "xx.xx",
        "4": "xx.xx",
        "5": "……"
    }
}
```
1076 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1079 酒精呼气测试^^Alcohol Breath Test
安全性分析集^^Safety set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "",
        "3": "",
        "4": "xxx",
        "5": "",
        "6": "……",
        "7": ""
    },
    "访视*^^Visit*": {
        "0": "",
        "1": "x",
        "2": "x.x",
        "3": "x.x",
        "4": "x",
        "5": "x.x",
        "6": "……",
        "7": ""
    },
    "是否进行酒精呼气测试/未查原因^^Was alcohol breath test performed/Reason": {
        "0": "",
        "1": "是^^Yes",
        "2": "是^^Yes",
        "3": "是^^Yes",
        "4": "否/xxxx^^No/xxx",
        "5": "是^^Yes",
        "6": "",
        "7": ""
    },
    "测试日期^^Date of Test": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "YYYY-MM-DD",
        "3": "YYYY-MM-DD",
        "4": "",
        "5": "YYYY-MM-DD",
        "6": "……",
        "7": ""
    },
    "结果 (mg/dl)^^Result (mg/dl)": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "",
        "5": "xxx",
        "6": "",
        "7": ""
    }
}
```
1081 *：非整数访视为计划外访视^^*: Non-integer visits are considered as unscheduled visits.
1083 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1086 编程说明：
1087 编程人员需在编程过程中补齐访视脚注，如“*：非整数访视为计划外访视，1=筛选期 (D-7~D-2)，2=入住 (D-2)，…….”
1089 尿药筛查^^Urine Drug Test
安全性分析集^^Safety set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "xxx"
    },
    "访视*^^Visit*": {
        "0": "",
        "1": "x",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "x"
    },
    "是否进行尿药筛查/未查原因^^Was urine drug test performed/Reason": {
        "0": "",
        "1": "是^^Yes",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "否/xxxx^^No/xxxx"
    },
    "采样日期^^Date of Sampling": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": ""
    },
    "项目^^Test Name": {
        "0": "",
        "1": "吗啡^^Morphine",
        "2": "四氢大麻酚酸^^Tetrahydrocannabinolic acid",
        "3": "甲基安非他明^^Methamphetamine",
        "4": "二亚甲基双氧安非他明^^M ethylenedioxymethamphet amine",
        "5": "氯胺酮^^Ketamine",
        "6": ""
    },
    "结果^^Result": {
        "0": "",
        "1": "阴性^^Negative",
        "2": "阳性^^Positive",
        "3": "阴性^^Negative",
        "4": "阴性^^Negative",
        "5": "阴性^^Negative",
        "6": ""
    }
}
```
1091 *：非整数访视为计划外访视^^*: Non-integer visits are considered as unscheduled visits.
1093 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1096 编程说明：
1097 编程人员需在编程过程中补齐访视脚注，如“*：非整数访视为计划外访视，1=筛选期 (D-7~D-2)，2=入住 (D-2)，…….”
1099 病毒学筛查^^Virological screening
安全性分析集^^Safety set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "xxx",
        "7": "",
        "8": "xxx",
        "9": "……"
    },
    "访视*^^Visit*": {
        "0": "",
        "1": "x",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "x.x",
        "7": "",
        "8": "x",
        "9": ""
    },
    "是否进行病毒学筛查^^Was Virological screening performed/Reason": {
        "0": "",
        "1": "是^^Yes",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "是^^Yes",
        "7": "",
        "8": "否/xxxx^^No/xxx",
        "9": ""
    },
    "采样日期^^Date of sampling": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "YYYY-MM-DD",
        "7": "",
        "8": "",
        "9": ""
    },
    "项目 (单位)^^Test Name (Unit)": {
        "0": "",
        "1": "乙肝表面抗原^^Hepatitis B surface antigen",
        "2": "乙肝E抗原^^Hepatitis B E antigen",
        "3": "丙型肝炎病毒抗体 IgG^^Hepatitis C virus IgG",
        "4": "梅毒螺旋体抗体检 测^^Antibodies to treponema pallidum",
        "5": "",
        "6": "乙肝表面抗原^^Hepatitis B surface antigen",
        "7": "……",
        "8": "",
        "9": "……"
    },
    "结果^^Result": {
        "0": "",
        "1": "xx.x",
        "2": "xx.x",
        "3": "xx.x",
        "4": "xx.x",
        "5": "",
        "6": "",
        "7": "……",
        "8": "",
        "9": "……"
    },
    "临床意义判定^^Clinical\nSignificance": {
        "0": "",
        "1": "正常^^Normal",
        "2": "异常有临床意义^^Abnormal, clinically significant",
        "3": "异常无临床意义^^Abnormal, not clinically significant",
        "4": "正常^^Normal",
        "5": "",
        "6": "未查^^Not done",
        "7": "……",
        "8": "",
        "9": "……"
    }
}
```
1101 *：非整数访视为计划外访视^^*: Non-integer visits are considered as unscheduled visits.
1103 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1106 编程说明：
1107 检查指标有单位需带上单位
1108 编程人员需在编程过程中补齐访视脚注，如“*：非整数访视为计划外访视，1=筛选期 (D-7~D-2)，2=入住 (D-2)，…….”
1110 腹部B超^^Abdominal B ultrasound
安全性分析集^^Safety set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "",
        "7": "",
        "8": "xxx",
        "9": "……"
    },
    "访视*^^Visit*": {
        "0": "",
        "1": "x",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "x.x",
        "7": "",
        "8": "x",
        "9": "……"
    },
    "是否进行腹部B超检查/未查原因^^Was abdominal B-mode ultrasound examination performed/Reason": {
        "0": "",
        "1": "是^^Yes",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "是^^Yes",
        "7": "",
        "8": "否/xxxx^^No/xxx",
        "9": "……"
    },
    "检查日期^^Date of Examination": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "YYYY-MM-DD",
        "7": "",
        "8": "",
        "9": "……"
    },
    "项目^^Test name": {
        "0": "",
        "1": "肝^^Liver",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "胆^^Gallbladder",
        "7": "",
        "8": "",
        "9": ""
    },
    "结果^^Result": {
        "0": "",
        "1": "正常^^Normal",
        "2": "异常有临床意义^^Abnormal, clinically significant",
        "3": "异常无临床意义^^Abnormal, not clinically significant",
        "4": "正常^^Normal",
        "5": "异常有临床意义^^Abnormal, clinically significant",
        "6": "正常^^Normal",
        "7": "……",
        "8": "",
        "9": "……"
    },
    "异常描述^^Abnormal Description": {
        "0": "",
        "1": "",
        "2": "xxxxxx",
        "3": "xxxxxx",
        "4": "",
        "5": "xxxxxx",
        "6": "",
        "7": "",
        "8": "",
        "9": ""
    }
}
```
1112 *：非整数访视为计划外访视^^*: Non-integer visits are considered as unscheduled visits.
1114 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1117 编程说明：
1118 编程人员需在编程过程中补齐访视脚注，如“*：非整数访视为计划外访视，1=筛选期 (D-7~D-2)，2=入住 (D-2)，…….”
1120 胸部X光片^^Chest X-ray 
安全性分析集^^Safety set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "xxx",
        "5": "xxx",
        "6": "xxx",
        "7": "……"
    },
    "访视*^^Visit*": {
        "0": "",
        "1": "x",
        "2": "x",
        "3": "x",
        "4": "x",
        "5": "x.x",
        "6": "x",
        "7": ""
    },
    "是否进行胸部CT检查/未查原因^^Was chest X-ray examination performed/Reason": {
        "0": "",
        "1": "是^^Yes",
        "2": "是^^Yes",
        "3": "是^^Yes",
        "4": "是^^Yes",
        "5": "是^^Yes",
        "6": "否/xxxx^^No/xxx",
        "7": ""
    },
    "检查日期^^Date of Examination": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "YYYY-MM-DD",
        "3": "YYYY-MM-DD",
        "4": "YYYY-MM-DD",
        "5": "YYYY-MM-DD",
        "6": "",
        "7": ""
    },
    "结果^^Result": {
        "0": "",
        "1": "正常^^Normal",
        "2": "异常有临床意义^^Abnormal, clinically significant",
        "3": "异常无临床意义^^Abnormal, not clinically significant",
        "4": "正常^^Normal",
        "5": "正常^^Normal",
        "6": "",
        "7": "……"
    },
    "异常描述^^Abnormal Description": {
        "0": "",
        "1": "",
        "2": "xxxxxx",
        "3": "xxxxxx",
        "4": "",
        "5": "",
        "6": "",
        "7": "……"
    }
}
```
1122 *：非整数访视为计划外访视^^*: Non-integer visits are considered as unscheduled visits.
1124 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1127 编程说明：
1128 编程人员需在编程过程中补齐访视脚注，如“*：非整数访视为计划外访视，1=筛选期 (D-7~D-2)，2=入住 (D-2)，…….”
1130 甲状腺功能检查^^Thyroid Function Examination
安全性分析集^^Safety set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "",
        "3": "",
        "4": "xxx",
        "5": "",
        "6": "xxx",
        "7": "……"
    },
    "访视*^^Visit*": {
        "0": "",
        "1": "x",
        "2": "",
        "3": "",
        "4": "x.x",
        "5": "",
        "6": "x",
        "7": ""
    },
    "是否进行甲状腺功能检查/未查原因^^Was thyroid function test performed/Reason": {
        "0": "",
        "1": "是^^Yes",
        "2": "",
        "3": "",
        "4": "是^^Yes",
        "5": "",
        "6": "否/xxxx^^No/xxx",
        "7": ""
    },
    "采样日期^^Sampling Date": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "",
        "3": "",
        "4": "YYYY-MM-DD",
        "5": "",
        "6": "",
        "7": ""
    },
    "项目 (单位)^^Test Name (Unit)": {
        "0": "",
        "1": "游离T3 (单位)^^Free t3 (Unit)",
        "2": "游离T4 (单位)^^\nFree t4 (Unit)",
        "3": "促甲状腺激 (单位)^^Thyroid stimulating hormone (Unit)",
        "4": "……",
        "5": "……",
        "6": "",
        "7": "……"
    },
    "结果^^Result": {
        "0": "",
        "1": "xx.x",
        "2": "xx.x",
        "3": "xx.x",
        "4": "xx.x",
        "5": "……",
        "6": "",
        "7": "……"
    },
    "临床意义判定^^Clinical\nSignificance": {
        "0": "",
        "1": "正常^^Normal",
        "2": "异常有临床意义^^Abnormal, clinically significant",
        "3": "异常无临床意义^^Abnormal, not clinically significant",
        "4": "正常^^Normal",
        "5": "……",
        "6": "",
        "7": "……"
    }
}
```
1132 *：非整数访视为计划外访视^^*: Non-integer visits are considered as unscheduled visits.
1134 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1137 编程说明：
1138 检查指标有单位需带上单位
1139 编程人员需在编程过程中补齐访视脚注，如“*：非整数访视为计划外访视，1=筛选期 (D-7~D-2)，2=入住 (D-2)，…….”
1141 肛门指检^^Digital Rectal Examination
安全性分析集^^Safety set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "xxx",
        "5": "",
        "6": "xxx",
        "7": "……"
    },
    "访视*^^Visit*": {
        "0": "",
        "1": "x",
        "2": "x",
        "3": "x",
        "4": "x",
        "5": "x.x",
        "6": "x",
        "7": ""
    },
    "是否进行肛门指检/未查原因^^Was Digital anal examination Performed/Reason": {
        "0": "",
        "1": "是^^Yes",
        "2": "是^^Yes",
        "3": "是^^Yes",
        "4": "是^^Yes",
        "5": "是^^Yes",
        "6": "否/xxxx^^No/xxx",
        "7": ""
    },
    "检查日期^^Date of Examination": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "YYYY-MM-DD",
        "3": "YYYY-MM-DD",
        "4": "YYYY-MM-DD",
        "5": "YYYY-MM-DD",
        "6": "",
        "7": ""
    },
    "结果判定^^Result": {
        "0": "",
        "1": "正常^^Normal",
        "2": "异常有临床意义^^Abnormal, clinically significant",
        "3": "异常无临床意义^^Abnormal, not clinically significant",
        "4": "正常^^Normal",
        "5": "正常^^Normal",
        "6": "",
        "7": ""
    },
    "异常描述^^Abnormal Description": {
        "0": "",
        "1": "",
        "2": "xxxxx",
        "3": "xxxxx",
        "4": "",
        "5": "",
        "6": "",
        "7": "……"
    }
}
```
1143 *：非整数访视为计划外访视^^*: Non-integer visits are considered as unscheduled visits.
1145 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1147 编程说明：
1148 检查指标有单位需带上单位
1149 编程人员需在编程过程中补齐访视脚注，如“*：非整数访视为计划外访视，1=筛选期 (D-7~D-2)，2=入住 (D-2)，…….”
1151 病史^^Medical History
安全性分析集^^Safety set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "……"
    },
    "疾病名称^^Medical condition or Event Term": {
        "0": "",
        "1": "xxxxxx",
        "2": "xxxxxx",
        "3": "xxxxxx",
        "4": "……"
    },
    "SOC\n/PT": {
        "0": "",
        "1": "xxxxxx\n/xxxxxx",
        "2": "xxxxxx\n/xxxxxx",
        "3": "xxxxxx\n/xxxxxx",
        "4": "……"
    },
    "开始日期^^Start date": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "YYYY-MM-DD",
        "3": "YYYY-MM-DD",
        "4": "……"
    },
    "是否持续^^Ongoing": {
        "0": "",
        "1": "是^^Yes",
        "2": "否^^No",
        "3": "否^^No",
        "4": "……"
    },
    "结束日期^^End Date": {
        "0": "",
        "1": "",
        "2": "YYYY-MM-DD",
        "3": "YYYY-MM-DD",
        "4": "……"
    }
}
```
1153 本列表仅收集有既往或现病史的受试者信息^^This listing only collects information on subjects with Previous and concomitant medical history
1154 病史依据&MedDRA.进行编码^^Medical History encoded according to &MedDRA.
1155 SOC：系统器官分类，PT：首选术语^^SOC: System Organ Class; PT: Preferred Term.
1157 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1160 编程说明：
1161 根据实际编码字典版本，更新脚注
1163 手术史^^Operation history
安全性分析集^^Safety set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "……"
    },
    "手术名称^^Surgery Term": {
        "0": "",
        "1": "xxxxxx",
        "2": "xxxxxx",
        "3": "xxxxxx",
        "4": "……"
    },
    "SOC\n/PT": {
        "0": "",
        "1": "xxxxxx\n/xxxxxx",
        "2": "xxxxxx\n/xxxxxx",
        "3": "xxxxxx\n/xxxxxx",
        "4": "……"
    },
    "手术日期^^Start Date of Surgery": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "YYYY-MM-DD",
        "3": "YYYY-MM-DD",
        "4": "……"
    }
}
```
1165 本列表仅收集有手术史的受试者信息^^This listing only collects information on subjects with surgery history
1166 手术史依据&MedDRA.进行编码^^Surgical Conditions encoded according to &MedDRA.
1167 SOC：系统器官分类，PT：首选术语^^SOC: System Organ Class; PT: Preferred Term.
1169 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1172 编程说明：
1173 编程时根据实际字典及版本替换脚注中“&MedDRA.”内容
1175 过敏史^^Allergy History
安全性分析集^^Safety set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "……"
    },
    "过敏原^^Allergen": {
        "0": "",
        "1": "xxxxx",
        "2": "xxxxx",
        "3": "",
        "4": "……"
    },
    "过敏症状^^Allergy symptoms": {
        "0": "",
        "1": "xxxx",
        "2": "xxxx",
        "3": "",
        "4": "……"
    }
}
```
1177 本列表仅收集有药物或非药物过敏史的受试者信息^^This listing only collects information on subjects with allergy history
1180 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1183 一般情况问询^^General Information Inquiries
安全性分析集^^Safety set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "",
        "7": "xxx",
        "8": "",
        "9": "……"
    },
    "一般情况问询^^General Information Inquiries": {
        "0": "",
        "1": "受试者是否酗酒或筛选前6个月内经常饮酒，即每周饮酒超过14个单位的酒精（1单位=360mL啤酒或45mL酒 精量为40%的烈酒或150mL 葡萄酒），或筛选期时酒精呼气试验结果≥20 mg/dl 者，或在使用研究药物前48小时内饮酒者，或在试验期间无法戒断酒精^^Whether the subject was heavy drinkers or had been drinking frequently within the 6 months prior to the screening, that is,consuming more than 14 units of alcohol per week (1 unit = 360 mL of beer or 45 mL of 40% alcohol spirits or 150 mL of wine), or if the alcohol breath test result was ≥ 20 mg/dl during the screening period, or if they consumed alcohol within 48 hours before using the study drug, or if they were unable to abstain from alcohol during the trial",
        "2": "每日吸烟量大于5支或习惯性使用含尼古丁制品者，或在试验期间无法戒断^^Subject smoked more than five cigarettes per day or were habitual users of nicotine-containing products in the 3 months before screening, or were unable to quit during the trial",
        "3": "受试者是否滥用药物或筛选前3个月使用过软毒品（如 ：大麻）或筛选前1年服用硬毒品（如：可卡因、苯丙胺类、苯环己哌啶等）^^Whether the subject abused drugs or used soft drugs (e.g., marijuana) in the 3 months before screening or hard drugs (e.g., cocaine, amphetamines, phyclohexidine) in the year before screening",
        "4": "受试者是否在筛选前3个月内参加过任何临床试验且接受过试验用药品或使用过试验用器械^^Whether the subject had participated in any clinical trial and received investigational drugs or used investigational devices within 3 months before screening",
        "5": "受试者是否在签署知情同意书后至完成试验后1年内有生育或捐献精子计划者，或者不同意在签署知情同意书后至完成试验后1年内受试者及其配偶采取严格的避孕措施^^Whether the subject had a plan to give birth or donate sperm within 1 year after signing the informed consent form or did not agree to use strict contraception for the subject and his/her spouse within 1 year after signing the informed consent form and completing the trial",
        "6": "受试者是否在筛选前3个月内曾有过失血或献血≥400 mL者，或1个月内接受输血/血液成分者，或计划服药期间及停药后3个月内献血^^Whether the subject had lost blood or donated ≥400 mL of blood within 3 months before screening, received blood transfusion/blood components within 1 month, or donated blood during planned medication and within 3 months after discontinuation",
        "7": "……",
        "8": "",
        "9": "……"
    },
    "结果^^Result": {
        "0": "",
        "1": "是^Yes",
        "2": "是^Yes",
        "3": "否^No",
        "4": "否^No",
        "5": "NA",
        "6": "NA",
        "7": "……",
        "8": "",
        "9": "……"
    }
}
```
1186 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1189 既往用药^^Previous Medications
安全性分析集^^Safety set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "xxx",
        "5": "……"
    },
    "药物名称^^Medication Name": {
        "0": "",
        "1": "xxxxxx",
        "2": "xxxxxx",
        "3": "xxxxxx",
        "4": "xxxxxx",
        "5": "……"
    },
    "ATC2\n/PN": {
        "0": "",
        "1": "xxxxxx\n/xxxxxx",
        "2": "xxxxxx\n/xxxxxx",
        "3": "xxxxxx\n/xxxxxx",
        "4": "xxxxxx\n/xxxxxx",
        "5": "……"
    },
    "用药原因^^Reasons for Medication use": {
        "0": "",
        "1": "不良事件/编号：xx^^Adverse event/No.: xx",
        "2": "既往及合并用药^^Previous and concurrent medications",
        "3": "预防/xx^^\nProphylaxis/xx",
        "4": "其他/xxx^^Other/xx",
        "5": "……"
    },
    "单位^^Unit": {
        "0": "",
        "1": "ug",
        "2": "mg",
        "3": "片^^Tablet",
        "4": "粒^^Grains",
        "5": ""
    },
    "用药频率^^Frequency": {
        "0": "",
        "1": "1",
        "2": "7",
        "3": "9/xxx",
        "4": "9/xxx",
        "5": "……"
    },
    "给药途径^^Route": {
        "0": "",
        "1": "1",
        "2": "10/xxx",
        "3": "4",
        "4": "4",
        "5": "……"
    },
    "开始日期^^Start Date": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "YYYY-MM-DD",
        "3": "YYYY-MM-DD",
        "4": "YYYY-MM-DD",
        "5": "……"
    },
    "是否持续^^Ongoing": {
        "0": "",
        "1": "否^^No",
        "2": "是^^Yes",
        "3": "否^^No",
        "4": "否^^No",
        "5": ""
    },
    "结束日期^^End Date": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "",
        "3": "YYYY-MM-DD",
        "4": "YYYY-MM-DD",
        "5": "……"
    }
}
```
Don't know what object this is
1192 本列表仅收集有既往用药的受试者信息^^This listing only collects information on subjects with Previous medications
1193 给药途径：1：口服，2：肌注，3：皮下注射，4：静脉注射，5：吸入，6：局部，7：直肠给药，8：舌下给药，9：皮内注射，10：其他^^Route : 1: Oral, 2: Intramuscular, 3: Subcutaneous, 4: Intravenous, 5: Inhalation, 6: Topical, 7: Rectal, 8: Sublingual, 9: Intradermal, 10: Other
1194 用药频率：1：一次，2：一次/日，3：两次/日，4：三次/日，5：四次/日，6：一次/小时，7：按需服用，8：隔日一次，9：其他^^Frequency:1: Once, 2: Once daily, 3: Twice daily, 4: Three times daily, 5: Four times daily, 6: Once an hour, 7: As Necessary, 8: Every Other Days, 9: Other
1195 编码字典：&DrugDIR.^^Encoded dictionary: &DrugDIR.
1196 ATC2：解剖学、治疗学及化学分类法2级，PN：首选药名^^ATC2: Anatomical Therapeutic Classification 2nd; PN: Preferred Name.
1198 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1201 编程说明：
1202 编程时根据实际字典及版本替换脚注中“&DrugDIR.”内容
1204 依从性^^Compliance
1205 服药记录^^Study Medication Administration
安全性分析集^^Safety Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "…"
    },
    "受试者是否服药/未服药原因^^Did the subject take study medication/Reason": {
        "0": "",
        "1": "是^^Yes",
        "2": "是^^Yes",
        "3": "是^^Yes",
        "4": "…"
    },
    "服药开始时间^^Time of Start Medication": {
        "0": "",
        "1": "YYYY-MM-DDTHH:MM",
        "2": "YYYY-MM-DDTHH:MM",
        "3": "YYYY-MM-DDTHH:MM",
        "4": "…"
    },
    "服药剂量^^Dosage": {
        "0": "",
        "1": "150 mg/200 µCi",
        "2": "其他/xx^^Other/xx",
        "3": "150 mg/200 µCi",
        "4": ""
    },
    "送服饮水量^^Volume of Water Intake": {
        "0": "",
        "1": "240 mL",
        "2": "其他/xx^^Other/xx",
        "3": "其他/xx^^Other/xx",
        "4": ""
    }
}
```
1208 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1211 禁食/禁水情况记录^^Food Fasting/Water Fasting
安全性分析集^^Safety Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "xxx",
        "5": "xxx",
        "6": "xxx",
        "7": "……"
    },
    "受试者是否在给药前禁食至少10h、禁水1 h^^Whether the subject fasted for at least 10h and water for 1 h before administration": {
        "0": "",
        "1": "是^^Yes",
        "2": "是^^Yes",
        "3": "是^^Yes",
        "4": "是^^Yes",
        "5": "是^^Yes",
        "6": "否/xxx^^No/xxx",
        "7": "……"
    },
    "受试者是否在服药后禁食4h（早餐除外）、禁水1h（早餐包含的及服药用水除外）^^Whether the subject fasted for 4 h (except for breakfast) and for 1 h (except for water included in breakfast and medication ) after the medication": {
        "0": "",
        "1": "是^^Yes",
        "2": "是^^Yes",
        "3": "是^^Yes",
        "4": "是^^Yes",
        "5": "否/xxx^^No/xxx",
        "6": "是^^Yes",
        "7": "…..."
    }
}
```
1214 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1217 合并用药^^Concomitant Medications
安全性分析集^^Safety Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "xxx",
        "5": "……"
    },
    "药物名称^^Medication Name": {
        "0": "",
        "1": "xxxxxx",
        "2": "xxxxxx",
        "3": "xxxxxx",
        "4": "xxxxxx",
        "5": "……"
    },
    "ATC2\n/PN": {
        "0": "",
        "1": "xxxxxx\n/xxxxxx",
        "2": "xxxxxx\n/xxxxxx",
        "3": "xxxxxx\n/xxxxxx",
        "4": "xxxxxx\n/xxxxxx",
        "5": "……"
    },
    "用药原因^^Reasons for Medication use": {
        "0": "",
        "1": "不良事件/编号：xx^^Adverse event/No.: xx",
        "2": "既往及合并用药^^Previous and concurrent medications",
        "3": "预防/xx^^\nProphylaxis/xx",
        "4": "其他/xxx^^Other/xx",
        "5": "……"
    },
    "单位^^Unit": {
        "0": "",
        "1": "ug",
        "2": "mg",
        "3": "片^^Tablet",
        "4": "粒^^Grains",
        "5": ""
    },
    "用药频率^^Frequency": {
        "0": "",
        "1": "1",
        "2": "7",
        "3": "9/xxx",
        "4": "9/xxx",
        "5": "……"
    },
    "给药途径^^Route": {
        "0": "",
        "1": "1",
        "2": "10/xxx",
        "3": "4",
        "4": "4",
        "5": "……"
    },
    "开始日期^^Start Date": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "YYYY-MM-DD",
        "3": "YYYY-MM-DD",
        "4": "YYYY-MM-DD",
        "5": "……"
    },
    "是否持续^^Ongoing": {
        "0": "",
        "1": "否^^No",
        "2": "是^^Yes",
        "3": "否^^No",
        "4": "否^^No",
        "5": ""
    },
    "结束日期^^End Date": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "",
        "3": "YYYY-MM-DD",
        "4": "YYYY-MM-DD",
        "5": "……"
    }
}
```
1219 本列表仅收集有合并用药的受试者信息^^This listing only collects information on subjects with Concomitant Medications
1220 给药途径：1：口服，2：肌注，3：皮下注射，4：静脉注射，5：吸入，6：局部，7：直肠给药，8：舌下给药，9：皮内注射，10：其他^^Route : 1: Oral, 2: Intramuscular, 3: Subcutaneous, 4: Intravenous, 5: Inhalation, 6: Topical, 7: Rectal, 8: Sublingual, 9: Intradermal, 10: Other
1221 用药频率：1：一次，2：一次/日，3：两次/日，4：三次/日，5：四次/日，6：一次/小时，7：按需服用，8：隔日一次，9：其他^^Frequency:1: Once, 2: Once daily, 3: Twice daily, 4: Three times daily, 5: Four times daily, 6: Once an hour, 7: As Necessary, 8: Every Other Days, 9: Other
1222 编码字典：&DrugDIR.^^Encoded dictionary: &DrugDIR.
1223 ATC2：解剖学、治疗学及化学分类法2级，PN：首选药名^^ATC2: Anatomical Therapeutic Classification 2nd; PN: Preferred Name.
1225 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1228 编程说明：
1229 编程时根据实际字典及版本替换脚注中“&DrugDIR.”内容
1232 非药物治疗^^Concomitant Procedure/ Surgery
安全性分析集^^Safety Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "……"
    },
    "治疗名称^^Procedure Name": {
        "0": "",
        "1": "xxxxxx",
        "2": "xxxxxx",
        "3": "xxxxxx",
        "4": "……"
    },
    "SOC\n/PT": {
        "0": "",
        "1": "xxxxxx\n/xxxxxx",
        "2": "xxxxxx\n/xxxxxx",
        "3": "xxxxxx\n/xxxxxx",
        "4": "……"
    },
    "治疗原因^^Procedure Reason": {
        "0": "",
        "1": "不良事件/编号：xx^^Adverse event/No.:xx",
        "2": "病史/编号^^Medical history/No.: xx",
        "3": "其他/xxx^^Other/xx",
        "4": "……"
    },
    "开始日期^^Start Date": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "YYYY-MM-DD",
        "3": "YYYY-MM-DD",
        "4": "……"
    },
    "是否持续^^Ongoing": {
        "0": "",
        "1": "否^^No",
        "2": "否^^No",
        "3": "是^^Yes",
        "4": "……"
    },
    "结束日期^^End Date": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "YYYY-MM-DD",
        "3": "",
        "4": "……"
    }
}
```
1234 本列表仅收集入组后有非药物治疗的受试者信息^^This listing only collects information on subjects with concomitant procedure/ surgery
1235 编码字典：&MedDRA.^^Concomitant Procedure/ Surgery encoded according to &MedDRA.
1236 SOC：系统器官分类，PT：首选术语^^SOC: System Organ Class; PT: Preferred Term.
1238 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1241 编程说明：
1242 编程时根据实际字典及版本替换脚注中“&MedDRA.”内容
1244 不良事件列表^^Listing of Adverse Events
1245 不良事件^^Adverse Events
安全性分析集^^Safety Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "xxx",
        "5": "……"
    },
    "SOC\n/PT\n/AE名称^^/AE": {
        "0": "",
        "1": "xxxxxx\n/xxxx\n/xxxxxx",
        "2": "xxxxxx\n/xxxx\n/xxxxxx",
        "3": "xxxxxx\n/xxxx\n/xxxxxx",
        "4": "xxxxxx\n/xxxx\n/xxxxxx",
        "5": ""
    },
    "开始时间^^Start Time": {
        "0": "",
        "1": "YYYY-MM-DDTHH:MM",
        "2": "YYYY-MM-DDTHH:MM",
        "3": "YYYY-MM-DDTHH:MM",
        "4": "YYYY-MM-DDTHH:MM",
        "5": ""
    },
    "是否为AESI^^Is it AESI": {
        "0": "",
        "1": "是^^Yes",
        "2": "否^^No",
        "3": "否^^No",
        "4": "否^^No",
        "5": ""
    },
    "严重程度^^Severity": {
        "0": "",
        "1": "轻度^^Mild",
        "2": "中度^^Moderate",
        "3": "重度^^Severe",
        "4": "重度^^Severe",
        "5": ""
    },
    "与试验用药品关系^^Relationship to Study Medicine": {
        "0": "",
        "1": "相关^^Related",
        "2": "无关^^Not related",
        "3": "无关^^Not related",
        "4": "无关^^Not related",
        "5": ""
    },
    "对研究受试者采取措施^^Measures were taken with study subject": {
        "0": "",
        "1": "无^^None",
        "2": "采用合并用药^^Concomitant medication",
        "3": "其他/xxx^^Other/xxx",
        "4": "采用非药物治疗^^Concomitant procedure/surgery",
        "5": ""
    },
    "对试验药物采取的措施^^Measures taken with respect to study medicine": {
        "0": "",
        "1": "停止用药^^Permanently Withdrawn",
        "2": "剂量不变^^Dose Not Changed",
        "3": "不适用^^Not Applicable",
        "4": "未知^^Unknown",
        "5": ""
    },
    "是否为SAE/ SAE标准/符合严重程度标准的时间^^Was the adverse event serious/SAE serious criteria/Time of Event Becoming Serious": {
        "0": "",
        "1": "是/2/YYYY-MM-DDTHH:MM^^Yes/2/ YYYY-MM-DDTHH:MM",
        "2": "否^^No",
        "3": "是/2/YYYY-MM-DDTHH:MM^^Yes/2/ YYYY-MM-DDTHH:MM",
        "4": "是/2/YYYY-MM-DDTHH:MM^^Yes/2/ YYYY-MM-DDTHH:MM",
        "5": "……"
    },
    "AE转归^^Outcome": {
        "0": "",
        "1": "恢复/痊愈^^Recovered/Resolved",
        "2": "恢复/痊愈伴有后遗症^^Recovered/Resolved With Sequel",
        "3": "好转/缓解^^Recovering/Resolving",
        "4": "死亡/死亡日期：{yyyy}-{MM}\n{dd}^^Death/Date of death: {yyyy}-{MM}-{dd}",
        "5": "……"
    },
    "受试者是否因此不良事件而 退出试验^^Did the adverse event cause the subject to be discontinued from the study": {
        "0": "",
        "1": "是^^Yes",
        "2": "是^^Yes",
        "3": "否^^No",
        "4": "否^^No",
        "5": ""
    }
}
```
1247 AE：不良事件；SAE：严重不良事件^^AE: Adverse Event; SAE: Serious AE
1248 SAE标准：1=致死，2=危及生命，3=需住院治疗或延长住院时间，4=导致持续或严重的残疾/失能，5=母亲暴露于研究药物后所生的新生儿/婴儿有先天性异常/出生缺陷，6=研究者判断有重大意义的医学事件^^SAE serious criteria: 1=Death, 2=Life threatening, 3= Requires or prolongs hospitalization, 4= Causing sustained or severe disability or incapacity, 5= Newborns/infants born to mothers exposed to study drugs had congenital anomalies/birth defects, 6= Researchers determine significant medical events
1249 不良事件采用&MedDRA.进行编码^^AE is Encoded by &MedDRA..
1250 SOC：系统器官分类，PT：首选术语^^SOC: System Organ Class; PT: Preferred Term.
1252 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1255 编程说明：
1256 编程时根据实际字典及版本替换脚注中“&MedDRA.”内容
1258 实验室检查列表^^Listing of Clinical Laboratory Tests
1259 血常规检查^^Hematology Test
安全性分析集^^Safety Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "",
        "3": "",
        "4": "xxx",
        "5": "",
        "6": "xxx",
        "7": "",
        "8": "xxx",
        "9": "……"
    },
    "访视*^^Visit*": {
        "0": "",
        "1": "x",
        "2": "",
        "3": "",
        "4": "x.x",
        "5": "",
        "6": "x.x",
        "7": "",
        "8": "x",
        "9": ""
    },
    "是否进行血常规检查/未查原因^^Was hematology test performed/ Reason": {
        "0": "",
        "1": "是^^Yes",
        "2": "",
        "3": "",
        "4": "是^^Yes",
        "5": "",
        "6": "是^^Yes",
        "7": "",
        "8": "否/xxxx^^No/xxxx",
        "9": ""
    },
    "采样日期^^Date of Sampling": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "",
        "3": "",
        "4": "YYYY-MM-DD",
        "5": "",
        "6": "YYYY-MM-DD",
        "7": "",
        "8": "",
        "9": ""
    },
    "项目 (单位)^^Test Name (Unit)": {
        "0": "",
        "1": "白细胞计数 (单位)^^White blood cells (Unit)",
        "2": "淋巴细胞计数 (单位)^^Lymphocyte count (Unit)",
        "3": "……",
        "4": "白细胞计数 (单位)^^White blood cells (Unit)",
        "5": "……",
        "6": "白细胞计数 (单位)^^White blood cells (Unit)",
        "7": "……",
        "8": "",
        "9": "……"
    },
    "结果^^Result": {
        "0": "",
        "1": "xx.x",
        "2": "xx.x",
        "3": "……",
        "4": "xx.x",
        "5": "……",
        "6": "xx.x",
        "7": "……",
        "8": "",
        "9": "……"
    },
    "临床意义判定^^Clinical Significance": {
        "0": "",
        "1": "正常^^Normal",
        "2": "异常无临床意义^^Abnormal, not clinically significant",
        "3": "……",
        "4": "异常有临床意义^^Abnormal, clinically significant",
        "5": "……",
        "6": "正常^^Normal",
        "7": "……",
        "8": "",
        "9": "……"
    }
}
```
1261 *：非整数访视为计划外访视^^*: Non-integer visits are considered as unscheduled visits.
1263 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1266 编程说明：
1267 使用血常规指标，检查指标有单位需带上单位
1268 编程人员需在编程过程中补齐访视脚注，如“*：非整数访视为计划外访视，1=筛选期 (D-7~D-2)，2=入住 (D-2)，…….”
1270 尿常规检查^^Urinalysis Test
安全性分析集^^Safety Set
1271 *：非整数访视为计划外访视^^*: Non-integer visits are considered as unscheduled visits.
1273 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1276 编程说明：^^Programming Note:
1277 按照列表16.2.8-1.1的结构生成此表^^Use the same shell with 16.2.8-1.1
1278 使用尿常规指标，检查指标有单位需带上单位
1279 编程人员需在编程过程中补齐访视脚注，如“*：非整数访视为计划外访视，1=筛选期 (D-7~D-2)，2=入住 (D-2)，…….”
1282 血生化检查^^Blood ChemistryTest
安全性分析集^^Safety Set
1283 *：非整数访视为计划外访视^^*: Non-integer visits are considered as unscheduled visits.
1285 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1288 编程说明：^^Programming Note:
1289 按照列表16.2.8-1.1的结构生成此表^^Use the same shell with 16.2.8-1.1
1290 使用血生化指标，检查指标有单位需带上单位
1291 编程人员需在编程过程中补齐访视脚注，如“*：非整数访视为计划外访视，1=筛选期 (D-7~D-2)，2=入住 (D-2)，…….”
1294 凝血功能检查^^Coagulation Test
安全性分析集^^Safety Set
1295 *：非整数访视为计划外访视^^*: Non-integer visits are considered as unscheduled visits.
1297 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1300 编程说明：^^Programming Note:
1301 按照列表16.2.8-1.1的表结构生成此表^^Use the same shell with 16.2.8-1.1
1302 使用凝血功能指标，检查指标有单位需带上单位
1303 编程人员需在编程过程中补齐访视脚注，如“*：非整数访视为计划外访视，1=筛选期 (D-7~D-2)，2=入住 (D-2)，…….”
1306 便常规+隐血检查^^Stool Routine and Occult Blood Test
安全性分析集^^Safety Set
1307 *：非整数访视为计划外访视^^*: Non-integer visits are considered as unscheduled visits.
1309 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1312 编程说明：^^Programming Note:
1313 按照列表16.2.8-1.1的表结构生成此表^^Use the same shell with 16.2.8-1.1
1314 使用便常规+隐血检查指标，检查指标有单位需带上单位
1315 编程人员需在编程过程中补齐访视脚注，如“*：非整数访视为计划外访视，1=筛选期 (D-7~D-2)，2=入住 (D-2)，…….”
1317 实验室检查指标临床意义变化^^Change of Clinical Significance of Laboratory Tests
安全性分析集^^Safety Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "",
        "7": "xxx",
        "8": "……"
    },
    "项目^^Test Name": {
        "0": "",
        "1": "血常规^^Hematology",
        "2": "",
        "3": "",
        "4": "",
        "5": "尿常规^^ Urinalysis",
        "6": "……",
        "7": "血生化^^Blood chemistry",
        "8": "……"
    },
    "实验室指标 (单位)^^Laboratory Indicators (Unit)": {
        "0": "",
        "1": "白细胞计数 (xx)^^white blood cells (xx)",
        "2": "红细胞计数 (xx)^^red blood cells (xx)",
        "3": "……",
        "4": "",
        "5": "尿蛋白质 (xx)^^urine protein (xx)",
        "6": "……",
        "7": "钾 (xxx)^^potassium (xxx)",
        "8": "……"
    },
    "基线结果^^Result of Baseline": {
        "0": "",
        "1": "xx.x",
        "2": "xx.x",
        "3": "……",
        "4": "",
        "5": "xx.x",
        "6": "……",
        "7": "xx.x",
        "8": "……"
    },
    "基线临床意义判定^^Clinical Significance of Baseline": {
        "0": "",
        "1": "正常^^Normal",
        "2": "正常^^Normal",
        "3": "……",
        "4": "",
        "5": "正常^^Normal",
        "6": "……",
        "7": "异常无临床意义^^Abnormal, not clinically significant",
        "8": "……"
    },
    "样本采集结束/提前出组临床意义判定^^Clinical Significance of End of Sample Collections/ Early Withdrawal": {
        "0": "",
        "1": "异常有临床意义^^Abnormal, clinically significant",
        "2": "异常有临床意义^^Abnormal, clinically significant",
        "3": "……",
        "4": "",
        "5": "异常有临床意义^^Abnormal, clinically significant",
        "6": "……",
        "7": "异常有临床意义^^Abnormal, clinically significant",
        "8": "……"
    }
}
```
1319 列表仅显示以下两种情况：基线的临床意义判定为正常，但样本采集结束/提前出组的临床意义判定为异常有临床意义的受试者；基线的临床意义判定为异常无临床意义，但样本采集结束/提前出组的临床意义判定为异常有临床意义的受试者。^^The list will only show the following two conditions: subjects whose clinical significance of baseline is normal but clinical significance of sample collection / early withdrawal is abnormal, clinically significant; clinical significance of baseline is abnormal, not clinically significant but clinical significance of sample collection / earl withdrawal is abnormal, clinically significant.
1321 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1324 12导联心电图^^12-Lead ECG
安全性分析集^^Safety Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "",
        "7": "",
        "8": "xxx",
        "9": "",
        "10": "xxx",
        "11": "……"
    },
    "访视*^^Visit*": {
        "0": "",
        "1": "x",
        "2": "x.x",
        "3": "x.x",
        "4": "x",
        "5": "x",
        "6": "x",
        "7": "……",
        "8": "x",
        "9": "x.x",
        "10": "x",
        "11": "……"
    },
    "计划时间点^^Planned Time Point": {
        "0": "",
        "1": "",
        "2": "给药前1h内^^1 hour pre-dose",
        "3": "给药后6h^^6 hours post-dose",
        "4": "",
        "5": "",
        "6": "",
        "7": "",
        "8": "给药前1h内^^1 hour pre-dose",
        "9": "",
        "10": "",
        "11": ""
    },
    "是否进行\n12导联\n心电图检查/未查原因^Was the 12-Lead ECG examination performed/Reason": {
        "0": "",
        "1": "是^^Yes",
        "2": "是^^Yes",
        "3": "是^^Yes",
        "4": "是^^Yes",
        "5": "是^^Yes",
        "6": "是^^Yes",
        "7": "……",
        "8": "是^^Yes",
        "9": "是^^Yes",
        "10": "否/xxx^^No/xxx",
        "11": ""
    },
    "检查时间^^Date of examination": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "YYYY-MM-DD",
        "3": "YYYY-MM-DD",
        "4": "YYYY-MM-DD",
        "5": "YYYY-MM-DD",
        "6": "YYYY-MM-DD",
        "7": "……",
        "8": "YYYY-MM-DD",
        "9": "YYYY-MM-DD",
        "10": "",
        "11": "……"
    },
    "心率\n(次/分)^^Heart Rate\n(Bpm)": {
        "0": "",
        "1": "xx.xx",
        "2": "xx.xx",
        "3": "xx.xx",
        "4": "xx.xx",
        "5": "xx.xx",
        "6": "xx.xx",
        "7": "……",
        "8": "xx.xx",
        "9": "xx.xx",
        "10": "",
        "11": "……"
    },
    "结果判定^^Result": {
        "0": "",
        "1": "正常^^Normal",
        "2": "异常无临床意义^^Abnormal, not clinically significant",
        "3": "异常有临床意义^^Abnormal, clinically significant",
        "4": "正常^^Normal",
        "5": "正常^^Normal",
        "6": "异常有临床意义^^Abnormal, clinically significant",
        "7": "……",
        "8": "正常^^Normal",
        "9": "正常^^Normal",
        "10": "",
        "11": "……"
    },
    "异常描述^^Abnormal Description": {
        "0": "",
        "1": "",
        "2": "xxx",
        "3": "xxx",
        "4": "",
        "5": "",
        "6": "xxx",
        "7": "……",
        "8": "",
        "9": "",
        "10": "",
        "11": "……"
    }
}
```
1326 *：非整数访视为计划外访视^^*: Non-integer visits are considered as unscheduled visits.
1328 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1331 编程说明：
1332 编程人员需在编程过程中补齐访视脚注，如“*：非整数访视为计划外访视，1=筛选期 (D-7~D-2)，2=入住 (D-2)，…….”。
1334 12导联心电图临床意义变化^^Change of Clinical Significance of 12-Lead ECG
安全性分析集^^Safety Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "……",
        "4": "xxx",
        "5": "xxx",
        "6": "xxx",
        "7": "……"
    },
    "基线临床意义判定^^Baseline Clinical significance": {
        "0": "",
        "1": "正常^^Normal",
        "2": "正常^^Normal",
        "3": "……",
        "4": "",
        "5": "正常^^Normal",
        "6": "异常无临床意义^^Abnormal, not clinically significant",
        "7": "……"
    },
    "样本采集结束/提前出组临床意义判定^^Clinical Significance of End of Sample Collections/ Early Withdrawal": {
        "0": "",
        "1": "异常有临床意义^^Abnormal, clinically significant",
        "2": "异常有临床意义^^Abnormal, clinically significant",
        "3": "……",
        "4": "",
        "5": "异常有临床意义^^Abnormal, clinically significant",
        "6": "异常有临床意义^^Abnormal, clinically significant",
        "7": "……"
    }
}
```
1336 列表仅显示以下两种情况：基线的临床意义判定为正常，但样本采集结束/提前出组的临床意义判定为异常有临床意义的受试者；基线的临床意义判定为异常无临床意义，但样本采集结束/提前出组的临床意义判定为异常有临床意义的受试者。^^The list will only show the following two conditions: subjects whose clinical significance of baseline is normal but clinical significance of sample collection / early withdrawal is abnormal, clinically significant; clinical significance of baseline is abnormal, not clinically significant but clinical significance of sample collection / early withdrawal is abnormal, clinically significant.
1338 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1341 生命体征^^Vital Signs
安全性分析集^^Safety Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "",
        "7": "",
        "8": "",
        "9": "",
        "10": "",
        "11": "",
        "12": "",
        "13": "",
        "14": "xxx",
        "15": "……"
    },
    "访视*^^Visit*": {
        "0": "",
        "1": "x",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "……",
        "7": "x",
        "8": "",
        "9": "",
        "10": "",
        "11": "",
        "12": "x",
        "13": "",
        "14": "x",
        "15": "……"
    },
    "计划时间点": {
        "0": "",
        "1": "",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "",
        "7": "给药前1h内^^1 hour pre-dose",
        "8": "",
        "9": "给药后6h^^6 hours post-dose",
        "10": "",
        "11": "",
        "12": "给药前1h内^^1 hour pre-dose",
        "13": "",
        "14": "",
        "15": "……"
    },
    "是否进行生命体征检查/未查原因^^Was vital signs examination performed/Reason": {
        "0": "",
        "1": "是^^Yes",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "",
        "7": "是^^Yes",
        "8": "",
        "9": "",
        "10": "",
        "11": "",
        "12": "是^^Yes",
        "13": "",
        "14": "否/xxx^^No/xxx",
        "15": "……"
    },
    "检查时间^^Time of examination": {
        "0": "",
        "1": "YYYY-MM-DDTHH:MM",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "……",
        "7": "YYYY-MM-DDTHH:MM",
        "8": "……",
        "9": "YYYY-MM-DDTHH:MM",
        "10": "……",
        "11": "",
        "12": "YYYY-MM-DDTHH:MM",
        "13": "……",
        "14": "",
        "15": "……"
    },
    "项目 (单位)^^Test Name (Unit)": {
        "0": "",
        "1": "耳温(℃)^^Ear temperature (℃)",
        "2": "收缩压 (mmHg)^^Systolic Blood Pressure (mmHg)",
        "3": "舒张压 (mmHg)^^Diastolic Blood Pressure (mmHg)",
        "4": "脉搏 (次/分)^^Pulse (Bpm)",
        "5": "呼吸 (次/分)^^Breathe (Bpm)",
        "6": "……",
        "7": "体温 (℃)^^Temperature (℃)",
        "8": "……",
        "9": "体温 (℃)^^Temperature (℃)",
        "10": "……",
        "11": "",
        "12": "体温 (℃)^^Temperature (℃)",
        "13": "……",
        "14": "",
        "15": "……"
    },
    "结果^^Result": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "xxx",
        "5": "xxx",
        "6": "……",
        "7": "xxx",
        "8": "…",
        "9": "xxx",
        "10": "……",
        "11": "",
        "12": "xxx",
        "13": "……",
        "14": "",
        "15": "……"
    },
    "临床意义判定^^Clinical Significance": {
        "0": "",
        "1": "正常^^Normal",
        "2": "异常无临床意义^^Abnormal, not clinically significant",
        "3": "异常无临床意义^^Abnormal, not clinically significant",
        "4": "异常有临床意义^^Abnormal, clinically significant",
        "5": "异常有临床意义^^Abnormal, clinically significant",
        "6": "……",
        "7": "正常^^Normal",
        "8": "……",
        "9": "正常^^Normal",
        "10": "……",
        "11": "",
        "12": "正常^^Normal",
        "13": "……",
        "14": "",
        "15": "……"
    }
}
```
1343 *：非整数访视为计划外访视^^*: Non-integer visits are considered as unscheduled visits.
1345 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1348 编程说明：
1349 生命体征检查计划时间点为筛选期、入住（D-2）、基线（D-1）、给药前1 h内及给药后6 h、24 h、48 h、72 h、96 h、 120 h、144 h、168 h、192 h、216 h、240 h、264 h、288 h、312 h、336 h、360 h、384 h、408 h、432 h、456 h、480 h、504 h 进行，测定时间窗为±30 min；若研究时间需延长 超过504 h，则后续仍然需要每天测量一次生命体征。如有新增检查时间点，请编程时同步更新
1350 使用生命体征指标，检查指标有单位需带上单位
1351 编程人员需在编程过程中补齐访视脚注，如“*：非整数访视为计划外访视，1=筛选期 (D-7~D-2)，2=入住 (D-2)，…….”
1353 生命体征检查临床意义变化^^Change of Clinical Significance of Vital Signs
安全性分析集^^Safety Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "xxx",
        "7": "……"
    },
    "项目 (单位)^^Test Name (Unit)": {
        "0": "",
        "1": "耳温 (℃)^^Ear temperature (℃)",
        "2": "收缩压 (mmHg)^^Systolic Blood Pressure (mmHg)",
        "3": "舒张压 (mmHg)^^Diastolic Blood Pressure (mmHg)",
        "4": "脉搏 (次/分)^^Pulse (Bpm)",
        "5": "呼吸 (次/分)^^Breathe (Bpm)",
        "6": "体温 (℃)^^Temperature (℃)",
        "7": "……"
    },
    "基线结果^^Result of Baseline": {
        "0": "",
        "1": "xx.x",
        "2": "xx.x",
        "3": "xx.x",
        "4": "xx.x",
        "5": "xx.x",
        "6": "xx.x",
        "7": "……"
    },
    "基线临床意义判定^^Clinical Significance of Baseline": {
        "0": "",
        "1": "正常^^Normal",
        "2": "正常^^Normal",
        "3": "……",
        "4": "",
        "5": "正常^^Normal",
        "6": "异常无临床意义^^Abnormal, not clinically significant",
        "7": "……"
    },
    "样本采集结束/提前出组临床意义判定^^Clinical Significance of End of Sample Collections/ Early Withdrawal": {
        "0": "",
        "1": "异常有临床意义^^Abnormal, clinically significant",
        "2": "异常有临床意义^^Abnormal, clinically significant",
        "3": "异常有临床意义^^Abnormal, clinically significant",
        "4": "异常有临床意义^^Abnormal, clinically significant",
        "5": "异常有临床意义^^Abnormal, clinically significant",
        "6": "异常有临床意义^^Abnormal, clinically significant",
        "7": "……"
    }
}
```
1355 列表仅显示以下两种情况：基线的临床意义判定为正常，但样本采集结束/提前出组的临床意义判定为异常有临床意义的受试者；基线的临床意义判定为异常无临床意义，但样本采集结束/提前出组的临床意义判定为异常有临床意义的受试者。^^The list will only show the following two conditions: subjects whose clinical significance of baseline is normal but clinical significance of sample collection / early withdrawal is abnormal, clinically significant; clinical significance of baseline is abnormal, not clinically significant but clinical significance of sample collection / early withdrawal is abnormal, clinically significant.
1357 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1360 体格检查^^Physical Examination
安全性分析集^^Safety Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "",
        "7": "",
        "8": "",
        "9": "",
        "10": "",
        "11": "",
        "12": "",
        "13": "",
        "14": "",
        "15": "",
        "16": "",
        "17": "xxx",
        "18": "",
        "19": "",
        "20": "",
        "21": "",
        "22": "",
        "23": "……"
    },
    "访视*^^Visit*": {
        "0": "",
        "1": "x",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "",
        "7": "",
        "8": "",
        "9": "",
        "10": "",
        "11": "",
        "12": "x.x",
        "13": "",
        "14": "",
        "15": "",
        "16": "……",
        "17": "x",
        "18": "x.x",
        "19": "x.x",
        "20": "",
        "21": "",
        "22": "",
        "23": "……"
    },
    "是否进行体格检查/未查原因？^^Was physical examination performed/Result": {
        "0": "",
        "1": "是^^Yes",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "",
        "7": "",
        "8": "",
        "9": "",
        "10": "",
        "11": "",
        "12": "是^^Yes",
        "13": "",
        "14": "",
        "15": "",
        "16": "……",
        "17": "否/xxx^^No/xxx",
        "18": "否/xxx^^No/xxx",
        "19": "是^^Yes",
        "20": "",
        "21": "",
        "22": "",
        "23": "……"
    },
    "检查日期^^Date of Examination": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "",
        "7": "",
        "8": "",
        "9": "",
        "10": "",
        "11": "",
        "12": "YYYY-MM-DD",
        "13": "",
        "14": "",
        "15": "",
        "16": "……",
        "17": "",
        "18": "",
        "19": "YYYY-MM-DD",
        "20": "",
        "21": "",
        "22": "",
        "23": "……"
    },
    "项目^^Test Name": {
        "0": "",
        "1": "皮肤^^Skin",
        "2": "黏膜^^Mucous",
        "3": "淋巴结^^Lymph nodes",
        "4": "头颈部^^Head and neck",
        "5": "胸部^^Chest",
        "6": "腹部^^Abdomen",
        "7": "肌肉骨骼^^Musculoskeletal",
        "8": "神经系统^^Nervous system",
        "9": "脊柱^^Spine",
        "10": "四肢^^Limbs",
        "11": "其他^^Other",
        "12": "皮肤^^Skin",
        "13": "黏膜^^Mucous",
        "14": "淋巴结^^Lymph nodes",
        "15": "头颈部^^Head and neck",
        "16": "……",
        "17": "",
        "18": "",
        "19": "皮肤^^Skin",
        "20": "黏膜^^Mucous",
        "21": "淋巴结^^Lymph nodes",
        "22": "头颈部^^Head and neck",
        "23": "……"
    },
    "临床意义判定^^Clinical Significance": {
        "0": "",
        "1": "正常^^Normal",
        "2": "异常有临床意义^^Abnormal, clinically significant",
        "3": "异常有临床意义^^Abnormal, clinically significant",
        "4": "正常^^Normal",
        "5": "异常无临床意义^^Abnormal, not clinically significant",
        "6": "正常^^Normal",
        "7": "正常^^Normal",
        "8": "异常无临床意义^^Abnormal, not clinically significant",
        "9": "正常^^Normal",
        "10": "正常^^Normal",
        "11": "异常无临床意义^^Abnormal, not clinically significant",
        "12": "正常^^Normal",
        "13": "异常无临床意义^^Abnormal, not clinically significant",
        "14": "异常无临床意义^^Abnormal, not clinically significant",
        "15": "未查",
        "16": "……",
        "17": "",
        "18": "",
        "19": "正常^^Normal",
        "20": "异常无临床意义^^Abnormal, not clinically significant",
        "21": "异常有临床意义^^Abnormal, clinically significant",
        "22": "未查",
        "23": "……"
    },
    "异常描述^^Abnormal Description": {
        "0": "",
        "1": "",
        "2": "xxxxxx",
        "3": "xxxxxx",
        "4": "",
        "5": "xxxxxx",
        "6": "",
        "7": "",
        "8": "xxxxxx",
        "9": "",
        "10": "",
        "11": "xxxxxx",
        "12": "",
        "13": "xxxxxx",
        "14": "xxxxxx",
        "15": "",
        "16": "",
        "17": "",
        "18": "",
        "19": "",
        "20": "xxxxxx",
        "21": "xxxxxx",
        "22": "",
        "23": "……"
    }
}
```
1362 *：非整数访视为计划外访视^^*: Non-integer visits are considered as unscheduled visits.
1364 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1367 编程说明：
1368 编程人员需在编程过程中补齐访视脚注，如“*：非整数访视为计划外访视，1=筛选期 (D-7~D-2)，2=入住 (D-2)，…….”
1370 体格检查临床意义变化^^Change of Clinical Significance of Physical Examination
安全性分析集^^Safety Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "",
        "7": "……"
    },
    "项目^^Test Name": {
        "0": "",
        "1": "皮肤^^Skin",
        "2": "黏膜^^Mucous",
        "3": "淋巴结^^Lymph nodes",
        "4": "头颈部^^Head and neck",
        "5": "胸部^^Chest",
        "6": "腹部^^Abdomen",
        "7": "……"
    },
    "基线临床意义判定^^Baseline Clinical Significance": {
        "0": "",
        "1": "正常^^Normal",
        "2": "正常^^Normal",
        "3": "……",
        "4": "",
        "5": "正常^^Normal",
        "6": "异常无临床意义^^Abnormal, not clinically significant",
        "7": "……"
    },
    "样本采集结束/提前出组临床意义判定^^Clinical Significance of End of Sample Collection/Early Withdrawl": {
        "0": "",
        "1": "异常有临床意义^^Abnormal, clinically significant",
        "2": "异常有临床意义^^Abnormal, clinically significant",
        "3": "异常有临床意义^^Abnormal, clinically significant",
        "4": "异常有临床意义^^Abnormal, clinically significant",
        "5": "异常有临床意义^^Abnormal, clinically significant",
        "6": "异常有临床意义^^Abnormal, clinically significant",
        "7": "……"
    }
}
```
1372 列表仅显示以下两种情况：基线的临床意义判定为正常，但样本采集结束/提前出组的临床意义判定为异常有临床意义的受试者；基线的临床意义判定为异常无临床意义，但样本采集结束/提前出组的临床意义判定为异常有临床意义的受试者。^^The list will only show the following two conditions: subjects whose clinical significance of baseline is normal but clinical significance of sample collection / early withdrawal is abnormal, clinically significant; clinical significance of baseline is abnormal, not clinically significant but clinical significance of sample collection / early withdrawal is abnormal, clinically significant.
1374 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1377 其他检查^^Other Test
安全性分析集^^Safety Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "xxx",
        "4": "……"
    },
    "访视*^^Visit*": {
        "0": "",
        "1": "x.x",
        "2": "x.x",
        "3": "x.x",
        "4": "……"
    },
    "检查日期^^Date of Examination": {
        "0": "",
        "1": "YYYY-MM-DD",
        "2": "YYYY-MM-DD",
        "3": "YYYY-MM-DD",
        "4": ""
    },
    "项目^^Test Name": {
        "0": "",
        "1": "xxx",
        "2": "xxxx",
        "3": "xxxx",
        "4": "……"
    },
    "结果^^Result": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "",
        "4": "……"
    },
    "单位^^Unit": {
        "0": "",
        "1": "xxx",
        "2": "xxx",
        "3": "",
        "4": ""
    },
    "正常值范围^^Normal Range": {
        "0": "",
        "1": "",
        "2": "",
        "3": "",
        "4": ""
    },
    "临床意义判定^^Clinical Significance": {
        "0": "",
        "1": "正常^^Normal",
        "2": "异常无临床意义^^Abnormal, not clinically significant",
        "3": "异常有临床意义^^Abnormal, clinically significant",
        "4": "……"
    }
}
```
1379 *：非整数访视为计划外访视^^*: Non-integer visits are considered as unscheduled visits.
1380 仅收集有其他检查的受试者信息^^Only subject information with other tests was collected.
1382 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1385 编程说明：
1386 编程人员需在编程过程中补齐访视脚注，如“*：非整数访视为计划外访视，1=筛选期 (D-7~D-2)，2=入住 (D-2)，…….”
1388 血药浓度和排泄数据^^Drug Concentration and Excretion Data
1389 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆总放射性数据^^The Total Radioactivity Data in Plasma following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
PK浓度集^^PK Concentration Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "R001",
        "1": "",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "……",
        "7": ""
    },
    "计划采血点^^Planned Blood Collection Points": {
        "0": "用药前1h^^1 hour pre-dose",
        "1": "用药后1h^^1 hour post-dose",
        "2": "……",
        "3": "用药后144h^^144 hour post-dose",
        "4": "用药后168h^^^^168 hour post-dose",
        "5": "",
        "6": "……",
        "7": ""
    },
    "给药开始日期^^Dosing Start Date\n/时间^^/Time": {
        "0": "YYYY-MM-DD",
        "1": "YYYY-MM-DD",
        "2": "……",
        "3": "YYYY-MM-DD",
        "4": "YYYY-MM-DD",
        "5": "",
        "6": "……",
        "7": ""
    },
    "实际采血点 (h)^^Actual Blood Collection Points (h)": {
        "0": "0",
        "1": "-0.0xxx",
        "2": "……",
        "3": "",
        "4": "",
        "5": "",
        "6": "……",
        "7": ""
    },
    "是否超窗^^Out of Visit Window or Not": {
        "0": "否^^No",
        "1": "是^^Yes",
        "2": "……",
        "3": "x",
        "4": "x",
        "5": "",
        "6": "……",
        "7": ""
    },
    "血浆总放射性浓度^^Total Radioactivity in Plasma\n(ng Eq./mL)": {
        "0": "BLQ",
        "1": "BLQ",
        "2": "……",
        "3": "xxxx",
        "4": "xxxx",
        "5": "",
        "6": "……",
        "7": ""
    },
    "LLOQ\n(ng Eq./mL)": {
        "0": "xx.xx",
        "1": "xx.xx",
        "2": "……",
        "3": "xx.xx",
        "4": "xx.xx",
        "5": "",
        "6": "……",
        "7": ""
    }
}
```
1391 BLQ：低于放射性定量下限^^BLQ: below the lower limit of quantitation of radioactivity.
1392 NS：无样品，未收集。^^NS: No sample, no collection. 
1394 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1396 编程说明：
1397 展示到所有受试者中最长的采集时间点；当某时间段未采集时，浓度数据展示为“NS”，LLOQ及ULOQ展示为空。
1399 6例受试者单次口服约150mg/200µCi的[14C]AP306后全血总放射性数据^^The Total Radioactivity Data in Whole Blood following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
PK浓度集^^PK Concentration Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "R001",
        "1": "",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "……",
        "7": ""
    },
    "计划采血点^^Planned Blood Collection Points": {
        "0": "用药前1h^^1 hour pre-dose",
        "1": "用药后2h^^2 hours post-dose",
        "2": "……",
        "3": "用药后144h^^144 hours pose-dose",
        "4": "用药后168h^^168 hours post-dose",
        "5": "",
        "6": "……",
        "7": ""
    },
    "给药开始日期^^Dosing Start Date\n/时间^^/Time": {
        "0": "YYYY-MM-DD\nTHH:MM",
        "1": "YYYY-MM-DD\nTHH:MM",
        "2": "……",
        "3": "YYYY-MM-DD\nTHH:MM",
        "4": "YYYY-MM-DD\nTHH:MM",
        "5": "",
        "6": "……",
        "7": ""
    },
    "实际采血点 (h)^^Actual Blood Collection Points (h)": {
        "0": "0",
        "1": "-0.0xxx",
        "2": "……",
        "3": "",
        "4": "",
        "5": "",
        "6": "……",
        "7": ""
    },
    "是否超窗^^Out of Visit Window or Not": {
        "0": "否^^No",
        "1": "是^^Yes",
        "2": "……",
        "3": "x",
        "4": "x",
        "5": "",
        "6": "……",
        "7": ""
    },
    "全血总放射性浓度^^Total Radioactivity in Whole Blood\n(ng Eq./mL)": {
        "0": "BLQ",
        "1": "BLQ",
        "2": "……",
        "3": "xxxx",
        "4": "xxxx",
        "5": "",
        "6": "……",
        "7": ""
    },
    "LLOQ\n(ng Eq./mL)": {
        "0": "xx.xx",
        "1": "xx.xx",
        "2": "……",
        "3": "xx.xx",
        "4": "xx.xx",
        "5": "",
        "6": "……",
        "7": ""
    }
}
```
1401  BLQ：低于放射性定量下限^^BLQ: below the lower limit of quantitation of radioactivity.
1402 NS：无样品，未收集。^^NS: No sample, no collection. 
1404 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1406 编程说明：
1407 展示到所有受试者中最长的采集时间点；当某时间段未采集时，浓度数据展示为“NS”，LLOQ及ULOQ展示为空。
1409 6例受试者单次口服约150mg/200µCi的[14C]AP306后血浆中原形药AP306数据^^The Unchanged AP306 Data in Plasma following a Single Oral Dose of [14C]AP306 in 6 Subjects at 150 mg/200 µCi
PK浓度集^^PK Concentration Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "R001",
        "1": "",
        "2": "",
        "3": "",
        "4": "",
        "5": "",
        "6": "",
        "7": "……"
    },
    "计划采血点^^Planned Blood Collection Points": {
        "0": "用药前1h^^1 hour pre-dose",
        "1": "用药后1h^^1 hour post-dose",
        "2": "用药后2h^^2 hours post-dose",
        "3": "……",
        "4": "用药后120h^^120 hours pose-dose",
        "5": "用药后144h^^144 hours pose-dose",
        "6": "用药后168h^^168 hours post-dose",
        "7": "……"
    },
    "给药开始日期^^Dosing Start Date\n/时间^^/Time": {
        "0": "YYYY-MM-DD\nTHH:MM",
        "1": "YYYY-MM-DD\nTHH:MM",
        "2": "YYYY-MM-DD\nTHH:MM",
        "3": "……",
        "4": "YYYY-MM-DD\nTHH:MM",
        "5": "YYYY-MM-DD\nTHH:MM",
        "6": "YYYY-MM-DD\nTHH:MM",
        "7": "……"
    },
    "实际采血点 (H)^^Actual Blood Collection Points (h)": {
        "0": "0",
        "1": "xx.xx",
        "2": "xx.xx",
        "3": "……",
        "4": "xx.xx",
        "5": "xx.xx",
        "6": "xx.xx",
        "7": "……"
    },
    "是否超窗^^Out of Visit Window or Not": {
        "0": "否^^No",
        "1": "是^^Yes",
        "2": "否^^No",
        "3": "……",
        "4": "否^^No",
        "5": "否^^No",
        "6": "否^^No",
        "7": "……"
    },
    "原形药AP306浓度^^Unchanged AP306\n(ng/mL)": {
        "0": "BLQ",
        "1": "BLQ",
        "2": "xx.xx",
        "3": "……",
        "4": "BLQ",
        "5": "BLQ",
        "6": "BLQ",
        "7": "……"
    },
    "LLOQ\n (ng/mL)": {
        "0": "xx.xx",
        "1": "xx.xx",
        "2": "……",
        "3": "xx.xx",
        "4": "xx.xx",
        "5": "xx.xx",
        "6": "xx.xx",
        "7": "……"
    }
}
```
1411 BLQ：低于定量下限^^BLQ: below the lower limit of quantification.
1412 NS：无样品，未收集。^^NS: No sample, no collection. 
1414 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1416 编程说明：
1417 展示到所有受试者中最长的采集时间点；当某时间段未采集时，浓度数据展示为“NS”，LLOQ及ULOQ展示为空。
1419 受试者R001单次口服约150mg/200µCi的[14C]AP306后尿液中的回收率数据^^Excretion Data in Urine following a Single Oral Dose of [14C]AP306 in Subject R001 at 150 mg/200 µCi
物质平衡分析集^^Mass Balance Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "xxxx",
        "1": "xxxx",
        "2": "xxxx"
    }
}
```
1421 BLQ：低于放射性定量下限^^BLQ: below the lower limit of quantitation of radioactivity.
1422 NS：无样品，未收集。^^NS: No sample, no collection. 
1424 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
Don't know what object this is
1427 编程说明：
1428 当某时间段未采集时，放射性回收率及重量展示为“NS”，放射性给药量展示实际数值。
1429 展示到所有受试者中最后采集的计划时间段，如受试者1尿液采集到168h, 其他受试者尿液采集到192h, 则受试者1的168h~192h 尿液采集数值为“NS”，且所有受试者的尿液列表不显示192~216以及216~240两行内容。
1431 受试者R002单次口服约150mg/200µCi的[14C]AP306后尿液中的回收率数据^^Excretion Data in Urine following a Single Oral Dose of [14C]AP306 in Subject R002 at 150 mg/200 µCi
物质平衡分析集^^Mass Balance Set
1432 BLQ：低于定量下限^^BLQ: below the lower limit of quantification.
1433 NS：无样品，未收集。^^NS: No sample, no collection. 
1434 . 
1436 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1439 编程说明：^^Programming Note:
1440 按照列表 16.2.9-3.1的表结构生成此列表^^Use the same shell with 列表 16.2.9-3.1
1442 当某时间段未采集时，放射性回收率及重量展示为“NS”，放射性给药量展示实际数值。
1443 展示到所有受试者中最后采集的计划时间段，如受试者1尿液采集到168h, 其他受试者尿液采集到192h, 则受试者1的168h~192h 尿液采集数值为“NS”，且所有受试者的尿液列表不显示192~216以及216~240两行内容。
1446 受试者R003单次口服约150mg/200µCi的[14C]AP306后尿液中的回收率数据^^Excretion Data in Urine following a Single Oral Dose of [14C]AP306 in Subject R003 at 150 mg/200 µCi
物质平衡分析集^^Mass Balance Set
1447 BLQ：低于放射性定量下限^^BLQ: below the lower limit of quantitation of radioactivity.
1448 NS：无样品，未收集。^^NS: No sample, no collection. 
1450 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1452 编程说明：^^Programming Note:
1453 按照列表 16.2.9-3.1的表结构生成此列表^^Use the same shell with 列表 16.2.9-3.1
1454 当某时间段未采集时，放射性回收率及重量展示为“NS”，放射性给药量展示实际数值。
1455 展示到所有受试者中最后采集的计划时间段，如受试者1尿液采集到168h, 其他受试者尿液采集到192h, 则受试者1的168h~192h 尿液采集数值为“NS”，且所有受试者的尿液列表不显示192~216以及216~240两行内容。
1457 受试者R004单次口服约150mg/200µCi的[14C]AP306后尿液中的回收率数据^^Excretion Data in Urine following a Single Oral Dose of [14C]AP306 in Subject R004 at 150 mg/200 µCi
物质平衡分析集^^Mass Balance Set
1458 BLQ：低于放射性定量下限^^BLQ: below the lower limit of quantitation of radioactivity.
1459 NS：无样品，未收集。^^NS: No sample, no collection. 
1461 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1464 编程说明：^^Programming Note:
1465 按照列表 16.2.9-3.1的表结构生成此列表^^Use the same shell with 列表 16.2.9-3.1
1466 当某时间段未采集时，放射性回收率及重量展示为“NS”，放射性给药量展示实际数值。
1467 展示到所有受试者中最后采集的计划时间段，如受试者1尿液采集到168h, 其他受试者尿液采集到192h, 则受试者1的168h~192h 尿液采集数值为“NS”，且所有受试者的尿液列表不显示192~216以及216~240两行内容。
1469 受试者R005单次口服约150mg/200µCi的[14C]AP306后尿液中的回收率数据^^Excretion Data in Urine following a Single Oral Dose of [14C]AP306 in Subject R005 at 150 mg/200 µCi
物质平衡分析集^^Mass Balance Set
1470 BLQ：低于放射性定量下限^^BLQ: below the lower limit of quantitation of radioactivity.
Don't know what object this is
1472 NS：无样品，未收集。^^NS: No sample, no collection. 
1474 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1477 编程说明：^^Programming Note:
1478 按照列表 16.2.9-3.1的表结构生成此列表^^Use the same shell with 列表 16.2.9-3.1
1479 展示所有计划时间段，当某时间段未采集时，放射性回收率及重量展示为“NS”，放射性给药量展示实际数值。
1481 受试者R006单次口服约150mg/200µCi的[14C]AP306后尿液中的回收率数据^^Excretion Data in Urine following a Single Oral Dose of [14C]AP306 in Subject R006 at 150 mg/200 µCi
物质平衡分析集^^Mass Balance Set
1482 BLQ：低于放射性定量下限^^BLQ: below the lower limit of quantitation of radioactivity.
1483 NS：无样品，未收集。^^NS: No sample, no collection. 
1485 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1487 编程说明：^^Programming Note:
1488 按照列表 16.2.9-3.1的表结构生成此列表^^Use the same shell with 列表 16.2.9-3.1
1489 当某时间段未采集时，放射性回收率及重量展示为“NS”，放射性给药量展示实际数值。
1490 展示到所有受试者中最后采集的计划时间段，如受试者1尿液采集到168h, 其他受试者尿液采集到192h, 则受试者1的168h~192h 尿液采集数值为“NS”，且所有受试者的尿液列表不显示192~216以及216~240两行内容。
1492 受试者R001单次口服约150mg/200µCi的[14C]AP306后粪便中的回收率数据^^Excretion Data in Feces following a Single Oral Dose of [14C]AP306 in Subject R001 at 150 mg/200 µCi
物质平衡分析集^^Mass Balance Set
```json
{
    "受试者编号^^Subject No.": {
        "0": "xxxx",
        "1": "xxxx",
        "2": "xxxx",
        "3": "xxxx"
    }
}
```
1494 BLQ：低于放射性定量下限^^BLQ: below the lower limit of quantitation of radioactivity.
1495 NS：无样品，未收集。^^NS: No sample, no collection. 
1497 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1499 编程说明：
1500 当某时间段未采集时，放射性回收率及重量展示为“NS”，放射性给药量展示实际数值。
1501 展示到所有受试者中最后采集的计划时间段，如受试者1粪便采集到168h, 其他受试者粪便采集到192h, 则受试者1的168h~192h 粪便采集数值为“NS”，且所有受试者的粪便列表不显示192~216以及216~240两行内容。
1503 受试者R002单次口服约150mg/200µCi的[14C]AP306后粪便中的回收率数据^^Excretion Data in Feces following a Single Oral Dose of [14C]AP306 in Subject R002 at 150 mg/200 µCi
物质平衡分析集^^Mass Balance Set
1504 BLQ：低于放射性定量下限^^BLQ: below the lower limit of quantitation of radioactivity.
1505 NS：无样品，未收集。^^NS: No sample, no collection. 
1507 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1510 编程说明：^^Programming Note:
1511 按照列表 16.2.9-4.1的表结构生成此列表^^Use the same shell with 列表 16.2.9-4.1
1512 当某时间段未采集时，放射性回收率及重量展示为“NS”，放射性给药量展示实际数值。
1513 展示到所有受试者中最后采集的计划时间段，如受试者1粪便采集到168h, 其他受试者粪便采集到192h, 则受试者1的168h~192h 粪便采集数值为“NS”，且所有受试者的粪便列表不显示192~216以及216~240两行内容。
1515 受试者R003单次口服约150mg/200µCi的[14C]AP306后粪便中的回收率数据^^Excretion Data in Feces following a Single Oral Dose of [14C]AP306 in Subject R003 at 150 mg/200 µCi
物质平衡分析集^^Mass Balance Set
1516 BLQ：低于放射性定量下限^^BLQ: below the lower limit of quantitation of radioactivity.
1517 NS：无样品，未收集。^^NS: No sample, no collection. 
1519 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1522 编程说明：^^Programming Note:
1523 按照列表 16.2.9-4.1的表结构生成此列表^^Use the same shell with 列表 16.2.9-4.1
1524 当某时间段未采集时，放射性回收率及重量展示为“NS”，放射性给药量展示实际数值。
1525 展示到所有受试者中最后采集的计划时间段，如受试者1粪便采集到168h, 其他受试者粪便采集到192h, 则受试者1的168h~192h 粪便采集数值为“NS”，且所有受试者的粪便列表不显示192~216以及216~240两行内容。
1527 受试者R004单次口服约150mg/200µCi的[14C]AP306后粪便中的回收率数据^^Excretion Data in Feces following a Single Oral Dose of [14C]AP306 in Subject R004 at 150 mg/200 µCi
物质平衡分析集^^Mass Balance Set
1528 BLQ：低于放射性定量下限^^BLQ: below the lower limit of quantitation of radioactivity.
1529 NS：无样品，未收集。^^NS: No sample, no collection. 
1531 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1534 编程说明：^^Programming Note:
1535 按照列表 16.2.9-4.1的表结构生成此列表^^Use the same shell with 列表 16.2.9-4.1
1536 当某时间段未采集时，放射性回收率及重量展示为“NS”，放射性给药量展示实际数值。
1537 展示到所有受试者中最后采集的计划时间段，如受试者1粪便采集到168h, 其他受试者粪便采集到192h, 则受试者1的168h~192h 粪便采集数值为“NS”，且所有受试者的粪便列表不显示192~216以及216~240两行内容。
1539 受试者R005单次口服约150mg/200µCi的[14C]AP306后粪便中的回收率数据^^Excretion Data in Feces following a Single Oral Dose of [14C]AP306 in Subject R005 at 150 mg/200 µCi
物质平衡分析集^^Mass Balance Set
1540 BLQ：低于放射性定量下限^^BLQ: below the lower limit of quantitation of radioactivity.
1541 NS：无样品，未收集。^^NS: No sample, no collection. 
1543 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1546 编程说明：^^Programming Note:
1547 按照列表 16.2.9-4.1的表结构生成此列表^^Use the same shell with 列表 16.2.9-4.1
1548 当某时间段未采集时，放射性回收率及重量展示为“NS”，放射性给药量展示实际数值。
1549 展示到所有受试者中最后采集的计划时间段，如受试者1粪便采集到168h, 其他受试者粪便采集到192h, 则受试者1的168h~192h 粪便采集数值为“NS”，且所有受试者的粪便列表不显示192~216以及216~240两行内容。
1551 受试者R006单次口服约150mg/200µCi的[14C]AP306后粪便中的回收率数据^^Excretion Data in Feces following a Single Oral Dose of [14C]AP306 in Subject R006 at 150 mg/200 µCi
物质平衡分析集^^Mass Balance Set
1552 BLQ：低于放射性定量下限^^BLQ: below the lower limit of quantitation of radioactivity.
1553 NS：无样品，未收集。^^NS: No sample, no collection. 
1555 <路径>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM^^<Path>/<XXX.SAS>                                                                                    draft YYYY-MM-DD HH:MM
1558 编程说明：^^Programming Note:
1559 按照列表 16.2.9-4.1的表结构生成此列表^^Use the same shell with 列表 16.2.9-4.1
Don't know what object this is
1561 当某时间段未采集时，放射性回收率及重量展示为“NS”，放射性给药量展示实际数值。
1562 展示到所有受试者中最后采集的计划时间段，如受试者1粪便采集到168h, 其他受试者粪便采集到192h, 则受试者1的168h~192h 粪便采集数值为“NS”，且所有受试者的粪便列表不显示192~216以及216~240两行内容。
Don't know what object this is
